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ABSTRACT 
This study aimed to identify factors affecting women’s utilisation of the prevention of 
mother-to-child transmission (PMTCT) of HIV, evaluate the quality of PMTCT services, 
describe health outcomes of mothers and infants and to identify factors that influence 
mother-to-child transmission (MTCT) of HIV.  Structured interviews were conducted with 
384 women who had utilised PMTCT services.  Information was also obtained from the 
health records of these women and of their infants.   
Better educated women, who had male partners and were self-employed were more 
likely to use PMTCT services. Being unmarried, poor and feeling stigmatised made it 
difficult for women to use these services. 
Respondents were satisfied with PMTCT services except that clinics sometimes had no 
medications. The health care workers followed the Ethiopian guidelines during HIV 
testing and counseling but not when prescribing treatment.   
Although the respondents’ CD4 cell counts improved, their clinical conditions did not 
improve.   
The MTCT rate was significantly higher if infants did not receive ARVs, had APGAR 
scores below seven, weighed less than 2.5kg at birth, were born prematurely, and if 
their mothers had nipple fissures.   
v 
 
PMTCT services could be improved if more women used these services, health care 
workers followed the national guidelines when prescribing ARVs, clinics had adequate 
supplies of medicines, all infants received ARVs, and mothers’ nipple fissures could be 
prevented. Antenatal care should help to avoid premature births of infants weighing less 
than 2.5kg and having APGAR scores below 7.  
Future research should compare formula feeding versus breastfeeding of infants with 
HIV-positive mothers.  
KEY CONCEPTS: APGAR score, antenatal care (ANC) , antiretroviral therapy (ART), 
antiretrorivals (ARVs), Donabedian’s Model of Health Care Quality, Ethiopian health 
care services, Health Belief Model (HBM), HIV/AIDS, HIV counseling and testing, infant 
feeding options, mother-to-child transmission of HIV (MTCT), nipple fissures, partner 
testing; prevention of mother to child transmission of HIV (PMTC)
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CHAPTER 1 
 
ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION 
 
The Human Immune Deficiency Virus (HIV) can be transmitted from an infected mother 
to her unborn baby (foetus) during pregnancy, delivery or breast feeding. This virus can 
be transmitted to the foetus as early as during the 1st and 2nd trimesters of pregnancy. 
Nevertheless, mother-to-child transmission (MTCT) occurs most commonly during the 
perinatal period. In the absence of prevention of mother to child transmission (PMTCT) 
interventions, the probability of MTCT is 15-25% in developed countries and 25-35% in 
developing countries. The factors associated with higher levels of MTCT include high 
levels of maternal plasma viraemia and low maternal CD4 cell counts (Fauci & Lane 
2005:1082). The use of recommended PMTCT interventions can reduce MTCT to less 
than 5% in breast feeding populations and to less than 2% in non-breast feeding 
populations (World Health Organization [WHO] 2010a:12).  
 
Following the 2001 declaration of commitment at the United Nations General Assembly 
Special Session on HIV/AIDS (UNGASS), considerable progress has been made by 
PMTCT programmes. In 2009, 53% of pregnant women living with HIV received some 
antiretroviral medications (ARVs) for PMTCT in low and middle income countries. 
During the same year, the Joint United Nations Programme on HIV/AIDS (UNAIDS) 
called for “virtual elimination” of MTCT. This call finally led to global goals and targets 
for the “virtual elimination” of MTCT by 2015. Hence, the global target for MTCT is to 
reduce the number of new HIV infections among children by 90% and reduce the 
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number of AIDS-related maternal deaths by 50%. There are four elements/prongs that 
are helpful to reduce the incidence of MTCT:  
• primary prevention of HIV infections 
• family planning 
• antiretroviral therapy (ART) interventions, as well as  
• care, treatment and follow-up.  
 
The intent of primary prevention is to prevent HIV infections among pregnant women. 
Programmes must be integrated within the overall HIV prevention efforts. In this way it 
is possible to decrease the number of HIV-positive women who become pregnant. 
Pregnant women, who utilise ante natal care (ANC) services and test HIV-negative, 
should be targeted for appropriate behavioural interventions to remain HIV-negative.  
 
The 2nd prong is to prevent unintended pregnancies among all women, including those 
who are HIV-positive, by providing effective and accessible family planning services. 
The goal of the 3rd prong is to maximise the health of the HIV-positive mother and 
decrease the chances of MTCT, by decreasing the viral load (VL) and increasing the 
CD4 count and maintaining the maximum level of health throughout pregnancy. So, the 
target population to reduce MTCT rates comprises all HIV-infected pregnant women 
and all HIV-exposed infants. The interventions for this prong include HIV counseling and 
testing of all pregnant women, lifelong ART for all eligible women and anti-retroviral 
(ARV) prophylaxis for HIV-positive pregnant women and all infants who are not eligible 
for ARV and safer infant feeding practices. The major emphasis of prong 4 is improving 
survival through ongoing chronic care and treatment for HIV-infected pregnant/post 
partum women and their HIV-exposed and HIV-infected children (WHO 2011a:1-12).  
 
The 2010 revised PMTCT (WHO 2010) guideline is based on two key approaches: 
lifelong ART for HIV-infected women in need of treatment for their own health; and ARV 
prophylaxis for PMTCT during pregnancy, delivery and breast feeding for HIV-infected 
women who are not in need of treatment. For HIV-positive pregnant women, initiation of 
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ART is recommended when the CD4 cell count is ≤350cells/mm3, irrespective of the 
WHO clinical stage or for all women in WHO clinical stages 3 or 4, irrespective of CD4 
cell count. HIV-infected pregnant women, in need of treatment for their own health, 
should start ART irrespective of gestational age and should continue throughout 
pregnancy, delivery, breast feeding and for the rest of their lives. The preferred first line 
recommended ARV regimen in pregnancy include Zidovudine (AZT) and Lamivudine 
(3TC) back bone combined with a non-nucleoside reverse transcriptase inhibitor 
(NNRTI): AZT and 3TC+Nevirapine (NVP) or AZT and 3TC and Efavirenz (EFV). 
Alternative recommended regimens are: Tenofovir (TDF) and 3TC (Emitricitabine 
(FTC)) and NVP or TDF and 3TC (FTC) and EFV. Maternal ART should be coupled with 
the daily administration of NVP or twice daily AZT to infants from birth or as soon as 
feasible thereafter until the child is 4-6 weeks old, irrespective of the mode of infant 
feeding (WHO 2010a:2). 
 
ARV prophylaxis should be started as early as gestational age of 14 weeks or as soon 
as possible during pregnancy, delivery, post partum or during the breast feeding period. 
For all pregnant women who are not in need of ART, there are two equally efficient ARV 
prophylaxis options recommended. The choice of these options should be made at 
country level by considering the capacity of the country and advantages and 
disadvantages of the options. Option A comprises maternal AZT and infant ARV 
prophylaxis while option B supports maternal triple ARV prophylaxis. Option A should 
be coupled with daily administration of NVP to the breast feeding infant from birth or as 
soon as feasible thereafter until at least 4-6 weeks of age and until one week after 
cessation of all breast milk exposure. Infants who receive replacement feeding have 
only option A, which should be coupled with daily NVP or Sd-NVP + twice daily AZT 
from birth until 4-6 weeks of age. For option B, infants should be provided with daily 
NVP or twice daily AZT from birth until 4-6 weeks of age (WHO 2010:3-4). Ethiopia has 
adopted the WHO 2010 guideline with option A and started implementation of the 
programme during December 2011 (FMOH 2011:1). 
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By the end of June 2013, the WHO has released a new consolidated guideline on the 
use of ARV for treatment and prevention including new recommendations for PMTCT. 
All HIV-infected pregnant and breast feeding women should start triple ARVs and 
continue treatment for at least the period of MTCT, during breast feeding. In generalised 
epidemics, the ART treatment should be continued for life. This approach is option B+. 
A once daily fixed dose combination of TDF+3TC (FTC)+EFV is recommended. The 
infant should receive six weeks of prophylaxis with once daily NVP, if breast fed. If the 
infant is on replacement feeding, he/she should receive 4-6 weeks of prophylaxis with 
once daily NVP or twice daily AZT (WHO 2013:100). In August, 2012 Ethiopia endorsed 
the new PMTCT approach, namely option B+. The implementation of the programme is 
being phased-in during 2013. This option was adopted even prior to the release of the 
new consolidated WHO ARV guideline. The adoption was based on the WHO 
programme update released during April 2012 about the use of ARVs for treating 
pregnant women and preventing HIV infection in infants (FMOH 2013:2). 
 
It is anticipated that adopting the new PMTCT guideline should help to improve the 
quality of PMTCT services. Quality PMTCT services can improve patient satisfaction 
and health outcomes. Hence, patient satisfaction can serve as a measure of the quality 
of PMTCT services. Patient satisfaction refers to attitudes towards care and/or 
treatment provided by the health system. Clinical quality is one aspect of patient 
satisfaction (Kronenfeld 2007:7). Patient satisfaction is a summation of a patient’s 
experiences in the hospital and/or with the health services. Satisfaction can be high or 
low. Patient satisfaction is not only an indicator of quality of care but also a component 
of quality care. When patients are satisfied they are likely to be more trusting, less 
stressed, less intimidated by staff and more collaborative during any aspect of care. 
Trust results in greater compliance with and greater tolerance of frightening procedures. 
When patients become less stressed, medical outcomes improve (Press 2006:10-15).  
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1.2   BACKGROUND INFORMATION ABOUT THE RESEARCH PROBLEM 
 
In this section the source of the research problem, the global HIV/AIDS burden, 
HIV/AIDS prevalence, historical and geographical background, population and health 
system of Ethiopia will be discussed.  
 
1.2.1   The source of the research problem 
 
There are three sources of this research problem. First the investigator has many years 
of HIV/AIDS-related work experience. During these years he noticed a major gap in the 
PMTCT progamme. While undertaking site visits to hospitals and health centers, and 
having discussions with experts in the area, it became apparent the PMTCT programme 
is lagging behind other HIV/AIDS programme areas. Activities of the PMTCT 
programme are failing to reach its targets. While there is a global plan towards virtual 
elimination of MTCT, the Ethiopian PMTCT programme did not make progress as 
expected.  
 
The second source of the research problem is a literature review of research 
undertakings in Ethiopia. All of them show that the programme is underutilised. A study 
from the Jimma zone, in the South Western region of Ethiopia, found that the effective 
coverage of PMTCT in this area was very low; only 1.1% of the target group (all 
pregnant women) utilised the service. The researchers recommended improved PMTCT 
service coverage through the enhanced implementation of the strategies of Ethiopia’s 
Federal Ministry of Health (FMoH) to increase the utilisation of PMTCT services at 
hospitals and health centers. PMTCT services were also recommended to be 
decentralised to primary health care units (PHCUs) and counselors should get adequate 
training (Hussein, Jira & Girma 2011:6).  
 
The third reason is the report of the FMoH of Ethiopia. This progress report shows that 
the number of health facilities providing PMTCT service has increased from 32 in 2004 
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to 1 352 in 2010 and to 1 445 by the end of June 2011. However, in 2011 the 
percentage of HIV-positive women who received ARVs to reduce the risk of MTCT was 
only 24%, indicating missed opportunities to reduce the impact of HIV/AIDS in Ethiopia 
(FMOH/HAPCO 2012:30). Furthermore MTCT rate, health status of the mother and 
patient satisfaction with PMTCT services require further investigations to evaluate the 
impact of the PMTCT programme in Ethiopia so that recommendations can be made to 
improve these services. 
 
1.2.2    Global HIV/AIDS burden 
 
During 2009, an estimated 2.6 million people were newly infected with HIV worldwide.  
However, in 33 countries the incidence has fallen by 25% between 2001 and 2009. In 
Sub-Saharan Africa (SSA), 1.8 million people became infected during the same period.  
The annual number of AIDS-related deaths decreased from 2.1 million in 2004 to 1.8 
million in 2009. This could be due to the increased availability of ART, care and support 
particularly in low and middle income countries. Globally, the number of deaths among 
children, younger than 15 years of age, is also declining. The estimated 260 000 deaths 
in 2009, were 19% lower than the estimated 320 000 AIDS-related deaths in 2004. This 
trend is attributable to the increased expansion of ART programmes, including PMTCT 
services. The global number of people living with HIV/AIDS in 2009 was estimated to be 
33.3 million (UNAIDS 2010:16-30).  
 
In 2011, globally 34 million people were living with HIV. SSA is still the most severely 
affected region with 4.9% HIV prevalence which accounts for 69% of all people living 
with HIV worldwide. The number of new infections is declining globally.  During 2011, 
2.5 million persons were newly infected with HIV which is a 20% decline from 2001. The 
sharpest decline has been observed in the Caribbean (42%) and SSA (25%) regions. 
The number of deaths from AIDS-related causes declined since 2000 because of ART 
expansion. In 2011, 1.7 million people died from AIDS-related causes worldwide. This is 
a 24% decline since 2005. In SSA alone, the decline was 32% (UNAIDS 2012:6-12). 
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However, the number of people living with HIV/AIDS in 2012 was 35.3 million because 
more people were receiving life-saving ART. During the same year there were 2.3 
million newly HIV infected people globally which is a 33% decline from 2001. At the 
same time the number of people dying from HIV/AIDS was 1.6 million, down from 2.3 
million in 2005 (UNAIDS 2013:4). 
 
1.2.3   HIV/AIDS prevalence in Ethiopia 
 
The HIV prevalence in Ethiopia is 1.5% among adults aged 15-49. Among men the 
prevalence is 1.0% while among women it is 1.9%. However, the prevalence in Addis 
Ababa is higher at 5.2% with the prevalence among men being 4.3% and among 
women 6.0%. The HIV prevalence among ANC attendees for the last birth during the 
preceding three years in the public sector was 1.7% while it was 3.1% outside the public 
sector (CSAE/ICFI 2012:232-236). Since Addis Ababa has a relatively high HIV 
prevalence, compared to Ethiopia’s national HIV prevalence, it is reasonable to have 
sound PMTCT and other HIV/AIDS services in this area, and to conduct research about 
the impact of these services on the MTCT rates. 
 
1.2.4    Historical and geographical background information about Ethiopia 
 
Ethiopia is located in the eastern part of Africa with a total surface area of about 1.1 
million square kilometers. Countries that border Ethiopia are Djibouti, Republic of South 
Sudan, Republic of Sudan, Eritrea, Kenya and Somalia. Ethiopia’s map is found in 
annexure 21. Historically Ethiopia was ruled by emperors and kings, with a feudal 
system of government. A military junta took the power by force and administered the 
country from 1974-1991. Currently a federal system of government exists and political 
leaders are elected every five years. Ethiopia is administratively structured into nine 
regional states namely Tigray, Afar, Amhara, Oromya, Somali, Benishangul-Gumuz, 
Southern Nations Nationalities and People, Gambela and Harari and two city 
administrations, namely Addis Ababa and Diredawa (CSAE/ICFI 2012:1). 
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1.2.5     Population and health system of Ethiopia 
 
 According to the 2007 census report of Ethiopia, the country’s estimated population 
was 73 750 930. Out of these 37 217, 130 were males and 36 533 802 were females. 
The country’s population predominantly lives in rural areas (84.0%). In Addis Ababa the 
total population was 2 739 551 with a male to female ratio of 0.48:0.52 (Population 
Census Commission [PSC] 2007:7).  
The Ethiopian health care system comprises a three tier system:  
• primary health care units (PHCUs) 
• general hospitals and  
• specialised hospitals.  
 
The PHCU has five satellite health posts, a health center and a primary hospital. Each 
health post is expected to serve 5 000 people, each health center 25 000 people and 
each primary hospital 100 000 people. The general hospital serves 1 000 000 people 
while the specialised hospital serves 5 000 000 people (FMOH 2010:2). During the last 
five years, 34% of Ethiopian women received ANC from skilled health care providers, 
mainly nurses and/or trained midwives (28%). Only 11% of these women received ANC 
before the fourth month of their pregnancies and 19% recorded four or more ANC visits.  
 
Only 10.0% of Ethiopian births occurred at public health facilities. Home deliveries in 
rural areas were 95.0% and in urban areas 50.0%. Postnatal care coverage is 
extremely low in Ethiopia with only 7.0% of women receiving postnatal checkups within 
two days of delivery. The maternal mortality rate for Ethiopia is 676 deaths per 100 000 
live births. Breast feeding is a common practice in Ethiopia with 98.0% of mothers 
breastfeeding their babies at some stage and 52.0% of them practising exclusive breast 
feeding during the first six months of their babies’ lives. Reportedly, 51.0% of children 
aged 6-9 months in Ethiopia are eating supplementary food (CSAE/ICFI 2012:119).  
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1.3    PMTCT AND VIRTUAL ELIMINATION OF HIV 
 
A global plan strives to attain “virtual elimination” of new HIV infections among children 
and improve the health of mothers by 2015. This ambitious plan aims to reduce new 
HIV infections among children by 90%, reduce the number of women dying from HIV-
associated conditions during pregnancy, delivery and postpartum by 50% and reduce 
MTCT of HIV to less than 5%. In 2010, 35% of pregnant women in low and middle 
income countries received HIV counseling and testing (HCT) compared to 26% in 2009. 
In SSA this coverage increased from 35% to 42% with the highest increase in eastern 
and southern Africa (from 52% to 61%). In 2010 the coverage of effective regimens for 
PMTCT was 48%. Out of the estimated 1.49 million infants born to HIV-infected 
mothers, 42% received ARVs to prevent HIV infections from their mothers (WHO 
2011b:139). 
 
According to a study done in China, risk factors significantly associated with low birth 
weight babies, included low maternal weight at enrolment, gestational age of less than 
37 weeks at delivery, low CD4 cell count (200cells/µl or lower) and high HI viral load 
(≥20,000 copies/ml). Preterm delivery occurred in 9.8% of mother-infant pairs. The only 
factor associated with preterm delivery was maternal HIV infection through drug use as 
compared to sexual transmission of HIV infection. Therefore optimal ANC is critical to 
PMTCT intervention for reduction of MTCT and prevention of low birth weight 
pregnancy outcomes (Lan, Wen-ying, Chen, Zhi-rong, Jun, Xiu-zhi, Xiu-ning & Fu-jie 
2012:405).  In Thailand, despite positive effects of ART on the reduction of morbidity 
and mortality, ARVs were also associated with adverse drug reactions such as 
anaemia, nausea and vomiting. PMTCT was able to reduce the perinatal transmission 
of HIV to 3.9% and the incidence of preterm delivery was 10.7%. The incidence of low 
birth weight was high (20%). Antenatal care (ANC) should be emphasised for all HIV-
positive pregnant women in addition to PMTCT services (Areechokchai, 
Bowonwatanuwong, Phonrat, Pitisuttithum & Maek-a-Nantawat 2009:12). A French 
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study reported that out of 404 responses to items, related to satisfaction with physicians 
and services, 15.6% of PLHIV showed complete satisfaction. Factors associated with 
complete satisfaction with physicians included older age, having being infected by HIV 
through sexual contact, not being infected with Hepatitis C, comfortable housing 
conditions, enjoying strong support from friends and experiencing few side effects from 
ARVs (Preau, Protopopescu, Raffi, Rey, Chene, Marcellin, Perronne, Ragnaud, Leport 
& Spire 2012:436). 
 
According to a study done in Abidjan, Cote d’Ivoire, highly active anti-retroviral 
treatment (HAART) during pregnancy among women with advanced HIV, reduced 
MTCT to 2.3% but it was associated with low birth weight babies. Additionally low body 
mass index of the mother was also associated with low birth weight babies (Ekouevi, 
Coffie, Becquet, Tonwe-Gold, Horo, Thiebaut, Leroy, Blanche, Dabis & Abrams 
2008:1819). The same finding has been documented from a study done in Cameroon 
with a MTCT rate of 4.5%. In the Cameroonian study, the main risk factor identified with 
MTCT was the type of ARV regimen, but the mode of infant feeding, gestational age at 
delivery and birth weight were not associated with higher rates of MTCT (Nlend, Ekobo, 
Junior, Ekani, Tchokoteu, Lyeb, Chewa, Moyo & Takam 2001:5). A study from Abidjan, 
Cote d’Ivoire, revealed that among HIV-positive children who were not treated with 
ARVs, the risk of morbidity was 42% with at least one HIV-related condition. 
Accordingly, at least some clinical complications such as persistent diarrhoea, fever and 
pneumonia are preventable with early initiation of ART among children infected with HIV 
(Desmonde, Coffie, Aka, Amani-Bosse, Messou, Debis, Alioum, Ciaranell & Leroy 
2011:10). 
 
A different study from Cote d’Ivoire indicated that HIV testing was not proposed to 
women attending ANC before the introduction of the PMTCT programme. However, 
after the introduction of the programme, 63% of women attending ANC, were offered 
HIV testing and 42% of these were tested. Among those who tested HIV-positive, 82% 
of the mothers and 78% of their infants received Niverapine (NVP). Interpersonal 
11 
 
communication and confidentiality improved ANC and delivery of care, and was also 
improved after the introduction of the PMTCT programme (Delvaux, Konan, Ake-Tano, 
Gohou-Kouassi, Bosso, Buve & Ronsmans 2008:972). Any effective PMTCT 
programme should follow the PMTCT cascade starting from acceptance of HIV 
counseling and testing, taking ARVs (if necessary) and safe infant feeding practices, 
according to a study done in Nigeria. Early diagnosis of HIV in infants provides an 
opportunity for providing effective follow-up services of HIV-exposed infants. If HIV-
positive children are untreated, the mortality rate is high. Improved tracking of HIV-
positive persons, and strengthening the link between PMTCT, early infant diagnosis 
(EID) and paediatric ART coupled with appropriate counseling of the mother helps to 
enroll and retain babies in the ART programme (Anoje, Aiyenigba, Suzuki, Badru, 
Akpoigbe, Odo, Odafe, Adedokun, Torpey & Chabikulu 2012:7). 
 
According to a South African study, sub-optimal infant feeding practices were noted 
among HIV-positive and HIV-negative mothers, after the introduction of a national 
PMTCT programme. However, HIV-positive mothers were more likely to practise 
exclusive breast feeding during the first six months, compared to HIV-negative mothers. 
Strong interventions were needed in order to promote exclusive breast feeding among 
HIV-negative mothers since they lived in high HIV prevalence areas in South Africa 
(Goga, Doherty, Jackson, Sanders, Covin, Chopra & Kuhn 2012:15).  
 
According to a study done in Malawi, the administration of HAART to pregnant women 
for PMTCT is cost-effective. However, the cost of drugs and laboratory tests remain the 
most significant expenses incurred by such a programme. International aid is required 
to cover such costs (Orlando, Marazzi, Mancinelli, Liotta, Ceffa, Giglio, Alumanda, 
Ziegler, Shawa & Palombi 2010:633).  
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A South African study indicated that a significant improvement of the PMTCT 
programme is possible through a combination of interventions, the introduction of better 
PMTCT protocols and strategic additions of resources. Such an approach can further 
help to improve the programme’s performance in SSA (Youngleson, Nkorunziza, 
Jennings, Arendse, Mate & Barker 2010:6). Another South African study found that 
women, who attended ANC, missed HIV counseling and testing during their first visit 
due to shortages of staff and supplies. Another reported delay was that some pregnant 
women did not get their CD4 counts on time to initiate either ART or ARV prophylaxis 
for PMTCT. During postnatal and ANC visits, women were not properly counseled about 
appropriate infant feeding practices due to the health care providers’ lack of knowledge. 
Early infant diagnosis was not practised due to the mothers’ lack of knowledge about 
where to take their children for HIV testing. Due to fear of stigma and discrimination 
formula feeding of these infants was not practised in societies where breast feeding is 
the norm. When such a community’s members noticed that the mother was feeding her 
baby formula, then they might suspect that she is HIV-positive, and this observation 
could result in stigma and discrimination (Sprague, Chersich & Black 2011:3-5). A  
South African study revealed that one third of the clinical staff members had received 
PMTCT training. Others, who prescribed ARVs and who did not have the formal PMTCT 
training, felt that they were not supposed to provide PMTCT services.  This resulted in 
low coverage of PMTCT services and poor outcomes (Doherty, Chopra, Nsibande & 
Mngoma 2009:4). 
 
A Mombasa study reported that clients in Kenya who attended ANC seldom received 
more than one post test counseling session. Among HIV-negative clients, the post test 
counseling should focus on disclosing one’s HIV status, and on remaining negative. 
Among HIV-positive clients, emotional reactions were reportedly not addressed in 80% 
of the women. Among 84% of HIV-positive patients the counselor did not check the 
availability of follow-up support outside the clinic. However, information about infant 
feeding and explanations of the NVP administrations (15mg once daily if birth weight 
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>2500 g or 10 mg once daily if birth weight ≤2500g) were addressed among 84% and 
88% of the cases respectively. This study recommended that in order to achieve more 
frequent, longer and more comprehensive voluntary counseling and testing (VCT) at 
ANC clinics, investments in extra staff, training and infrastructure were needed (Delva, 
Mulunga, Quaghebeur & Temmerman 2006:190). 
 
A study, from Western Kenya, revealed a significant reduction in MTCT and infant 
deaths among those whose mothers received ARV prophylaxis during pregnancy. Many 
infants could not be traced for follow-up actions and clinicians did not adhere to the 
clinical guidelines (Nyandiko, Otieno-Nyunya, Musick, Bucher-Yiannoutsos, Akhaabi, 
Lane, Yiannoutsos & Wools-Kaloustian 2010:47). A study conducted in rural Kenya 
compared patient satisfaction, based on those who visited fully integrated HIV and ANC 
services, compared to those who visited non-integrated HIV and ANC services. Of the 
HIV-infected women, attending fully integrated services, 79% were very satisfied as 
compared to only 54% of such women attending non-integrated services. HIV-negative 
women who preferred the integrated service were 68% (Vo, Cohen, Smith, Bukusi, 
Onono, Schwartz, Washington & Turan 2012:4). Ethiopia has instituted quality 
improvements as an essential component of health services because quality is the 
concern of individuals, the population and the FMOH due to health service expansion 
(FMOH/HAPCO 2008a:3).  
 
1.4   PMTCT IN ETHIOPIA 
 
Ethiopia has adopted the four pronged WHO/UNICEF/UNAIDS PMTCT strategy. So the 
previous Ethiopian PMTCT guideline advises ART for HIV-infected pregnant women 
eligible for HAART and their infants. For those not eligible for HAART, ARV prophylaxis 
should be given during the pregnancy, starting from 14 weeks’ gestation. Antenatal, 
delivery, and post partum care should be provided to all women, irrespective of HIV 
status (FMOH 2011:28). A study in the Jimma zone, in the south western region of 
Ethiopia, found that effective coverage of PMTCT in this area was very low (1.1%). The 
14 
 
researchers recommended improved PMTCT service coverage through the enhanced 
implementation of the strategies of the FMOH to increase the utilisation of PMTCT 
services at hospitals and health centers. PMTCT services were also recommended to 
be decentralised to PHCUs and counselors should get adequate training (Hussein et al 
2011:6).  
 
A study from southern Ethiopia indicated that interventions to reduce MTCT were failing 
to reach their goal and its enhancement required quick reconsiderations of strategies at 
all levels. PMTCT services needed to be assessed. Identification of HIV-positive 
pregnant women and linking them with ARV services is a definite requirement 
(Merdekios & Adedimeji 2011:364). Another study conducted in Ethiopia showed that, 
despite increased PMTCT service coverage, an annual average of 1.3 million pregnant 
women, who attended ANC, missed PMTCT services. Based on the 2010 report, every 
PMTCT site missed on average 63 pregnant women over one year at ANC clinics, for 
providing HIV counseling services. On the other hand, the number of pregnant women 
at PMTCT sites who accepted HIV testing increased from 52 428 in 2006 to 652 065 in 
2010. The prevalence of HIV among these tested women decreased from 8% to 2%. 
During the same period, the number of HIV-positive pregnant women who took ARV 
prophylaxis and the number of HIV-exposed infants who took ARVs, increased by more 
than 300% (Nigatu & Woldegebriel 2011:5).  
 
An Ethiopian study found that after people tested HIV-positive, their intention to have 
children reduces significantly. Men and women stopped desiring more children once 
they found out that one or both of them were HIV-positive. Men who stopped desiring 
more children were also more likely to be in agriculture or unskilled occupations and to 
have children from previous relationships. Women who stopped desiring more children 
were less likely to be repeat testers (Bonnenfant, Hindin & Gillespie 2012:1409). This 
finding shows that HIV testing is helpful prior to pregnancy to enable men and women to 
make informed decisions about having more children in future. This approach of testing 
prior to pregnancy and providing family planning service belongs to prong 2 of the 
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PMTCT programme. According to a study done in Addis Ababa, HIV-positive mothers 
are afraid to breast feed their babies. They think that they are poisoning the baby and 
passing HIV on to their children. The mothers feel that breast feeding is morally wrong 
or bad. They considered an HIV-negative baby after breast feeding to be only God’s 
mercy. As a result 8 out of the 22 participating mothers chose replacement feeding 
either infant formula or cow’s milk. This fear of breast feeding is linked to the counseling 
they received from health care providers. The study participants recalled how strongly 
they were discouraged from breast feeding and the advantage of replacement feeding. 
The counselors did not introduce all of the infant feeding options available; they simply 
provided the counseling based on their own personal fears that breast milk could pass 
on HIV to the babies (Koricho, Moland & Blystad 2010:4-6). 
 
A study conducted in Addis Ababa, Ethiopia, showed that follow-up of HIV-exposed 
infants was disorganised and inconsistent. Despite achieving a higher than 80% 
immunisation coverage among HIV-exposed infants, slightly more than 50% attended 
the infant follow-up clinics at six weeks and less than one third had documented HIV 
test results. Targeted interventions should be developed for HIV-exposed infants within 
the PMTCT package and integrated with the under fives’ health services to ensure 
continuity of care (Mirkuzie, Hinderaker, Sisay, Moland & Markve 2011:8). 
 
1.5   STATEMENT OF THE RESEARCH PROBLEM 
 
PMTCT services are available free of charge at health care facilities throughout 
Ethiopia. However, the literature reviewed and the FMOH’s statistics indicate that 
PMTCT services are underutilised in Ethiopia, implying that many pregnant women fail 
to utilise these services, placing their own and their infants’ lives at risk. The problem 
investigated in this study is that free PMTCT services are not utilised by pregnant 
women in Addis Ababa.  The factors (enablers and barriers) that affected women’s 
utilisation of PMTCT services need to be investigated and addressed, as well as the 
outcomes of using PMTCT services (infants’ HIV status and mothers’ health outcomes). 
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Women’s satisfaction with the PMTCT services in Addis Ababa is unknown and should 
also be investigated in an effort to enable more women to use these services. 
 
The infant’s HIV status, the mother’s health status (CD4 count and clinical condition) as 
well as patient satisfaction levels are dependent (outcome) variables. Factors affecting 
PMTCT service utilisation such as marital status, educational level, income, stigma and 
discrimination and partner HIV status are independent variables. Additional independent 
variables such as birth weight, nipple fissure, type of ARV for PMTCT, gestational age 
during delivery and the infant’s APGAR score, affecting the rate of MTCT, are also 
addressed. Other studied variables included HTC, infant breast feeding, counseling and 
practice. 
 
1.6    AIM OF THE STUDY 
 
In this section the research purpose and objectives will be addressed. 
 
1.6.1 Research purpose 
 
The purpose of this study was to examine PMTCT services, describe the HIV status of 
the infant, the health status of the mother, and patients’ satisfaction levels with PMTCT 
services, to identify factors affecting the rate of MTCT and identify factors affecting 
women’s utilisation of PMTCT services in Addis Ababa. Based on these findings, 
recommendations made for enhancing the utilisation of PMTCT services in Addis Ababa 
and for improving the outcomes (HIV-negative babies and healthy mothers) of this 
programme. These findings could contribute towards building a theoretical framework of 
the HBM and Donabedian’s Model of Health Care Quality and to improve the utilisation 
of PMTCT services.   
 
1.6.2 Research objectives 
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The objectives of this study were to: 
• identify factors affecting the utilisation of PMTCT services in Addis Ababa; 
• evaluate PMTCT services in Addis Ababa 
• assess patients’ satisfaction levels with PMTCT services in Addis Ababa 
• examine the health outcomes of mothers using PMTCT services in Addis Ababa; 
• describe the HIV status of infants whose HIV-positive mothers used PMTCT 
services in Addis Ababa; 
• identify factors affecting the HIV status of infants in Addis Ababa; 
•  make recommendations to enhance women’s utilisation of PMTCT services in 
Addis Ababa. 
 
1.7    SIGNIFICANCE OF THE STUDY 
 
From the literature reviewed it has been learned that the main source of HIV infection 
among infants is their HIV-positive mothers. A study from Romania indicated that 
vertical transmission of HIV from mother to infant was 25% (Cocu, Thorne, Matusa, 
Tica, Florea, Asandi & Giaquinto 2013:82). Another study was also conducted in India 
among 217 HIV exposed infants. Of these infants, 51.6% underwent DNA-PCR testing 
by the age of six weeks and 17.5% tested HIV-positive (Gupta, Singh, Kaushik, Joshi, 
Kalra & Chakraborty 2012:2). According to a study from Burkina Faso the rate of MTCT 
of HIV-1 was 6.2% among women who had received short course ART. This shows the 
significant impact with which PMTCT could reduce the rate of MTCT (Kouanda, Tougri, 
Cisse, Simpore, Pietra, Doulougou, Ouedraogo, Ouedraogo, Soudre & Sondo 
2010:846). Further investigations of PMTCT services, at various levels of health delivery 
facilities, could help to obtain better knowledge about the actual practices and 
associations between different variables. Policies and guidelines were prepared, based 
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on the capacity of these health facilities to address MTCT. The information generated 
from this research could thus update decision makers at all levels. Thus these findings 
might help in programme planning and implementation so that the current low level of 
PMTCT coverage could improve, contributing towards the reduction of MTCT and 
improving the mothers’ and babies’ health status in Addis Ababa, Ethiopia. 
 
1.8    DEFINITIONS OF KEY CONCEPTS 
 
Acquired Immune Deficiency Syndrome (AIDS) refers to HIV clinical stage 3 or 4 
disease or where CD4 is available, any clinical stage and CD4 <350cells/mm3 (WHO 
2005:10). 
Antenatal care (ANC) implies a service provided to pregnant women including at least 
four focused ANC clinic visits with the first visit as early as possible during pregnancy, 
the second visit at 28-32 weeks, the third visit after 36 weeks and the fourth one before 
the expected date of delivery. During the first ANC visit routine provider-initiated HIV 
counseling and testing should be provided in order to identify HIV-positive pregnant 
women and to offer them PMTCT services (FMOH 2011:11).  
Antiretroviral therapy (ART) describes the administration of ARV drugs to restore 
immune function, maintain maximum suppression of viral replication, reduce HIV-related 
morbidity and mortality and improve the quality of life with prolonged survival rates for 
both mothers and babies (FMOH/HAPCO 2008b:48). 
Exclusive breast feeding (EBF) occurs when an infant is fed breast milk only without 
any other foods or liquids for the first six months of the infant’s life (FMOH 2011:24).  
HIV testing and counseling (HTC) refers to counseling, testing and announcing of HIV 
test results to a client. If the client tests HIV-positive, it can be linked to appropriate care 
and treatment services. It has two components VCT and PITC provider-initiated testing 
and counselling (WHO 2009:7). 
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Human Immunodeficiency Virus (HIV) is a virus that damages the body’s immune 
system, the system that fights infections (Longo & Fauci 2005: 1071-1075). HIV is an 
aetiologic agent of AIDS and can be transmitted by sexual contact, from blood and 
 
blood products such as needle stick injuries or sharing injection needles or instruments 
used in tattooing or circumcision and by HIV-infected mothers to their infants during 
pregnancy, birth or breast feeding. After years of study there is no evidence that HIV 
can be transmitted by casual contact or spread by insects such as mosquito bites (Fauci 
& Lane 2005:1079).  
Patient satisfaction refers to patients’ attitudes towards medical care provided by the 
health system of people who experienced recent contact with the health care system 
(Kronenfeld 2007:7). 
Prevention of mother to child transmission (PMTCT) refers to the reduction of new 
paediatric HIV infections through the promotion of primary prevention of HIV amongst 
women and men of reproductive age, addressing family planning within the context of 
HIV, promoting access to HIV and ART or prophylaxis for HIV-infected pregnant women 
and their families and promoting access of HIV-exposed infants to care (FMOH 2011:3).  
Provider-initiated HIV testing and counseling (PITC) is the type of testing that “refers 
to HIV testing and counseling recommended by health care providers to patients 
attending health care facilities. Providers are expected to recommend testing as a 
standard component of medical care when patients exhibit clinical manifestations that 
might result from underlying HIV infection. PITC is provided to populations where the 
risks of exposure to HIV infection are thought to be considerable and to all patients in 
high prevalence settings. While this type of testing can be routine under certain 
conditions, it should never be mandatory or compulsory” (WHO 2009:7). 
Quality of health service is a term that refers to “the degree to which health services 
for individuals and populations increase the likelihood of achieving desired health 
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outcomes and are consistent with current professional knowledge” (FMOH/HAPCO 
2008a:2). 
Voluntary testing and counseling (VCT) refers to individuals who request HIV testing 
and counseling based on their own decisions “… actively seeking HIV testing and 
counseling. It is conducted in a wide variety of settings including health facilities, stand-
alone facilities outside health institutions, mobile services, community-based settings 
and even people’s homes” (WHO 2009:7). 
 
1.9    OPERATIONAL DEFINITIONS 
 
Antiretrovirals (ARVs) for the prevention of mother to child transmission of HIV 
include the administration of antiretroviral drugs to HIV-positive mothers and their 
infants to prevent HIV transmission from mother to infant. This includes ART provision 
for those pregnant women who are eligible for treatment and ARV prophylaxis for those 
who are not eligible for ART. 
 
HIV testing and counseling (HTC) refers to offering HIV testing by health care 
providers either during ANC or labour and delivery to mothers of unknown HIV status 
and the provision of post test counseling. 
Infant feeding counseling implies the counseling service provided by health care 
providers on options available for HIV-positive mothers on how to breast or 
formula/replacement feed their babies. 
Infant feeding practices refer to the actual practice of infant feeding such as exclusive 
breast feeding or formula/replacement feeding or mixed feeding by the mother. 
Patient satisfaction refers to the attitudes of patients towards PMTCT services 
provided by health care providers in Addis Ababa, Ethiopia.  
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Prevention of mother to child transmission (PMTCT) in this study includes 
prevention of mother to child transmission of HIV through HTC, ARVs for PMTCT and 
infant feeding counseling and practice.  
Quality of PMTCT service refers to the standard of PMTCT service provided to HIV-
positive women and their infants in health facilities of Addis Ababa, Ethiopia according 
to the national guideline. 
 
1.10    THEORETICAL FOUNDATIONS OF THE STUDY 
 
The following section presents the theoretical framework used for this study. 
 
1.10.1    Health Belief Model (HBM) 
 
The HBM’s primary concepts explain why people will take actions to prevent, to screen 
for, or to control illnesses. These include a person’s perceived susceptibility to and 
seriousness of a disease as well as the benefits of and barriers to implementing 
preventive actions/behaviours, cues to action and self efficacy to sustain the required 
preventive actions/behaviours. Perceived susceptibility concerns beliefs about the 
likelihood of getting a disease. Perceived severity is about the expected seriousness of 
the disease, if left untreated or if not prevented. Perceived benefits refer to beliefs about 
the advantages of performing the available preventive and/or treatment actions. 
Perceived barriers are the potential negative aspects making the performance of health 
actions difficult or impossible. Cues to action are those stimuli that can trigger actions. 
Self-efficacy refers to the conviction that one can successfully execute the behaviours 
required to produce the outcomes (Champion & Skinner 2008:47).  
 
Thus, according to the HBM, individuals will act to protect or promote their health based 
on the following circumstances. If they are susceptible to a condition or problem, if the 
consequences of the condition are severe, if the recommended actions to deal with the 
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problem are beneficial and if the benefits of action outweigh the costs or barriers. The 
HBM suggests that behaviour change is the result of scrutinising information and 
weighing up potential consequences of actions or inactions before a decision is made. 
Individual behaviour is guided by the rationality of protecting one’s health. The 
application of the HBM suggests that health risks should be personalised to encourage 
an awareness of a threat to a person’s health and thus his/her beliefs of susceptibility 
(Wills & Earle 2012:133-134). 
 
1.10.1.2    Donabedian’s Model of Health Care Quality 
 
Donabedian’s Model of Health Care Quality is based on three approaches. These are 
structure, process and outcome. Structure is the condition under which care is provided 
such as material resources, human resources and organisational characteristics. 
Process refers to activities that encompass health care including diagnosis, treatment, 
rehabilitation, prevention and patient education. Outcome refers to changes (desirable 
or undesirable) in individuals and populations that can be attributable to health care. 
Outcome variables include changes in health status, knowledge and/or behaviours of 
patients or family members and satisfaction of patients and their family members with 
the quality of health care services they received. Furthermore outcome could be 
classified as clinical, physiological-biochemical, physical, psychological (mental), social, 
integrative and evaluative (Donabedian 2003:46-48). Table 1.1 shows this classification. 
 
1.10.2     Relevance of the theoretical frameworks used for this study 
 
The HBM was selected for this study because a pregnant woman needs to accept HTC 
to receive appropriate PMTCT services, if HIV-positive. This action could prevent HIV 
from infecting her baby. Perceived susceptibility implies the pregnant women’s belief 
that she might be infected with HIV. Perceived severity explains that once the pregnant 
woman learns that she is HIV-positive, she needs to consider the consequences of HIV 
both for her own and her baby’s health, if left untreated. Perceived benefits pertain to 
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the pregnant woman’s beliefs about the benefits of PMTCT services for her own and for 
her baby’s health and wellbeing. Perceived barriers imply all obstacles that can make 
utilisation of PMCT services difficult or impossible, including the mother’s lack of 
education and financial resources as well as cultural and social issues. Cues to action 
include information about signs and symptoms of HIV from mass media and/or health 
care services about the importance of PMTCT services. Self-efficacy can be developed 
when the pregnant woman is confident about her utilisation of PMTCT services. 
 
Donabedian’s Model of Health Care Quality is appropriate for this study as the three 
approaches fit this study purpose. Structure of the PMTCT service encompasses all the 
medical equipment, health care providers and types of health facilities providing the 
services. 
Table 1.1: Classification of health outcomes 
Clinical Reported symptoms that have clinical significance, diagnostic 
categorisation as an indication of morbidity, disease staging, relevant to 
functional encroachment and prognosis and diagnostic performance. 
Physiological-
biochemical 
Abnormalities and functions 
Physical Loss or impairment of structural form or integrity and functional 
performance of physical activities 
Psychological  Feelings, beliefs, knowledge and impairment of mental functions 
Social Behaviours relevant to coping with current illness, role performance and 
performance under test conditions involving varying degrees of stress 
Integrative Mortality and longevity 
Evaluative Client opinions about and satisfaction with various aspects of care. 
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Process encompasses the PMTCT services, namely HCT, ARV intervention and breast 
feeding counseling and factors affecting the rate of MTCT, while outcomes imply the 
HIV status of the infant, health status of HIV-positive woman (CD4 and clinical 
condition) and patients’ levels of satisfaction with the health care services. 
 
 
 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perceived susceptibility: 
Pregnant women’s beliefs 
about being infected with HIV 
and their beliefs about MTCT  
 
Perceived severity: 
HIV positive pregnant 
women’s beliefs about 
the consequences of 
HIV for their own and 
their babies’ health 
 
 
Perceived benefits: 
Pregnant women’s 
beliefs about giving 
birth to HIV negative 
babies if they use 
PMTCT services  
 
 
Individual behaviours: 
Pregnant women’s 
utilisation of PMTCT 
services 
 
Perceived 
barriers:Lack of 
education and finances 
Myths and fears 
 
Cultural practices 
 
Side effects of ARVs 
 
Stigma and 
discrimination 
 
Perceived self 
efficacy: 
A pregnant 
woman’s 
confidence about 
her utilisation of 
PMTCT service 
 
Cues to action: 
Expectation of the HIV- 
positive mother about 
improved health and 
PMTCT education 
through mass media. 
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Figure 1.1: Theoretical framework: Health Belief Model (adapted from Champion & 
Skinner 2008:49) 
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 of satisfied  participation during service 
 patients 
 
Figure 1.2:  Theoretical framework: Donabedian’s Model of Health Care Quality 
(adapted from Donabedian 2003:50) 
1.11     RESEARCH DESIGN AND METHOD 
 
A quantitative retrospective cohort design was selected for this study. In cohort studies 
the researcher selects a group of study subjects, based on their exposure status, and 
then examines the rate of disease occurrence. Cohort studies are often conducted 
retrospectively and they fulfill at least one major criterium for causality: the time 
sequence of cause and effect (Stommel & Wills 2004:144). At the baseline people are 
classified according to their exposure status. Over time follow-up investigations are 
conducted to identify the development of the disease (Olsen, Christensen, Murray & 
Ekbam 2010:8). Mother-infant pairs who received PMTCT services are cohorts for this 
study. The exposures in this case are PMTCT services, factors affecting the rate of 
MTCT and factors affecting PMTCT service utilisation.  
 
This study was conducted in Addis Ababa, Ethiopia, which is the capital city of the 
country. This area is chosen because Addis Ababa has the highest HIV prevalence in 
the country and proportional to population, more PMTCT attendees are found in this 
area than anywhere else in Ethiopia. The PMTCT services are provided at hospitals and 
health centers in Addis Ababa. Stratified random sampling was used to select 
participating health facilities. The types of health facilities served as strata. The method 
of data collection involved both structured interviews and document reviews. HIV-
positive mothers, using PMTCT services, provided the information during interviews. 
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Consent was provided by these mothers, for themselves and on behalf of their babies, 
before data collection commenced. 
 
For this study, descriptive statistics and inferential statistics such as relative risk (RR) 
and chi-square tests were used to analyse the data. A p-value of 0.05 and a confidence 
interval of 95% were used as cut off values for association. Both the information sheet 
and the informed consent document have been prepared to inform each potential  
 
research respondent about the specific objectives of the study and that individual 
interviews and document review would be conducted to collect information. The 
informed consent form was given to potential respondents to read and sufficient time 
was allowed to enable them to make an independent decision.  
 
Ethical clearance was obtained from the Higher Degree Committee of the Department 
of Health Studies at the University of South Africa (Unisa), and from the Addis Ababa 
City Administration Health Bureau Ethical Committee. Finally heads of each selected 
hospital and health center granted permission to collect data. (Please see annexures 6-
18 for ethical clearance granted by the relevant authorities). 
 
1.12     SCOPE OF THE STUDY 
 
Since this study was conducted in Addis Ababa, the capital city of Ethiopia, it is not 
possible to generalise the findings to the wider national population. This study considers 
only those women who utilised ANC, or labour and delivery services and agreed to 
participate in the PMTCT progamme at hospitals and health centers. Consequently 
those women who did not utilise ANC services, and did not participate in the PMTCT 
programme, could not be reached.  
 
28 
 
Women who discontinued using PMTCT services could also not be reached to 
participate in this study, and these women might have had different experiences than 
women who used these services.  Only structured interviews were conducted, 
augmented by information obtained from the respondents’ medical files. Richer 
information might have been obtained by conducting individual in-depth interviews 
about these women’s experiences of using PMTCT services in Addis Ababa. 
 
 
 
1.13 STRUCTURE OF THE THESIS 
 
Chapter one presented the introduction and background information about the research 
problem. The statement of the research problem, aim of the study and significance of 
the study were also discussed as well as the theoretical foundations of the study and 
the research design and method. 
 
Chapter two presents a literature review of the subject matter under study, discussing 
the components of PMTCT in detail.  
Chapter three discusses the design and methodologies used in the study. Population, 
sampling, data collection, data analysis and ethical considerations will be further 
elaborated upon. 
Chapter four discusses the quantitative data analysis and also presents a discussion 
and presentation of the research findings. 
Chapter five presents conclusions, limitations and recommendations arising from the 
study.  
 
1.14   SUMMARY 
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This chapter presented the introduction, background information about the research 
problem and statement of the research problem, objectives, significance of the study 
and theoretical foundations. The findings of this study might help to improve the PMTCT 
programme’s achievements and contribute towards the reduction of MTCT rates in 
Addis Ababa, Ethiopia. 
 
 
 
 
CHAPTER 2 
LITERATURE REVIEW 
 
2.1   INTRODUCTION 
 
The global community has laid the foundation for ending the AIDS epidemic. The 2011 
United Nations’ political declaration on HIV/AIDS pledged to end the epidemic. Based 
on this declaration, the UNAIDS has articulated 10 targets to be met by 2015. To 
eliminate new infections among children and to substantially reduce the number of 
mothers dying from AIDS-related causes and to provide ART to 15 million people are 
some of the targets related to PMTCT (UNAIDS 2012:6-12). Coverage of ARVs for 
PMTCT increased from 57% in 2011 to 63% in 2012 worldwide. The annual number of 
newly HIV-infected children in 2012 was 260 000 in low and middle income counties 
which shows 52% decline from 2001. PMTCT services prevented more than 670 000 
children from becoming infected with HIV from 2009 to 2012. Nevertheless, Ethiopia 
was among the countries with less than 50% coverage of ARV prevention services for 
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pregnant women living with HIV in generalised epidemic countries in 2012 (UNAIDS 
2013:38-40). 
 
To achieve virtual elimination of new HIV infections among children and to keep their 
mothers alive, the following are required: 
• all women should be able to access quality HIV/AIDS prevention, care and 
treatment services;  
• the rights of women living with HIV should be respected so that women, their 
families and communities could be empowered to ensure their own health;  
 
• adequate resources, both human and financial should be available to provide 
PMTCT services; and  
• national and global leaders must support country-driven AIDS-related efforts. 
 
Therefore there are four key principles for success: 
• women living with HIV should be at the center of the response; 
• country ownership of the programme; 
• leveraging synergies, linkages and integration for improved sustainability, with 
shared responsibility and specific accountability; and  
• PMTCT programmes should be closely linked with ART programmes. This helps 
to reduce cost, avoid duplication, increase programmes’ efficiency and improve 
women’s access and uptake of needed services, as well as the quality of these 
services. The strategy to virtually eliminate new infections among children should 
be also based on the four-pronged strategy (UNAIDS 2011:2-12). 
 
Preventing HIV from infecting infants during breast feeding should balance this 
protection from other causes of morbidity and mortality. The WHO recommends that 
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countries should choose between two interventions by HIV-infected mothers regarding 
breast feeding. The mother should continue breast feeding and also receive ARV 
prophylaxis or avoid all breast feeding. This decision should be based on several factors 
including the socio-economic and cultural context of the population, availability and 
quality of health services, local epidemiology including HIV prevalence among pregnant 
women, main causes of maternal and child under-nutrition and infant and child mortality. 
When ARVs are not immediately available, breast feeding still provides infants born 
from HIV-infected mothers some chance of HIV free survival. It is also necessary to 
inform HIV-infected mothers about the available alternatives to breast feeding. Such 
information should be provided carefully without causing harm to the general 
population’s infant feeding practices (WHO 2010b:3). 
 
2.2    DISCRIPTION OF THE THEORETICAL FRAMEWORKS 
Theories are abstract but come alive in public health and health behaviour when they 
are filled with practical topics, goals and problems. Theories can be used to guide 
research undertakings. Theories have concepts as their components which are the 
building blocks. When concepts are developed or used for a particular purpose they 
become constructs. Variables are operational forms of constructs; they specify how a 
construct should be measured. Several theories combined can explain a specific 
problem or form models. Different theories are best suited to different situations. “The 
adequacy of theory is most often assessed in terms of three criteria:  
• its logic or internal consistency in not yielding mutually contradicting derivations; 
• the extent to which it is parsimonious or broadly relevant while using a 
manageable number of concepts; and  
• its plausibility for fitting in with prevailing theories in the field” (Glanz, Rimer & 
Viswanath 2008:26-35).  
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In line with these facts two theoretical frameworks have been chosen for this study, 
namely the HBM and Donabedian’s Model. 
 
2.2.1   Health Belief Model (HBM) 
 
A study conducted in SSA countries used the HBM to understand social barriers’ impact 
on the utilisation of PMTCT services. The different components of the model are 
explained in relation to the study. Perceived susceptibility has been used to explain a 
woman’s acceptance of HIV testing, receiving the result and believing that her infant is 
susceptible to vertical transmission of HIV. Perceived benefits are related to pregnant 
women’s knowledge and beliefs that PMTCT interventions are beneficial. Perceived 
barriers include fears of knowing one’s own HIV status, stigma and discrimination and 
opposition of male intimate partners. Self-efficacy indicates the woman’s level of 
confidence that she is able to complete the steps necessary for PMTCT adherence. 
Using this model the researcher was able to identify both biomedical and social 
approaches that are needed to address the complex behaviour of HIV-positive women’s 
adherence to PMTCT (Hamanda 2013:2). 
 
A study conducted in the northwestern areas of Ethiopia used the HBM to identify 
factors associated with readiness for VCT service utilisation among pregnant women 
attending ANC clinics. The variables considered by the study were knowledge about 
VCT, readiness to use VCT services during pregnancy, risk perceptions of being 
infected with HIV, educational status, gravidity and gestation age. The model fits the 
variables selected and helped the researcher to achieve the intended objectives of the 
study. The findings revealed that readiness to use VCT services among pregnant 
women was low (Moges & Amberbir 2011:109-110). A study in Kenya used the HBM to 
examine the correlates of and motivations for HIV testing. The researchers used 
different variables that fit into the model: for the perceived risk component anxiety about 
being infected with HIV, for modifying factors HIV knowledge, beliefs about condom use 
for HIV prevention and cues to action information on HIV and knowing someone 
33 
 
infected with HIV. Using this model, it was demonstrated that targeted interventions 
could help young people to assess their level of risk and increase their awareness 
levels about the benefits of VCT to enhance the utilisation of HIV/AIDS services (Kabiru, 
Beguy, Crichton & Zulu 2011:3). 
 
2.2.2   Donabedian’s Model 
 
Donabedian’s Model has been used during the assessment of improving HIV outcomes 
in resource limited countries. The desired outcomes in the case of the current study 
were a healthy mother and an HIV-negative baby. The three components of 
Donabedian’s Model (Ahonkhai, Bassett, Ferris & Freedberg 2012:2), considered by 
this study, were structure, process and outcome:  
• structure includes characteristics of physical deployment of resources such as 
physicians, nurses, buildings and supplies;  
• process includes health care professionals’ interactions with pregnant women; 
and 
• outcomes are what happen to people, especially with regard to their health.   
 
A study, conducted in Japan, used Donabedian’s Model to assess patients’ satisfaction 
levels and perceptions of nursing services. With regard to the structure component of 
the model, the variables chosen were patients’ convenience of care, comfort of 
surroundings and privacy. For process, the appropriateness of care procedures, patient-
nurse interactions and patient participation in the care process, were considered. For 
outcomes, changes in physical status, changes in patients’ knowledge that might 
influence future care and patients’ satisfaction with the care they received were 
considered (Kobayashi, Takemura & Kanda 2010:420-421).  
 
A study conducted in Canada used Donabedian’s Model with definitions of the three 
components similar to those used in the current study. Structure referred to the 
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attributes of the setting where health care was provided such as the physical setting and 
staff characteristics. Process referred to what was actually done during the delivery and 
receipt of care, including clinical care and interpersonal care. Clinical care referred to 
the application of medical and other sciences to achieve the best health result or 
outcome. Interpersonal care referred to the social and psychological interactions 
between the health care professionals and users of the health care system. Outcome, 
including patient satisfaction, was the consequence of care (Sword, Heaman, Brooks, 
Tough, Janssen, Young, Kingston, Helewa, Akhtar-Danesh & Hutton 2012:2-3).  A 
study conducted in Brazil also used Donabedian’s Model, but used different variables to 
fit the components. The structure variables were nursing staff, furniture and 
infrastructure. The process component included interpersonal relationships and 
professional training. Finally the outcome implied the effects of service and professional 
satisfaction with the care that was delivered as well as changes regarding people’s 
knowledge and behaviours. Using this model, the researchers were able to conclude 
favourable health service evaluations to improve the standard of care (Yuvi & Tronchin 
2010:331).  
 
A Zambian study used Donabedian’s Model as a theoretical framework. These 
researchers classified health facilities according to the level of service provision. They 
distinguished among the structure of health care, the actual care provided (process) and 
end result of the interaction between an individual and a health care system (outcome). 
The model helped to improve the level of service provided at ANC facilities and their 
accessibility, improving the quality of service (Kyei, Campbell & Gabrisch 2012:2). 
 
2.2.3 Justification for using the chosen theoretical frameworks 
 
These theoretical frameworks best fit this study’s variables of interest. The HBM deals 
with the health seeking behaviour component of the study. It is concerned with why 
people take actions to screen or control illnesses. The barriers or enabling factors of 
PMTCT service utilisation are best explained within the construct of this model. The rest 
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of the variables were described using Donabedian’s Model. This model deals with three 
components; structure, process and outcome (Donabedian 2003:46-48). PMTCT 
services at health facilities are considered as processes and health outcomes and 
patient satisfaction are considered as outcomes. 
 
The HBM helped to answer the research question as to what barriers and enablers 
influenced women’s PMTCT service utilisation. The variables considered include the 
educational level of the mothers, economic status, stigma and discrimination. 
Donabedian’s Model helped to address process variables such as VCT, ART and ARV 
prophylaxis, factors affecting HIV status of the baby, breast feeding counseling and 
practice.  Outcome variables were health status of the mother, HIV status of the baby 
and patient satisfaction.  The use of two models helped to incorporate all variables 
investigated in this study. Besides, it helped to answer the comprehensive research 
questions of PMTCT. The models helped to avoid addressing limited objectives. This 
also shows that it is possible to conduct a study using more than one theoretical 
framework. The models aided the researcher to maintain the focus of the study. It also 
assisted in organising the literature review, developing the data collection instrument, 
presenting and discussing the findings as well as making recommendations. The 
following sections are presented according to the concepts of HBM and Donabedian’s 
model. Section 2.3 is based on HBM. Sections 2.4 and 2.5 are based on the process 
component of Donabedian’s model and section 2.6 is based on the outcome component 
of Donabedian’s model.  
 
2.3 FACTORS AFFECTING THE UTILISATION OF PREVENTION OF MOTHER  
 TO CHILD TRANSMISSION OF HIV SERVICES  
 
This section presents factors affecting the utilisation of PMTCT services in terms of the 
HBM’s major tenets.  
 
2.3.1 Perceived susceptibility 
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According to a study done in Botswana, factors associated with HIV test acceptance for 
PMTCT, are being knowledgeable about PMTCT, knowing someone who had received 
ART or PMTCT and having a partner who had been tested for HIV. Out of 432 women 
who answered questions about pre-test counseling, 59% reported that counseling 
changed the way they felt about HIV testing. Those 59% who said counselling changed 
the way they felt about HIV testing, also felt more inclined to have a test done. The 
factors which were associated with higher PMTCT knowledge scores included receiving 
counselling from a lay counselor and hearing about PMTCT on the radio (Creek, Ntumy, 
Mazhani, Moore, Smith, Han, Shaffer & Kilmarx 2009:358).  
 
A study from north western Ethiopia used the HBM approach to assess factors 
associated with readiness for VCT service utilisation among pregnant women. Four 
focus group discussions (FGDs) were conducted with pregnant women. Most of these 
women reported they were not susceptible to HIV because they were married to a 
faithful husband and trusted their spouses. However, pregnant women who had high 
perceived susceptibility were three times more likely to accept VCT as compared to 
those who had low perceived susceptibility levels (Moges & Amberbir 2011:112). 
 
2.3.2 Perceived severity  
 
A study conducted in north western Ethiopia included 418 pregnant women attending 
ANC. Regarding VCT, 55.5% of them were not ready to use VCT services and they 
indicated that pregnancy was not the right time for VCT. The reasons mentioned were 
fears of blood drawing and receiving HIV-positive test results, stigma and discrimination 
and the husband’s disapproval (Moges & Amberbir 2011:109-110). According to a study 
in the Oromia region of Ethiopia, 62% of the study participants attending ANC, were 
offered HIV counseling and testing, but only 47% of them accepted HIV testing. The 
study further showed the major challenges of the PMTCT programme to be human 
resource limitations, inadequate coordination, erratic supplies of laboratory test kits and 
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ARV prophylactic medicines and disconnections between the regional health bureaux 
and local levels in terms of communicating new policies and guidelines (Balcha, Lecerof 
& Jeppsson 2011:188-189).  
 
2.3.3 Perceived benefits 
 
According to a study from Arba Minch, Ethiopia (Adedimeji, Abboud, Merdekios & 
Shiferaw 2012:3-4), most women attending ANC, knew that HIV testing is important for 
a woman since there is a possibility of transmitting the virus to her child. Participants 
further indicated that hospital delivery, counseling, ARV drugs and avoiding breast 
feeding were deemed necessary for PMTCT. However, out of 74 pregnant women who  
 
tested HIV-positive, only 7% returned to the facility to deliver their babies. HIV stigma is 
a key factor preventing women from returning to a health facility in order to keep the HIV 
status undisclosed to others. Stigma is also present in the health facility because health 
care providers are not enthusiastic to manage the deliveries of HIV-positive women. 
Another key issue, preventing pregnant women coming back to the health facility, was 
inadequate monitoring and referral structures within the health facility. Health workers 
did not have established systems to properly monitor HIV-infected women and follow 
them up to provide the required care and support. Inadequate human resources also 
posed challenges. Too few nurses provided PMTCT services. Other factors that 
affected PMTCT services included inadequate ARV supplies, cost of accessing the 
service and poor socioeconomic status of women (Adedimeji et al 2012:3-4).  
 
2.3.4 Perceived barriers 
 
According to a systematic review from India, the uptake of PMTCT service was low. 
Particularly ARV uptake was low both in private and public sectors. The uptake of HIV 
testing ranged from 64% to 100%. The uptake of ARVs ranged from 9% to 84%. There 
was a wide variation in the rate of MTCT ranging from 0% to 29%. Barriers of accessing 
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PMTCT services included the lack of training among health care providers and 
inadequate attention to social and gender issues, perceived stigma and experience of 
discrimination in health facilities, poor education, low economic status of women and 
lack of support from partners (Darak et al 2012:4). Another study was also conducted in 
India to understand stigma experienced by women accessing PMTCT services. Women 
faced different experiences from health care providers which included refusal for 
treatment, abusive behaviour, moral judgment and lack of confidentiality. Stigma-related 
behaviours from the community ranged from denial of personal contact to physical 
removal from one’s own community. The women also faced stigma from their own 
families in the form of moral judgment describing HIV status as being associated with 
immoral behaviour. Therefore fear and experiences of stigma by various agents that 
would normally be expected to provide support for HIV-infected pregnant women, might 
create barriers to PMTCT and maternity services (Rahangdale, Banandur, Sreenivas, 
Turan, Washington & Cohen 2010:838-840). 
 
2.3.5 Perceived self-efficacy 
 
A study conducted in Vietnam reported about HIV testing among pregnant women 
which is a first step to receive ARVs for PMTCT if found HIV positive. Out of 300 women 
who agreed to participate in the study, 40% had received HCT before the end of 34 
weeks of gestation, 5% at 35-40 gestational week and 55% were tested during labour 
(Nguyen, Christoffersen & Rasch 2010:44). A different study from India examined socio-
demographic factors associated with getting lost to follow-up of HIV-infected women 
using PMTCT services. Between 2002 and 2008, a total of 950 HIV-infected women 
registered for the PMTCT programme. Proportionally 10.9% of them were lost to follow-
up before delivery and 19.6% became lost to follow-up after delivery. A woman with less 
than graduate level educational status was 6.32 more likely to be lost to follow-up 
compared to graduates. The other factors associated with losses to follow-up are poor 
family, a woman registered into PMTCT programme after 20 weeks of pregnancy and a 
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woman whose partner’s HIV status is negative or unknown (Panditrao, Darak, Kulkarni, 
Kulkarni & Parchure 2011:595).  
 
2.3.6 Cues to action 
 
According to a study conducted across four African countries (Cameroon, Cote d’Ivoire, 
South Africa & Zambia), higher PMTCT service coverage was associated with HIV test 
kits being found in the ANC (as opposed to in the laboratory), HIV testing was available 
in the labour ward, availability of CD4 testing at the facility, infant testing with DNA-PCR 
availability on most days of the month and the presence of an ANC register with PMTCT 
information. PMTCT coverage was not associated with the type of facility, location of 
HIV testing during ANC, same day HIV test results and partner HIV testing.  PMTCT  
coverage was associated with higher PMTCT quality scores, infrastructure quality 
scores, patient satisfaction quality scores and patient understanding of medication 
scores. On the other hand, there was no association of PMTCT coverage with staff 
quality scores (Ekouevi, Stringer, Coetzee, Tih, Creek, Stinson, Westfall, Welty, Chintu, 
Chi, Wilfert, Shaffer, Stringer & Dabis  2012:3-4). 
 
2.4   PREVENTION OF MOTHER TO CHILD TRANSMISSION OF HIV 
 
This section deals with process of PMTCT based on Donabedian’s model. Intervention 
is necessary to lower the transmission rate of MTCT. Maternal factors that increase the 
HIV transmission risk include a high maternal viral load, new or recently acquired 
maternal HIV infection, low CD4 count, advanced maternal disease, viral or parasitic 
placental infections during pregnancy, labour and child birth, maternal malnutrition and 
nipple fissures, cracks, mastitis and breast abscesses. Infant factors that increase the 
transmission risk are preterm (low birth weight), duration of breast feeding, mixed 
feeding and oral diseases. The risk of MTCT, without intervention, during pregnancy is 
5-10%, during labour and delivery it is 10-15% and during breast feeding 5-20% 
(FMOH/HAPCO 2011:10). The WHO has developed seven strategic directions to 
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accelerate the scale up of HIV prevention, care and treatment for women and children, 
namely to:  
• strengthen commitment and leadership for achieving full coverage of PMTCT 
services;  
• provide technical guidance to optimise HIV prevention, care and treatment 
services for women and children;  
• promote and support the integration of HIV prevention, care and treatment 
services within maternal, newborn and child health and reproductive health 
programmes;  
• ensure reliable and equitable access for all women, including the most 
vulnerable;  
• promote and support health systems interventions to improve the delivery of HIV 
prevention, care and treatment services for women and children;  
• track programme performance and impacts on MTCT rates and maternal and 
child health outcomes; and 
• strengthen global, regional and country partnerships for providing HIV 
prevention, care and treatment for women, infants and young children and 
advocate for increased resources (WHO 2010c:12). 
 
Successful operational studies are those that can change policy and practice. 
Operational research can guide the scale up and implementation of PMTCT 
programmes. Countries may consider the following when undertaking operational 
research on PMTCT:  
• the most effective strategy for providing and monitoring CD4 testing; 
• the feasibility and impact of ART for eligible pregnant women in ANC settings; 
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• the effect and impact of task shifting for PMTCT programme, PMTCT 
interventions at facility, community and household level that have greater impact 
on retention in care; and 
• operational research related to PMTCT prong 1 and 2 (WHO 2012a:28).  
 
A study was conducted in Rwanda to compare two service delivery models for PMTCT 
during a transition from administering single Nevirapine at onset of labour to giving 
multidrug ARVs to pregnant women. The two service delivery models compared were 
full package versus stand-alone sites. Full package sites provide both ART and PMTCT 
at the same sites while stand-alone sites provide PMTCT services only. Accordingly by 
December 2006, 37.5% of sites were providing full package services and 62.5% were 
stand-alone sites in Ethiopia. Between July 2006 and December 2008, a total of 40 674 
women used ANC services, 99% accepted HIV testing and 4% tested HIV-positive. Out 
of these HIV-positive women, 69% received their CD4 count during pregnancy and 71% 
of them received ARVs for PMTCT. CD4 count assessments differed across the models 
with 30% more likely to be undertaken at full package than at stand-alone sites. 
Enrolment of HIV-positive women into ARV service was twice more likely to be provided 
at full package than at stand-alone sites (Tsague, Tsiouris, Carter, Mugisha, Tene, 
Nyankesha, Koblavi-Deme, Mugwaneza, Kayirangwa, Sahabo & Abrams 2010:4-5). 
 
2.4.1 Primary prevention of mother to child transmission of HIV 
 
A study from India interviewed 7 956 women and only 19% of them identified the correct 
and incorrect answers concerning ways of HIV transmission. Although 39% of them 
knew the correct way of transmission, 26% failed to describe this correctly. The 
awareness HIV transmission through sexual contacts was 73%, sharing needles 67%, 
blood transfusion 67%, vertical transmission 64% and breast feeding 42%. Only 13% of 
the women believed the use of ARVs could prevent MTCT while 74% were unsure 
(Firth, Jeyaseelan, Christina, Vonbara, Jeyaseelan, Elan, Abraha, Joseph, David, Cu-
Uvin, Lurie, Wanke & Lionel 2010:208).  
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Information, education and communication are essential to create awareness at 
community and facility level. Better informed and more aware people could be 
empowered to protect themselves and their children from HIV.  
 
A study in the town of Gondar, Ethiopia, interviewed 400 pregnant women and found 
that 88.5% of them knew that HIV could be transmitted from mother to child, 83.5% 
knew that MTCT of HIV is preventable; 35.9% indicated that HIV can be transmitted 
during pregnancy, 33.6% during labour and 24.9% during breast feeding; 58.4% knew 
about the protective effect of ARVs.  
 
Compared to older women (35-49yrs), women aged 15-24 were 4.48 times more likely 
to have better knowledge about MTCT. Women who had secondary and tertiary 
education were 6.85 times more likely to have MTCT knowledge than those with no  
 
education. Women who used ANC services in hospitals were 4.49 more likely to know 
about MTCT of HIV than those who used ANC services at health centers (Malaju & 
Alene 2012:3-4).  
 
2.4.2    Family planning, HIV counseling and testing for prevention of mother to 
child transmission of HIV 
 
A study from the United Kingdom (UK) assessed fertility intentions of HIV-infected 
women. Out of 521 women, 86% completed questionnaires and 6% were pregnant at 
the time of the survey. Three quarters of the women stated that they would like to have 
more children. Black African women were more likely to have three or more children 
and to have a history of trying to become pregnant for more than six months, compared 
to other women in that study. For 45% of women, their HIV diagnosis had not affected 
their intentions to have more children. The number of previous pregnancies and time 
since HIV diagnosis were significantly associated with not wanting more children. 
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Almost all women (91%) were aware of the availability of PMTCT services. This finding 
suggests the need for specialised family planning services targeting HIV-infected 
women (Cliffe, Townsend, Cortina-Borja & Newell 2011:1094-109).  
 
A systematic review from India reported that PMTCT services focused mainly on 
reducing MTCT and neglected the integration of family planning into this programme. As 
a result, women’s reproductive rights did not get due attention (Darak et al 2012:9).  
 
Family planning is prong 2 of the PMTCT strategy, as discussed in section 1.1 of this 
thesis. It helps to protect children from becoming infected by enabling the mother to 
make informed choices about using family planning services. So, this component should 
not be neglected.  
 
A Vietnamese study included 300 participants on prenatal HIV testing uptake. Out of 
them, 40% were tested before the end of 34 weeks’ gestation, 5% at 35-40 weeks’ 
gestation and the rest were tested during labour. Women who did not attend high school 
were less likely to be tested during the prenatal period compared to those who had 
done so.  Women who worked as farmers and earned less than two million Vietnamese 
Dong were less likely to be tested compared to women who were government workers 
and who earned more than four million Vietnamese Dong. Distance also affected HIV 
testing. Women who traveled more than 15km to the hospital were less likely to be 
tested compared to those who traveled less than 5km (Nguyen et al 2010:454-455).  
 
A different study from India reported that out of 7 956 interviewed women, 91% were 
tested for HIV and 51 of them were HIV-positive. The sero prevalence rate was 0.7% 
among both urban and rural women. All these HIV-positive women reportedly had one 
lifetime sexual partner, with the exception of one woman. However, 18 of the HIV-
negative women reported that they had more than one life time sexual partner. Only one 
woman out of 104, who had blood transfusions, were HIV-positive and out of 1 124 
women who underwent major surgery only one was HIV-positive (Firth et al 2010:208). 
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A South African study indicated that out of 116 HIV-positive women, 59.5%  had shared 
their HIV-positive status with someone else, with the highest disclosure being with 
partners (51.%), followed by mothers (20.7%), sisters (16.4%) and friends (1.7%). Only 
14.9% of HIV-positive pregnant women were accompanied by their partners to ANC 
clinics. Approximately half (54.3%) of the HIV-positive women were comfortable 
discussing condom use with their partners to prevent pregnancies; 76.3% were 
counseled about safe sex during pregnancy but only 65.8% of them practised safe sex. 
Postnatally, 92.2% of these women received family planning counseling. The most 
frequently used contraceptives were condoms, followed by hormonal injections and 
pills. Out of  these HIV-positive women, 4.3% intended to have another child within a 
year, 5.2% within 2-3 years, 29.3% after 3 years and 61.2% did not intend having any 
more children (Peltzer, Chao & Dana 2009:975-976). 
An Ugandan study examined contraceptive use and associated factors among women 
enrolled in HIV programmes. Among married HIV-positive women, 71% had HIV-
infected spouses, 5% had HIV-negative spouses, 18% did not know their spouses’ HIV 
status and 7% did not report their spouses’ HIV status. Only 7% of these HIV-positive 
women were on ART, 28% were using contraceptives, (52% used injectable hormones, 
30% condoms and 9% oral contraceptives). The variables that were significantly 
associated with contraceptive use were educational level, marital status, monthly 
income, having children (who are alive) and HIV status of the spouse. Contraceptive 
use among single and previously married women was lower than among married 
women. Having completed secondary education, earning higher monthly incomes and 
having three or more children were significantly associated with the use of 
contraceptives (Muyindike,  Fatch, Steinfield, Matthews, Musinguzi, Emenyonu, Martin 
& Hahn 2012:3). A rural western Kenyan study reported that out of 22 566 women who 
were tested for HIV at the ANC clinic, 1 668 were HIV-positive. Among the HIV-positive 
women, 1 036 actually registered for participation in the PMTCT programme.  However, 
632 of these women were lost during the follow-up actions (Azcoaga-Lorenzo, Ferreyra, 
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Alvarez, Palma, Velilla, E & Del Amo 2011:276). Addressing loss during the PMTCT 
follow-up phases is an important issue.  
 
A study was conducted in Gambela, Ethiopia, to identify determinants of refusal of HIV 
testing among women attending ANC. A total of 332 women participated in the study 
and their median age was 23 years among those willing to be tested and 22 years 
among those who refused HIV testing. Lower education levels were associated with 
refusal to use HIV testing services. Those women who rated pre-test counseling as fair 
were six times more likely to refuse HIV testing compared to those who rated pre-test 
counseling to be very good. Those women who were unsure about privacy issues were 
five times more likely to refuse HIV testing compared to those who expected that 
privacy would be maintained during counseling and testing. Pregnant women who had 
given birth to 2-3 live infants were more likely to refuse VCT compared to those who 
had not given birth to a live infant (Fanta & Worku 2012:3-6). A different study was 
conducted in Diredawa, Ethiopia, to identify determinants of acceptance of VCT at ANC. 
VCT is the entry point for PMTCT services since those pregnant women who test HIV-
positive can access PMTCT services. A total of 234 pregnant women participated in the 
study, 117 cases and 117 controls. Older women, ≥30 years old, were 78% less likely to 
accept VCT as compared to the younger women (≤19 years old). Married women were 
more likely to accept VCT as compared to single ones (OR=22.5).  Employed women 
were four times more likely to be tested than unemployed women. Variables like 
ethnicity, religion, educational status and family size were not associated with 
acceptance of VCT. Mothers who had good knowledge of HIV, MTCT and VCT were 23 
times more likely to be tested than those who had poor knowledge. Women who had 
two or more ANC visits were 2.5 times more likely to be tested for HIV (Demissie, 
Deribew & Abera 2009:142-144).  
 
2.4.3    Antiretroviral intervention, adherence and breast feeding for the 
prevention of mother to child transmission of HIV 
 
46 
 
A literature review was done to assess the effect of ARVs on PMTCT. One study from 
the review showed that out of 604 pregnant women, exposed to EFV during the first 
trimester, 2.8% gave birth to babies with birth defects. Another study from this review 
showed an overall birth defect rate of 4.3% after first trimester exposure to EFV. This 
shows some variations among studies on the effects of ARVs on birth defects. In a 
pooled adjusted analysis of American and European-based studies, triple ARV drugs 
reportedly had 1.5 times more premature deliveries than dual ARV regimens. A Dutch 
case control study revealed first trimester triple ARVs to be associated with a 44% 
preterm delivery rate and 21% when the ARV drugs were taken in the second or third 
trimester. Using data from a Botswana study, at birth HIV-uninfected infants’ in utero 
exposure to triple ARVs resulted in significantly lower weight, length and weight for 
length as compared to those exposed to ZDV alone. Another study from this review 
found no association between neurological assessment and exposure to ARV drugs in 
utero among HIV-exposed but uninfected children at two years of age (Heidari, 
Mofenson, Cotton, Marlink, Cahn & Katabira 2011:291-293).  
 
A study was done in Haiti to assess HIV free survival and morbidity among formula fed 
infants on a PMTCT programme. A total of 254 mother-infant pairs were included in the 
study. At 18 months of age, nine children were HIV-infected and 17 had died resulting in 
a 90.6% HIV-free survival. When analysis was restricted to exclusively formula fed 
infants, HIV free survival rate was 93.7% and MTCT rate of 3.2%. Among infants who 
were never breast fed, HIV free survival was slightly better. In this study prevalence of 
diarrhoea was 12.2% among those children in the PMTCT group. Diarrhoea was found 
to be 2.9 times more prevalent among the community group as compared to PMTCT 
infants. This study concluded that breast milk substitute was safe, effective and feasible 
for HIV-infected mothers choosing this option (Ivers, Appleton, Wang, Jerome, Cullen & 
Fawzi 2011:4-5). 
 
A systematic review was done in Nigeria to assess PMTCT’s effects. AZT has the 
longest history of effectiveness and safety during pregnancy. However, AZT is 
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associated with anaemia and should be avoided in women with haemoglobin levels of 
≤8mg/dl. NVP is used most commonly in developing countries for PMTCT as a single 
dose. It is also safe and effective but associated with hepatotoxicity, skin rashes and 
lactic acidosis. EVF is an alternative for NVP but associated with embryopathy in less 
than 1% of cases. Since Stavudine (D4T) and Didanosine (ddI) are associated with 
lactic acidosis, they are not recommended during pregnancy. Protease Inhibitors (PIs) 
are very effective ARVs but associated with muscular dystrophies. According to this 
review, the two main infant feeding options are breast milk substitutes (BMSs) and 
breast milk options. BMSs are animal milk that are modified and effective substitutes for 
human milk. BMSs are available as commercial infant formula or home-prepared infant 
formula. During the first 4-6 months of life the infant needs to be fed on breast milk 
substitutes when this option is chosen. If the breast milk options is selected, then infants 
should be breast fed exclusively for six months (Nkwo 2012:58-62). 
A study from Cameroon assessed the effectiveness of multidrug ARVs on MTCT. A 
total of 418 mother-infant pairs’ data were analysed. The median age of the women was 
27 years and the median CD4 count was 380cells/mm3. Taking into consideration that 
these women received multidrug ARV regimens before delivery, the MTCT rate was 
6.6%. Mothers with CD4 counts below 350cells/mm3 had a four fold increased risk for 
MTCT (Tchendjou, Same-Ekobo, Nga, Tejiokem, Kfutwah, Nlend, Tsague, Bissek, 
Ekoa, Orne-Gliemann, Rousset, Pouillot & Dabis 2010:4). Another study with a similar 
objective was conducted in Burkina Faso to examine the impact of HAART on MTCT. 
The sample size comprised 581 HIV-infected women, 55.6% of them were on 
monotherapy and 44.4% of them were on triple therapy. Among women on HAART, 
59.2% of them had received treatment before their current pregnancies and the rest 
received it during their current pregnancies. A total of 460 of the children received single 
doses of NVP. The rate of MTCT among those on short course ART was 6.2% and 
among those on HAART it was 0% when tested at 2-6 months of age. However, the rate 
of transmission was 3.6% among formula fed children and 7.8% among breast fed 
children for mothers on monotherapy. A total of 62 children died before their HIV status 
became known of whom 8% were born from mothers receiving short course ART and 
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13% from mothers receiving HAART. Among the deceased children, 10.5% were bottle-
fed and 14.3% were breast fed (Kouanda et al 2010:844-847) 
 
A South African study assessed factors associated with short course ARV prophylaxis 
adherence during PMTCT. Out of 139 HIV-positive pregnant women attending ANC, 
66.2% initiated AZT, 19.4% took ARVs and 14.4% were on neither AZT nor ARVs. Out 
of 607 HIV-positive post natal women, 88% had initiated AZT, 10% were on ARVs and 
2% had not received AZT. However, 61% of the antenatal women and 85.9% of the 
post natal women reported complete adherence to the regimen for the past four days 
preceding the interview date. Out of these women, 23 in the antenatal clinic and 40 in 
the post natal clinic, reported that they had missed at least one dose of the regimen. 
The most common reasons for missing doses were being away from home without the 
medication, forgetting to take the pills and falling asleep. A higher PMTCT knowledge 
score, disclosure of HIV status, not having consulted a traditional birth attendant during 
pregnancy, having social support and not having faced discrimination were associated 
with adherence to maternal AZT. Similarly lower levels of education, being single, 
disclosure of HIV status, not having consulted a traditional birth attendant during 
pregnancy, less experience of internalised stigma,  less experience of discrimination 
with care providers, lower depression and higher social support were associated with 
infant AZT adherence (Peltzer, Sikwane & Majaja 2011:1253-1256). 
 
A study from Soweto, South Africa, revealed that 57% of mothers and 31% of infants 
received inadequate PMTCT ARV regimens in accordance with the country’s national 
guideline. Challenges experienced by participants towards PMTCT services were 
delayed ANC attendance because of facility-related barriers and apprehension of 
antenatal HIV testing, maternal fears of HIV-related stigma affecting decision about 
PMTCT uptake and confusion about mixed messages on infant feeding. Different kinds 
of infant feeding options were introduced to the mothers such as formula feeding and all 
the available options. There was insufficient counseling about associated risks of the 
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infant feeding methods (Laher, Cescon, Lazarus, Kaida, Makongoza, Hogg, Soon, Miler 
& Gray 2012:93).  
 
A study from Mozambique revealed that the Ministry of Health recommended weaning 
the babies of HIV-infected women at six months of age and avoiding breast feeding 
altogether, if at all possible. However, no specific recommendations regarding 
pasteurisation or heating of expressed breast milk was provided by the clinic staff. 
Serious problems could arise when the health system transmits conflicting messages as 
opposed to the Ministry of Health’s recommendations (Agadjanian & Hayford 2009:107).  
 
According to a study from Cote d’Ivoire, HAART substantially reduced MTCT of HIV. 
The still birth rate was 3.1% but this did not differ among those women who received 
HAART and ARV prophylaxis. Low birth weights were reported in higher proportion 
among those who received HAART as compared to those who received ARV 
prophylaxis. Neither low birth weight nor maternal exposure to ARVs was associated 
with infant mortality among the HIV-uninfected infants. The only factor associated with 
infant mortality was paediatric HIV infection (Ekouevi et al 2008:1817-1818).  
 
A Ugandan study investigated the effect of ARVs on early infant HIV infection rates. 
From January 2007 to May 2009, 75 159 pregnant women were registered at Mulago 
Hospital for ANC. As many as 99.7% of these women knew their HIV status through 
either rapid HIV testing or with a known HIV-positive status result when registering for 
ANC. Prevalence of HIV was 10%, of whom 96.5% received ARVs, including sdNVP. 
Among women receiving HAART, 35.5% were older than 30. The early infection rate 
was highest among those infants whose mothers received no ARV interventions 
(36.4%), followed by infants whose mothers received sdNVP at the time of labour and 
delivery (11.2%). The infant infection rate for those babies whose mothers received a 
combination ARVs of AZT+sdNVP was 4.6%; and AZT/3TC+sdNVP was 3.9%. The 
lowest rate was found among those babies whose mothers received HAART at 1.7%. 
This study concluded that the use of combination ARVs is feasible and effective for 
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PMTCT (Namukwaya, Mudiope, Kekitiinwa, Musoke, Matovu, Kayma, Salmond, 
Bitarakwate, Mubiru, Maganda, Galla, Biamugisha & Fowler 2011:71-72). 
 
A study done in the Gurage Zone of Ethiopia had a total of 657 respondents. Among 
these, 60% mentioned exclusive replacement feeding for infants younger than six 
months of age as an option for PMTCT. The other 24% mentioned breast milk as an 
option. The rest (16%) mentioned mixed feeding but did not know what to feed their 
infants. Only 24% knew that HIV could be transmitted from mother to child through 
breast feeding. Those respondents, who knew about HIV/AIDS and resided in urban 
areas, knew more about infant feeding options as recommended by the WHO than 
other women. Hence more information and communication activities were required in 
this area to increase infant feeding knowledge and improve PMTCT outcomes 
(Belachew & Jira 2007:41-42).  
Another study from northwestern Ethiopia included 209 HIV-positive women and 90.4% 
of them gave birth between 30 and 48 weeks of gestation and out of these 8.6% had 
post term deliveries. Only 66% of these women were on ART. Among those not taking 
ART, 64.8% took NVP starting from 28 weeks’ gestation, 4.2% a week before the onset 
of labour, 12.7% during labour and 18.3% had never taken NVP. Regarding information, 
58.4% got information about infant feeding from nurses, 55.5% from counselors, 10.5% 
from the mass media, 3.8% from their families and 2.9% from their friends. Only 1.9% of 
them said that they had never been advised about infant feeding. With regard to HIV 
transmission, 92.3% of them knew that HIV could be transmitted to the child during 
pregnancy, labour and breast feeding. About feeding options, 39.2% mentioned that 
EBF is the only infant feeding option. As to the practice, 10.5% of the participants 
practised mixed feeding. Stigma of HIV/AIDS, insufficient breast milk and husbands’ 
opposition affected their infant feeding options and practices (Muluye, Weldeyohannes, 
Gizachew & Tiruneh 2012:2-4). 
 
A different study conducted in Ethiopia found progressive declines in medication 
adherence rates during PMTCT interventions. Out of a cohort of 282 mothers 
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participating in the study, 232 initiated ARVs during pregnancy. Taking into 
consideration the type of medication, 64% of them initiated AZT prophylaxis and 33% 
lifelong ART. Adherence was assessed using one week’s recall. Of those on AZT 
prophylaxis, 68% never missed a dose, 20% missed one dose and 12% missed more 
than one dose. Of those who initiated ART, 61% never missed a dose, 21% missed one 
dose and 18% missed more than one dose. Infants who were born at health facilities 
were more likely to ingest medication at delivery than those born at home (Mirkuzie et 
al. 2011:4-5).  
 
2.5    FACTORS AFFECTING MOTHER TO CHILD TRANSMISSION OF HIV 
 
Factors affecting MTCT of HIV are categorised as maternal factors, infant factors and 
obstetric and delivery practices. Maternal factors include high viral loads, new or recent  
maternal HIV infections, low CD4 counts, advanced maternal disease, viral or parasitic 
placental infections during pregnancy, labour and childbirth, maternal malnutrition and 
nipple fissures, cracks, mastitis and breast abscesses. Infant factors are first infant in 
multiple births, preterm low birth weight, duration of breast feeding, mixed feeding and 
oral diseases in the child. Obstetric and delivery practices include rupture of 
membranes for more than four hours prior to delivering the baby, injuries to the birth 
canal during child birth, ante partum procedures such as amniocentesis, external 
cephalic version, invasive child birth procedures, vaginal delivery, delayed infant drying 
with clean towels and eye care and routine infant airway suctioning (FMOH 2011:9-10).  
 
A study conducted in the Dominican Republic analysed infant and child data from the 
PMTCT programmes and identified factors contributing to the rate of MTCT. The MTCT 
rate varied by type of delivery. During the period 1999-2008, 6.8% of infants were born 
by Caesarean section and 23.9% of infants were born vaginally. For the period 2009-
2011, the MTCT rate was 2.5% among those delivered by Caesarean section and 7.5% 
among those born vaginally. The MTCT rate also varied in 1999-2008 from 8.1% among 
those exclusively formula fed infants to 37.3% among exclusively breast fed infants 
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(Lorenzo, Beck-Sague, Bautista-Soriano, Halpern, Roman-Poueriet, Henderson, Perez-
Then, Veras, Connolly, Callender & Nicholas 2012:5).  
 
A study from Zimbabwe assessed risk factors of HIV vertical transmission. Out of the 
initial cohort of 479 HIV-infected pregnant women, 9.4% had no delivery information. 
From the remaining 434 mother-infant pairs, 10.6% infants died without definitive HIV 
diagnosis. There was no significant difference among women who transmitted HIV and 
those who did not transmit HIV to their infants in terms of maternal and paternal age, 
gravidity, marital status, partner circumcision status and risky behaviours such as 
maternal alcohol use. Additionally no significant association was observed for maternal 
total lymphocyte count, haemoglobin, history of prolonged fever, diarrhoea and the 
presence of tuberculosis. Mothers with swollen and tender breasts discharging puss 
were twice more likely to be vertical transmitters. Vaginal infections (Trichomonas  
Vaginalis, Bacillus Vaginosis and Candida Albicans) were significantly associated with 
vertical transmission of HIV. Low birth weight infants were more likely to be infected 
(Gumbo, Duri, Kandawasvika, Kurewa, Mapingure, Munjoma, Rusakaniko, Chirenje & 
Stray-Pedersen 2010:718-719). 
 
2.6 OUTCOMES OF PREVENTION OF MOTHER TO CHILD TRANSMISSION      
 INTERVENTIONS 
 
Different metrics can be used to measure the effectiveness and impact of PMTCT 
programmes. These include new paediatric infections, rate of MTCT, maternal survival 
and health, child survival and health and HIV-free survival of babies born to HIV-positive 
mothers. It is recommended to estimate PMTCT outcomes at six weeks and 18 months 
post natally. The six weeks period reflects transmission during the peripartum phase 
and the 18 month period reflects transmission through breast feeding. Outcomes of 
PMTCT can be assessed by following a cohort of mother-child pairs either prospectively 
or retrospectively. In case of a retrospective cohort study, information can be obtained 
on mother-child pairs including PMTCT interventions received and these outcomes. 
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This study used a retrospective cohort design. To calculate the rate of MTCT, the 
number of infants with positive deoxyribonucleic acid polymerase chain reaction (DNA-
PCR) should be divided by the total number of HIV-exposed infants (HEI). Stratified 
early infant diagnosis (EID) by age group (less than six weeks and older ages) is 
important to differentiate early prenatal transmission and later post natal transmission 
(WHO 2012b:4-26). 
 
HIV antibody assays are used for children older than 18 months for screening purposes 
to determine their HIV status. This assay is used for those above 18 months of age as a 
diagnostic technique. However, because of the passage of maternal antibodies through 
the placenta the test cannot be used as a confirmation of infant HIV infection. 
Nevertheless, this test indicates maternal infection and exposure of the infant. HIV 
virological assay is used for children at or after six weeks of age for clinical diagnostic 
purposes. This technique can be used up to 18 months of age. Hence, early screening 
for exposure facilitates ARV prophylaxis for the HIV-exposed infant. Consent either from 
the parent or legal guardian is required whenever HIV testing is performed (WHO 
2010d:18-26). 
 
This research used the HIV status of the child, health status of the mother and patients’ 
satisfaction to measure PMTCT outcomes. A study from Thailand assessed pregnancy 
outcomes among HIV-infected women receiving ART. A total of 246 HIV-infected 
pregnant women were included in the study and classified into three groups. Those who 
received combined ART, those who received ARVs during ANC and those who received 
ARVs only during labour. Nausea and vomiting was documented only for 1.6% of these 
women as a side-effect of taking ARVs. The mode of delivery was normal for 72% of the 
women, caesarean sections for 19%, vacuum extractions for 2.8% and forceps 
extractions for 0.8%. Regarding gestational age at time of delivery, 84.6% had full term 
deliveries, 10.2% pre-term deliveries and one had a still birth. Pre-term delivery was 
significantly higher among pregnant women on combined ART and among those who 
started PMTCT during labour because of not attending ANC clinics than among women 
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on ART during ANC. The incidence of low birth weight was 20% and this was higher 
among infants whose mothers started PMTCT during labour. The incidence of low 
Apgar scores was 3.6% (Apgar score=0) and this was also higher among infants whose 
mothers started PMTCT during labour (Areechokchai et al 2009:9-12). 
 
A study from Zimbabwe assessed the effect of maternal HIV status on infant mortality.  
The study analysed 469 HIV-positive and 569 HIV-negative mother-infant pairs. Over a 
nine months’ follow-up period, 51 infants born to HIV-positive mothers and 20 infants 
born to HIV-negative mothers died. The mortality rate of infants was 150 per 1 000 
person-years among those born form HIV-infected women and 47 per 1 000 person-
years among those born form HIV-negative women. Additional risk factors for mortality 
among those born from HIV-infected mothers were infant HIV positive status, having a 
deceased mother and low birth weight. Infants who were not breast fed had the highest 
risk as compared to exclusively breast fed or mixed fed babies regardless of the HIV 
status of the mother. Among infants born to HIV-negative mothers, having a deceased 
mother was the only risk factor identified besides not being breast fed (Kurewa, Gumbo, 
Munjoma, Mapingure, Chirenje, Rusakaniko & Stray-Pedersen 2010:89-90). 
 
A study from Zomba district, Malawi, included 387 mother-infant pairs to examine the 
outcomes of PMTCT. There were 6.4% maternal deaths among HIV-infected women. 
Children of HIV-infected women were four times more likely to die during the time of the 
study than those of HIV-uninfected mothers. The rate of transmission among living 
tested children was 13.5%. HIV-free survival at 18-20 months of age among HIV-
exposed children was 66.2% and among HIV-unexposed children was 93.1% (Lettow, 
Bedell, Landes, Gawa, Gatto, Mayuni, Chan, Tenthani & Schouten 2011:4-5).  
According to a different study in Cote d’Ivoire, introducing the PMTCT programme can 
improve the quality of ANC and intra-artum care in general. Before the introduction of 
the PMTCT programme, VCT was never proposed to women attending ANC in five of 
the health facilities of the study sites. But after PMTCT introduction, VCT was offered to 
63% of the women visiting the clinic. After the introduction of the PMTCT programme, 
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inter-personal communication and confidentiality between health care providers and 
clients improved. This might also increase patient satisfaction. Additionally individual 
health information and promotion on nutrition, HIV prevention and family planning 
improved (Delvaux et al 2008:972-973). 
 
A study from an urban hospital in Angola examined the effectiveness of a PMTCT 
programme. A total of 104 mothers’ and 107 infants’ data were analysed. Regarding 
HIV status, 52.9% of the women were not diagnosed with HIV before pregnancy and 
19.2% of them had a previous history of ART. Data on duration of pregnancy was 
available for 69 women and preterm deliveries were recorded for 31.9% of them. The 
most common ARV regimen during pregnancy was AZT+3TC+NVP (91.2%). A total of 
36 women presented after delivery, having received no ART during pregnancy. As to 
the feeding option, 86.1% of their infants were breast fed, 69.4% through exclusive and 
16.7% through nonexclusive breast feeding, implying mixed feeding. Mortality during the 
follow-up period among the women with ART during pregnancy was 4.4% and among 
those with no ART was 16.6%. Among the infants who were followed up, 8.4% had died 
and 4.7% had unknown HIV status. HIV transmission in the two groups of infants, born 
from mothers who received ART and from mothers who received no ART, was 1.5% 
and 37.1%. Overall, exposure to breast feeding was associated with a significantly 
higher level of HIV transmission or death (OR: 5.70). The risk of HIV transmission or 
death was significantly higher among those who did not receive AZT as postnatal 
prophylaxis compared to infants who received postnatal AZT prophylaxis (OR: 6.23) 
(Lussiana, Clemente, Ghelardi, Lonardi, Tarquino & Floridia 2012:2-7). 
 
2.6.1    HIV status and exposure of children  
 
A study conducted in the Dominican Republic evaluated the progress towards the 
elimination of MTCT from 1999 to 2011. Data from 1 576 infants and children were 
analysed. The ages at specimen collection ranged from 20 days to 25 months. Overall 
HIV was diagnosed among 154 infants and children. The proportion of infection 
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declined from 11.1% in 1999-2008 to 4% in 2009-2011. The MTCT rate was higher 
among infants whose mothers used sdNVP than among those infants whose mothers 
used prenatal HAART in 1999-2008 and in 2009-2011 (6.4% versus 2.5% and 5.7% 
versus 2.9% respectively) (Lorenzo et al 2012:3-5).  
 
A study conducted at Saint Camille Medical Center in Burkina Faso included 1 300 
pregnant women in the study and 378 of them tested positive for HIV-1. As to ARVs, 
69.84% of them received ARV prophylaxis and 30.16% received HAART for PMTCT. 
The prevalence of HIV-1 among their children by DNA-PCR was 0% and 6.82% among 
those born from mothers receiving HAART and ARV prophylaxis respectively. The 
mortality rate was 1.32% among children who were born from HIV-positive mothers. 
This study showed the effectiveness of HAART in comparison to ARV prophylaxis for 
reducing the rate of MTCT (Linguissi, Bisseye, Sagna, Nagalo, Ouermi, Djigma, 
Pignatelli, Sia, Pietra, Moret, Nikiema, & Simpore 2012:992-994).  
 
A Nigerian study investigated the prevalence of HIV among exposed infants. A total of 
298 children participated in the study. Out of these, 77.9% were brought to hospital for 
early infant diagnosis within three months of birth. The rate of MTCT was 2.1% after 
receiving PMTCT services. Proportionally 72.7% of the infants were born to mothers 
with CD4 cell counts greater than 250cells per mm3. Mothers who had been on HAART 
for a long time, preceding their latest pregnancies, had a lower chance of transmitting 
HIV to their babies (Esene & Omoigberale 2012:107-110). A study from South Africa 
included data from 1 622 women in its analysis. Regarding HIV status, 99.2% of them 
tested for HIV and 630 (38.8%) were HIV-positive. There were 352 preterm deliveries in 
this study population. The median gestational age was 35 weeks. There was a 
significantly higher proportion of preterm deliveries from HIV-positive women than 
among HIV-negative women (25.20% vs 19.78%). Women who received HAART were 
no more at risk of delivering preterm babies as compared to those who did not receive 
HAART but eligible to receive HAART. There were eight still births among the study 
population but there was no significant difference between HIV-positive and HIV-
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negative women. Low birth weight was significantly more common among HIV-positive 
women. For diagnosis, 58.9% of the HIV-exposed children were tested for HIV by DNA 
PCR. Nine of these infants were confirmed to be HIV-infected at birth. The in-utero 
transmission rate was highest among those who required HAART but did not receive it 
(8.5%), followed by those who received HAART (2.7%) and finally those not eligible for 
HAART but receiving ARV prophylaxis (0.4%) (Hussain, Moodley, Naidoo & 
Esterhuizen 2011:304).  
 
A different study form South Africa assessed retrospectively infants of HIV-infected 
mothers who used PMTCT services. At six weeks, 220 infants were tested for HIV by 
DNA-PCR and six of them were HIV-positive. From birth to five months follow-up among 
264 infants in the cohort four of them died. The crude mortality rate at six months was 
15.2 per 1 000 live births (Chetty, Knight, Giddy, Crankshaw, Butler & Newell 2010:4-5). 
A South African study was conducted to determine the risk of being infected with severe 
infections among HIV-exposed infants. A total of 55 infants were included in the study of 
whom 27 were HIV-exposed uninfected and 28 HIV-unexposed uninfected. All HIV-
exposed uninfected infants remained HIV-uninfected at 6 and 12 weeks of age in the 
absence of breast feeding. Two HIV-unexposed uninfected infants at six months of age 
and 1 HIV-exposed uninfected infant at twelve months of age had moderate acute 
malnutrition. A total of 14 hospitalisations in the 10 HIV-exposed uninfected and four 
hospitalisations in the four HIV-unexposed uninfected infants were reported. The 
relative risk of hospitalisation for HIV-exposed uninfected infants were 2.74 times 
greater than for HIV-unexposed uninfected infants. Generally HIV-exposed uninfected 
children experienced increased risk of infection-related hospitalisations in the absence 
of the increased number of infectious agents, advanced maternal disease or infant 
malnutrition (Slogrove, Reiki, Naidoo, Beer, Kevin, Cotton, Bettinger, Speert, Esser & 
Kollmann 2012:507). 
 
A study from Rwanda examined under two child mortality rates according to maternal 
HIV status within the national PMTCT programme. A total of 3 020 children were 
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selected for the study of whom 48.2% were HIV-exposed. Among the HIV-exposed 
children, 61 died by the age of 9-24 months while 24 died of those not exposed to HIV. 
The cumulative risk of death was almost three times higher among those exposed to 
HIV as compared to those not exposed to HIV. Excluding HIV status, household assets 
were significantly associated with death. Ownership of assets were significantly lower 
among households who lost children as compared to households whose children lived. 
The risk of death was 50% lower among children whose mothers used four or more 
ANC visits as compared to children whose mothers used ANC services once only 
(Mugwaneza, Shema, Ruton, Rukundo, Lyambabaje, Bizimana, Tsague, Wagner, 
Nyankesha, Muita, Mutabazi, Nyemazi, Nsanzimana, Karema & Binagwaho 2011:4). A 
study from rural western Kenya showed that out of the 1 668 mothers initially identified 
as HIV-positive, the final HIV status after breast feeding was known for 309 babies 
alone revealing that 260 were HIV negative and 49 were HIV positive. Thus the rate of 
MTCT after the breast feeding period was 15.86%. Out of the 767 newborns, 40.2% of 
the babies completed the follow-up, 3.6% died and 19.3% were lost to follow-up. 
Therefore to reduce the burden of paediatric HIV infection significantly, universal access 
to PMTCT service is crucial (Azcoaga-Lorenzo et al 2011:276-278). 
 
2.6.2 Health outcomes of mothers receiving prevention of mother to child  
 transmission of HIV services 
 
A Nigerian study involved a population of 130 women between the ages of 17 and 40 
who came to a hospital for ANC and PMTCT services. Out of these, 65 were HIV-
positive and the other 65 were HIV-negative. The age group of 26-30 years had the 
highest HIV prevalence (33.4%) and the lowest HIV prevalence was observed among 
thos 36-40 years old. The median CD4 cell count among HIV-positive women was 287 
cells per µL and among HIV-negative women it was 534 cells per µL. The result from 
this study confirmed that HIV in pregnancy affects CD4 cell count and pregnancy by 
itself may partially deplete the CD4 cell count. In the absence of accompanying disease 
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conditions, chronological age did not affect the CD4 cell count (Ekwempu, Ekwempu, 
Ikeh, Olabode & Agaba 2012:169-170). 
 
A study from Malawi included 173 HIV-infected and 214 HIV-uninfected women to 
assess mortality and health outcomes with routine PMTCT services. At 18-20 months 
postpartum, no death was documented among the HIV-uninfected infants. However, 
among HIV-infected infants, the mortality rate was 42.4 deaths/1000 person years. 
Neither maternal age nor delivery at home was associated with maternal death. HIV-
infected women had higher parity than HIV-uninfected women. But there was no 
association of still births and preterm deliveries with HIV infection. The women who 
participated in the study were asked to rate their own health and 51.3% of them rated 
themselves to be in excellent health, 31.6% to be in good health, 15.7% as fair and 
1.3% reported poor health. Proportionally, 14% of the women had low body mass index 
(BMI) of less than 18.5 and this was not associated with HIV infection. Worse perceived 
health was associated with HIV infection and being poor. HIV-infected women were four 
times more likely to have minor signs and symptoms of disease and six times more 
likely to have major signs and symptoms than HIV-uninfected women. Only 20 of the 
HIV-infected women reported major signs and symptoms of ill health while being on 
ART (Landes, Lettow, Bedell, Mayuni, Chan, Tenthani & Schouten 2012: 2-4). 
 
A multi-country study in Africa revealed a decline in CD4 cell count after interruption of 
ARV prophylaxis received for PMTCT. At 12 and 24 months after delivery, 4.5% and 
11.6% of women with enrollment CD4 count of >250cells/mm3 had CD4 counts decline 
to <200cells/mm3 respectively. A total of 4.4% of the women experienced new WHO 
stage 3 and 0.4% of them reported new WHO stage 4 among those who initiated ARV 
prophylaxis with CD4 count >250cells/mm3. Among the women who initiated ARV 
prophylaxis with CD4 count >400cells/mm3, the cumulative probabilities of reaching 
CD4 count <350cells/mm3 at 12 and 24 months were 11.9% and 27.5% respectively. A 
total of 4.4% of these women experienced new WHO stage 3 but no new WHO stage 4 
manifestations occurred. ARV prophylaxis regimens, age and enrollment (baseline) 
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CD4 counts were significantly associated with CD4 count decline <200cells/mm3 and 
<350cells/mm3. Higher CD4 count at enrollment was associated with reduced 
probability of immunological decline at the end point (Ekouevi, Abrams, Schlesinger, 
Myer, Phanuphak & Carter 2012a:4-6). 
 
A different study was conducted in Kenya to examine CD4, viral response and 
adherence among ARV naïve breast feeding women while receiving PMTCT services. 
The study analysed data from 434 women who completed PMTCT interventions. The 
percentage of women with CD4 counts of <250 cell per microliter decreased from 23% 
at baseline to 5% at 24 weeks postpartum and this was significant. At baseline 6% of 
participants and at 24 weeks postpartum 79% of participants had undetectable viral 
loads. Among those who took NVP-based ARVs, 89% achieved undetectable viral loads 
as compared to 98% of participants who took Nelfinavir-based  ARVs. Adherence levels 
were significantly associated with achieving undetectable viral loads. A total of 82% of 
the adherent group achieved undetectable viral loads while only 65% non-adherent 
group achieved this (Okonji, Zeh, Weidle, Williamson, Akoth, Masaba, Fowler & 
Thomas 2012:251-254). 
 
2.6.3 Patients’ satisfaction with prevention of mother to child transmission of  
 HIV services 
 
According to a study at Hamidia Hospital in Bhopal, India, patient satisfaction towards 
ART services was rated to be excellent. A total of 256 respondents participated in the 
study, 17.79% of them were illiterate. Among the literate women, 7.03% were 
graduates. Clients’ attitudes with doctors’ services  were rated as excellent for the 
following factors: feeling at ease with doctor (83.98%), able to tell the doctor one’s 
problems (92.19%), doctors’ listening to one’s problems (87.90%), doctors’ 
understanding of the patients’ complaints (95.31%), doctors’ effective explanations 
(93.34%) and doctors’ help to improve the women’s health (93.34%) (Kishor, Pal, Rama 
& Vishal 2011:242). Similar findings were documented by a study done in Kenya, 
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including 326 women in the data analysis. This study compared the satisfaction levels of 
women attending fully integrated ANC, PMTCT and care and treatment services with 
non-integrated (or ‘stand-alone’) services. This integration of services made a difference 
in terms of satisfaction levels among those HIV-infected women, but not for HIV-
uninfected women. Hence, HIV-infected women preferred, and were more satisfied, with 
integrated services (Vo et al 2012:144). 
 
A study from public health facilities of Addis Ababa, Ethiopia, reported that 61.6% of 
pregnant women used ANC services (including VCT) on the same day they visited the 
health facility. The average waiting time at the ANC clinics was 39.8 minutes and the 
mean time for counseling (pre and post-test sessions) was 14 minutes. The women 
reportedly gained new knowledge from counseling about HIV and MTCT, the need for 
partner testing, living with HIV if HIV-infected, HIV prevention and transmission. As to 
clients’ satisfaction levels, 82.5% of the respondents reported that counseling room 
privacy was maintained and 92.2% were comfortable with the counselors’ handling of 
their clients and respecting of their clients. Regarding competency, 91.5% of the clients 
reported that they were satisfied with the technical competencies of the counselors 
(Ismail & Ali 2011:129-130). 
 
2.7    SUMMARY 
 
In this chapter the researcher reviewed relevant literature on PMTCT internationally, in 
Africa and according to the Ethiopian context. Detailed discussions were presented 
according to the theoretical frameworks of the study. The components of the two 
theoretical frameworks, HBM and Donabedian’s Model, were described. In this literature 
review the researcher focused on those factors affecting PMTCT service from HBF 
perspective, PMTCT services provided at health facility level, namely HCT, ARV 
intervention, breast feeding counseling and practices as well as outcomes of the PMTC 
services were described which included patient’s satisfaction with PMTCT services, 
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health status of the mother and HIV status of the baby from the perspective of 
Donabedian’s model.  
 
According to a systematic review from India, by Darak et al, the uptake of PMTCT 
service was low. Barriers of accessing PMTCT services included the lack of training 
among health care providers and inadequate attention to social and gender issues, 
perceived stigma and experience of discrimination in health facilities, poor education, 
low economic status of women and lack of support from partners. According to a study 
conducted across four African countries (Cameroon, Cote d’Ivoire, South Africa & 
Zambia) by Ekouevi et al (2012b: 6) higher PMTCT service coverage was associated 
with HIV test kits being found in the ANC (as opposed to in the laboratory), HIV testing 
was available in the labour ward, availability of CD4 testing at the facility, infant testing 
with DNA-PCR availability on most days of the month and the presence of an ANC 
register with PMTCT information.  
 
A study was conducted in Gambela, Ethiopia, by Fanta and Worku (2012) to identify 
determinants of refusal of HIV testing among women attending ANC. Lower education 
levels were associated with refusal to use HIV testing services. Studies from different 
parts of Africa such as in Burkina Faso by Kouanda et al (2010:848) and in Cameroon 
by Tchendjou et al (2010:6) showed decreased rates of MTCT after taking ARVs. 
Studies from Ethiopia by Belachew and Jira (2007:45) showed women breast fed their 
babies exclusively in the Gurage zone of Ethiopia. 
 
Patient satisfaction with ART services from India by Kishor et al (2011:242) was rated to 
be excellent. A multi country study in Africa by Ekouevi et al (2012a:10) showed a 
decline in CD4 count after interruption of ARV prophylaxis for PMTCT. Different factors 
affecting the HIV status of the baby were identified from the reviewed literature in 
relation to maternal, infant and obstetric and delivery practices. 
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In the next chapter the research design and methodology adopted by this study will be 
addressed. 
 
 
.  
.  
 
 
 
 
 
 
 
CHAPTER 3 
RESEARCH DESIGN AND METHOD 
 
3.1   INTRODUCTION 
 
This chapter describes the research design and method that were used to conduct the 
study. A quantitative research approach is essential to develop the body of knowledge 
that helps to improve health care and public health. Concepts that are relevant to 
quantitative research are basic research, applied research, rigour and control. Basic 
research is a scientific investigation that involves the pursuit of knowledge for the sake 
of knowledge. The purpose of basic research is to generate and refine theory and build 
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constructs. Hence, the findings might not be directly useful in practice. Basic research 
provides a basis for applied research.  
 
Applied research is conducted directly to improve public health and clinical practice. The 
purpose is then to solve problems, make decisions, or to predict outcomes. Applied 
research is also used to test theory. Thus this study used applied research methodology 
to examine PMTCT services and its outcomes which are relevant to improving mothers’ 
and infants’ health and to reduce the incidence of MTCT.  
 
Rigour implies striving for excellence in research and involves discipline, adherence to 
detail and accuracy. Rigour ensures precise measurement methods, representative 
samples and controlled design. The researcher in this study applied rigour through 
using appropriate data collection techniques, proper sample size determination and 
applying a cohort design. Control shows the application of rules by the researcher to 
avoid the possibility of errors and making sure that the findings are accurate reflections 
of reality. Controlling confounding variables, sampling criteria, selection of the research 
setting, data collection technique and analysis are some of the areas to which control 
applied during this study (Burns & Grove 2005:32-34).  
 
In an observational study the aim of the researcher is to examine the relationship 
between characteristics and events without manipulating the variables. The 
characteristic can be a treatment, behaviours, environmental factors, laboratory 
measurements, or genetic markers. An event can be an outcome or the occurrence of a 
disease. In this study the outcomes are related to maternal health, child HIV status and 
patient satisfaction. Observational studies can be either prospective or retrospective. In 
a prospective study subjects are selected based on the presence or absence of specific 
characteristics. In a retrospective study subjects are selected based on the presence or 
absence of events or occurrences in their lives. Subjects affected by the event are 
cases and those not affected are controls (Bacchieri & Cioppa 2007: 21). In this study, 
HIV-infected women were selected provided they enrolled in the PMTCT programme. 
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This chapter describes the study population, sampling, research instruments, data 
collection procedures and analysis. The procedures followed for ensuring validity and 
reliability of the research findings are outlined. The ethical considerations, followed 
during the conduct of this study, are also described.  
 
3.2 RESEARCH DESIGN 
 
The selected research design directs the selection of the population, sampling 
procedure, methods of measurement, and a plan for data collection and analysis. It 
depends on the researcher’s expertise, the problem and purpose of the study. “A 
research design is a blue print for the conduct of a study that maximises control over 
factors that could interfere with the study’s desired outcome” (Burns & Grove 2005:40). 
The two broad categories of study design are observational and experimental. 
Observational studies can be analysed using descriptive and/or analytical/correlational 
techniques. Descriptive studies quantify the extent of a disease or factor in a population 
while analytical/correlational studies help to identify a cause or risk factor of a disease 
or an outcome. Both descriptive and analytical/correlational studies use cohort and 
cross-sectional designs. A cohort is a group of people who share certain characteristic 
and are followed over a period of time. A cohort study is also sometimes called a follow-
up study. There are two types of cohort studies: prospective and retrospective. A 
retrospective study shortens the period of study as it makes use of previous data 
(Morroni & Myer 2007:77-81). This study used a retrospective cohort design. Both 
descriptive and correlational analyses were conducted during this study as elaborated in 
the data analysis section 3.3.3. 
 
Cohort studies can be conducted using historic data to identify outcomes. A 
retrospective cohort design is helpful in studying multiple risk factors or multiple 
outcomes. Cohort designs are considered to be relatively powerful to assess the 
association between risk factors and outcomes. When designing such kinds of studies, 
the researcher should have developed clearly stated dependent and independent 
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variables prior to commencing the study (Murphy 2009:20). In cohort studies the 
researcher selects a group of study subjects, based on their exposure status, and then 
examines the rate of disease or outcome occurrences. Cohort studies are often 
conducted retrospectively and they fulfill at least one major criterium for causality: the 
time sequence of cause and effect (Stommel & Wills 2004:144). At the baseline people 
are classified according to their exposure status. Overtime follow-up investigations are 
conducted to identify the development of the disease (Olsen et al 2010:8).  
 
In retrospective cohort designs, researchers assemble a cohort by reviewing their 
exposure status in the past. Then they also measure the occurrence of outcomes to 
some defined point in time. Tracing most of the cohort members must be possible in 
order to measure the outcome of interest. Retrospective cohort designs have 
comparative advantages over prospective designs that help to accomplish the research 
within shorter periods of time, rendering the study less expensive (Burns & Grove 
2005:308).  
In this study exposure status was determined based on PMTCT services. HCT, ART 
and ARV prophylaxis, infant feeding counseling and health care practices were taken 
into consideration. A cohort was assembled among women and their children who used 
PMTCT services at health facilities in Addis Ababa within two years prior to the study. 
Along with this additional variables were measured such as factors affecting HIV status 
of babies and barriers and enablers of PMTCT service utilisation. Outcome variables 
that were studied included the health status of the mother, HIV status of the baby and 
patient satisfaction with PMTCT service. These characteristics were studied 
retrospectively by reviewing patients’ records and conducting interviews with mothers 
who had utilised the PMTCT services.  
 
3.3    RESEARCH METHOD 
 
The chosen research paradigm for this study is quantitative. According to Burns and 
Grove (2005:23) ”…quantitative research is a formal, objective, systematic process in 
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which numerical data are used to obtain information about the world”. A quantitative 
approach deals with variables and might explore the association or cause and effect 
relationships between them. Stommel and Wills (2004:178) mentioned the features of 
quantitative research as being orientated toward theory testing, focusing on 
predetermined variables, preference for statistical and numerical summaries or 
descriptions, being analytical and providing explanations in terms of causal theories.  
 
This study identified relevant theories (the HBM and Donabedian’s Model) that had 
been used for other studies. Variables were selected prior to data collection and 
analysis. The selected variables were helpful for numerical and statistical 
measurements and analyses. Both descriptive and analytical analysis techniques were 
applied.  
 
 
 
3.3.1   Population and Sampling 
 
In probability (random) sampling techniques every element of the population has a 
greater than zero chance of being included in the sample. Probability samples are more 
likely to be representative of the population as compared to the non-probability samples. 
Most commonly probability sampling techniques are used in quantitative research. 
There are four kinds of probability sampling techniques: simple random sampling, 
stratified sampling, cluster sampling and systematic sampling. Stratified sampling is 
used in situations where the researcher knows some of the variables that are critical to 
achieve representativeness. Variables which are commonly used for stratification are 
age, gender, ethnicity, socioeconomic status, diagnosis, geographical region, type of 
institution, type of care and site of care. Subjects are then randomly selected from the 
chosen strata. Stratified sampling can be disproportionate sampling or proportionate 
sampling. In disproportionate sampling each stratum should have an equivalent number 
of subjects in the sample. During proportionate sampling each stratum should have a 
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number of subjects in proportion to their occurrence in the population (Burns & Grove 
2005:346-348).  
 
Probability sampling is considered in selecting a representative sample. In stratified 
random sampling the population is divided into sub-populations that are individually 
more homogeneous than the total population. These different sub-populations are 
called strata. Hence, strata are formed based on common characteristics. They are 
formed based on the past experience and personal judgment of the researcher. Usually 
the size of a sample from each stratum is proportional to the size of the relevant 
stratum. If P represents the proportion of population in the stratum i and n represents 
the sample size, then the number of elements selected from stratum i is n*P. To select 
elements from each stratum usually simple random sampling is applied (Kothari 
2004:62-64). 
 
3.3.1.1    Population 
 
A population constitutes the universe of interest and hence it is a universe of all of the 
units or elements to which the researcher wants to generalise the results obtained 
during a specific study. A researcher further defines these elements or units. This 
process of developing units or elements is referred to as the definition of the target 
population. Usually target populations are infinite or open ended. Practically researchers 
draw their samples from accessible populations that are often finite. Accessible 
populations may be defined in terms of their geographic locations or institutional 
affiliations or personal characteristics. Accessible populations are defined by 
observation periods chosen by the researcher. A sampling frame is a symbolic 
representation of study population. It is a list of all members of the target population or it 
is a set of procedures that allow the researcher to access members of the target 
population (Stommel & Wills 2004:297-306). Population, sometimes referred to as 
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target population, comprises the entire set of individuals or elements who meet the 
sampling criteria.  
 
An accessible population is a portion of a target population to which the researcher has 
reasonable access. Samples are obtained from accessible populations and hence, the 
generalisations made are applied to the accessible population and then to the target 
population. In order for each person in the target or accessible population to have a 
chance of being included in the sample, a sampling frame must be identified and 
random sampling must be implemented. A list of every member of the population must 
be acquired for this sampling frame. Hence, the sampling frame is this list of the 
population. The researcher then can select members from this list using the sample 
plan (Burns & Grove 2005:342-346). A sampling frame is a source list from which a 
sample is drawn. It should be comprehensive, correct, reliable and appropriate. It 
should represent the target population (Kothari 2004:56).  
 
For this study the population comprised 8 365 HIV-positive women and their babies 
utilising PMTCT services in Ethiopia. The target population comprised 1 689 HIV-
positive women and their babies who used PMTCT service in Addis Ababa, Ethiopia. 
The sampling frame comprised 796 mother-infant pairs who used PMTCT services at 
the selected 12 hospitals and health centers in Addis Ababa. The accessible population 
comprised those mother-infant pairs who received PMTCT services at selected public 
hospitals, private hospitals and health centers in Addis Ababa. Hence, inclusion criteria 
included mother-infant pairs who used PMTCT services, infants’ HIV known test results 
and the mothers who agreed to sign consent for themselves and on behalf of their 
babies. Exclusion criteria were mother-infant pairs who discontinued PMTCT services, 
pregnant women at the time of data collection, babies whose HIV test results were 
unknown and those who used PMTCT services at facilities outside Addis Ababa or at 
facilities that did not participate in this study. 
 
3.3.1.2 Sampling 
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In 2011 there were 1 445 hospitals and health centers providing PMTCT services in 
Ethiopia (FMOH/HAPCO 2012:30). The accessible population for this study 
encompassed PMTCT service users at health facilities in Addis Ababa during 2011-
2013. This area was chosen because Addis Ababa has the highest HIV prevalence in 
the country and more PMTCT attendees were found in this area than anywhere else in 
Ethiopia. In 2012 PMTCT services were provided at 61 hospitals and health centers in 
Addis Ababa, comprising the site target population for this study. Thus the accessible 
sites comprised 10 public hospitals, 15 private hospitals and 36 public health centers 
providing PMTCT services In Addis Ababa. All these health facilities are located within 
Addis Ababa. These sites provide PMTCT services and they were accessible for data 
collection purposes. 
 
Proportionate stratified random sampling was used to select health care facilities. The 
types of health facility served as strata. Public hospitals, private hospitals and health 
centers were selected to represent each category. These health facilities were 
categorised, given consecutive numbers within each category and from each group, 
sites were selected randomly. From each selected site, the respondents were selected 
using simple random sampling to ensure representativeness. Patients’ ART/pre-
ART/medical record numbers used. Then a table of random number was used to select 
women attending PMTCT services. Those selected women were contacted during their 
follow-up visits to the PMTCT service sites. The number of mother-infant pairs selected 
was proportional to the number of patients treated at each health facility. 
 
3.3.1.3 Sample size 
 
Twelve (19.7%) health facilities, out of a total of 61 health care institutions, were 
selected for this study. To ensure representativeness from each category of health 
facilities (private hospitals, public hospitals and health centers), approximately 20% of 
the facilities in each stratum were selected.  The names of all facilities in each of the 
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three strata were written on individual slips of paper, folded and placed into three 
different containers. Someone, not associated with this study, blindly selected two slips 
of paper indicating which public hospitals would participate in the study. The same 
procedure was followed to select three private hospitals and seven health centers. This 
amounted to stratified random selection without replacement. Subgroups of the health 
facilities, hospitals and health centers, were mutually exclusive. The selected public 
hospitals are Zewditu Hospital (Kirkos subcity) and Yekatit Hospital (Arada subcity). The 
selected private hospitals are Bethezata Hospital (Kirkose subcity), Myungsung 
Christian Medical Center (MCM) Hospital (Bole subcity) and Kadisco Hospital (Bole 
subcity). The public health centers selected are Addis Ketema (Addis ketema subcity), 
Bole17 (Bole subcity), Kolfe (kolfekeraneo subcity), Yeka (Yeka subcity), Meshualekia 
(Kirkose subcity), Kotebe (Yeka subcity) and Gulele (Arada subcity) health centers. 
 
The formula used for sample size calculation of respondents was S=p(1-p)z2 /d2 where 
p stands for anticipated population proportion, z refers to the cut-off value of the normal 
distribution and d is the precision required on either side of the proportion (Sayed 
2007:347). There were three scenarios considered for sample size calculation based on 
the outcome of the study. 
 
Patients’ satisfaction with PMTCT services was measured based on the assumptions of 
a 95.0% confidence interval, 80% frequency of satisfaction among mothers who utilised 
PMTCT services and 5% worst acceptable result. Using this scenario the sample size 
became S=0.8(1-0.8)1.962/0.052 = 246.  
 
The health status of mothers utilising PMTCT services, was based on the assumptions 
of a 95.0% confidence interval, 50% of the mothers who used PMTCT services showed 
improved health status and 5% worst acceptable result. Using this scenario the sample 
size became S=0.5(1-0.5)1.962/0.052 = 384. 
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The HIV status of infants, born from mothers utilising PMTCT services, was based on 
the assumptions of 95.0% confidence interval, 10% of infants born from mothers 
attending PMTCT service became HIV-infected and 5% worst acceptable result. Using 
this scenario the sample size became S=0.1(1-0.1)1.962/0.052 = 138. 
 
The second scenario generated higher sample sizes and as such the adopted sample 
size was 384. To ensure proportionate distribution of the size of sample among 
participating facilities, this sample size was divided by health care facilities according to 
their patient load. So, for each health facility the sample size was calculated as: patient 
load * sample size/ size of sample frame.  
• Zewditu hospital:201*384/796=97,  
• Yekatit 12 hospital: 104*384/796=50,  
• Bethezata hospital: 77*384/796=37,  
• MCM hospital: 61*384/796=29,  
• Kadisco hospital:35*384/796=17,  
• Addis Ketema health center: 34*384/796=16, 
• Bole17 health center: 61*384/796=30,  
• Kolfe health center:33*384/796=16,  
• Yeka health center: 79*384/796=38, 
• Meshualekia health center: 23*384/796=11,  
• Kotebe health center: 47*384/796=23 and  
• Gulele health center: 41*384/796=20 
 
3.3.2    Data collection 
 
Data can be classified into qualitative or quantitative. In case of qualitative data 
numerical figures cannot be assigned while in the case of quantitative data numerical 
calculations are used. Quantitative data can be measured in different scales of 
measurement, including nominal scale, ordinal or rank order scale, equal interval scale 
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and ratio scale. A nominal scale implies the classification of an item into two or more 
categories without any magnitude. In the case of an ordinal scale it allows assigning of 
values in relative rank order. An equal interval scale is the same as an ordinal scale but 
with the additional feature that the distance between any two numbers on the scale is 
known. Ratio scales have all the properties of equal interval scales with two additional 
characteristics: it has a true rather than an arbitrary zero and have the qualities of real 
numbers that can be added, multiplied, subtracted or divided (Singh 2006:313).  
 
In choosing a data collection method it is important to consider that it fits the purpose. 
The method should capture the information needed for the research. Hence, different 
kinds of data collection tools exist that range from questionnaires to observation. 
Questionnaires contain a set of questions that people will answer. When designing a 
questionnaire people may interpret it in different ways so it is important to make the 
questions as clear as possible. Questions can be open ended or closed ended. Open 
ended questions are not limited by definitive answers and closed ended questions have 
predetermined answers such as yes-no or true-false or responding to a predetermined 
Likert type scale such as yes definitely, yes, no, definitely not (Taylor, Wilkie & Baser 
2006:29). 
 
There are primary and secondary sources of data. In the case of primary data the 
researcher collects the data for the first time. Secondary data are collected for other 
purposes and have already passed through a statistical process. Primary data can be 
collected through interviews or questionnaires or observations. It can be done through 
personal or telephone interviews. Personal interviews are usually conducted through 
structured interviews where a set of pre-determined questions are prepared. In case of 
unstructured interviews the interviewer does not follow a system of pre-determined 
questions. The chief merits of the interview method include that more information and 
more observations can be applied. Personal information can easily be obtained, non-
response rates generally remain low and the language of the interview can be adapted 
to the ability or educational level of each interviewee.  
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Weaknesses of the interview method include that it is a very expensive method when 
wide geographical samples are involved, there is also the possibility of bias of the 
interviewer or respondent, certain groups of populations such as high ranking officials, 
or people with high incomes might not be easily approached and it is time consuming 
when the sample size is large.  
 
Another method of data collection through conducting structured interviews is also 
possible. In this method the data collector records information obtained from 
respondents on the structured interview schedule. When secondary data are used, the 
researcher has to look into the different sources where he/she can get the data. Such 
secondary data can be available in the form of reports, public records, publications and 
technical books (Kothari 2004:97).  
 
 
3.3.2.1   Data collection approach and method 
 
Data sources for this study were both primary and secondary data sources. Patients’ 
charts or records served as secondary data sources while interviews with mothers 
served as a primary data source. Hence, the method of data collection involved both 
structured interviews and document reviews. HIV-positive women, using PMTCT 
services, were interviewed individually using structured interview schedules. Once these 
mothers had signed consent for themselves and on behalf of their babies, data 
collection commenced.  
 
The information gathered during the interviews included patients’ characteristics, 
patients’ levels of satisfaction with PMTCT services, breast feeding practices, factors 
affecting MTCT and barriers and enablers of the use of PMTCT services. The other 
variables that were obtained from patients’ records were HCT, ARV intervention, breast 
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feeding counseling, factors affecting the rate of MTCT, HIV status of the infant and 
health status of the mother.  
 
3.3.2.2    Development and testing of the data collection instruments  
 
Two data collection instruments were used to capture both primary and secondary data, 
namely structured interview schedules and document review checklists. The 
instruments were developed by the researcher. An extensive literature review and 
consultation with experts in the field of data collection and PMTCT were made prior to 
developing the tool. After the tools had been developed, pre-testing was done and the 
instruments were revised to address deficits and ambiguous words.  
 
3.3.2.3 Characteristics of the data collection instruments 
The structured interview schedule has five sections:  
• Section A addresses patient characteristics like age of the mother, age of the 
baby, and residential address.  
• Section B asks questions about infant feeding counseling and practices.  
• Section C’s questions pertain to patient satisfaction. This section is again 
subdivided into different sections asking mothers about their satisfaction levels 
with different areas related to PMTCT like infrastructure and perceptions about 
health care providers.  
• Section D is about HIV testing and counseling.  
• Section E addresses factors affecting PMTCT services, as perceived by the 
participating women.  
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The second data collection instrument was a document review checklist, subdivided into 
two sections for the mother and for the baby. The document review checklist of the 
mother has six sections.  
• Section A is about background information of the health facility like public or 
private. 
• Section B deals with the health status of the mother using CD4 count, WHO 
stage and other illnesses.  
• Section C encompasses factors affecting the HIV status of the baby.  
• Section D contains HIV testing and counseling questions that could not be 
answered during the structured interview.  
• Section E is about ARVs for the mother.  
• Section F deals with family planning issues.  
 
 
The document review checklist of the baby has four sections.  
• Section A deals with background information of the baby.  
• Section B captures information about factors affecting the HIV status of the baby 
that could not be addressed by the mother’s checklist.  
• Section C captures information about ARV interventions for the baby.  
• Finally section D captures information about the HIV status of the baby. 
 
Both the English and Amharic structured interview schedule as well as the document 
review checklists has been attached as Annexures 1 and 2. 
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3.3.2.4    Pre-testing of the data collection instrument 
 
Prior to data collection, each data collector was trained to collect data for pre-testing 
purposes. Nineteen respondents were included in the pre-test at the randomly selected 
health facilities. During the pre-test phase ambiguous or unclear words and sentences 
were identified rephrased and corrected such as stigma and discrimination questions 
rephrased in order not to hurt the feeling of respondents. Questions which cannot 
gather data from the patients’ files were deleted. This helped to enhance the reliability of 
the data collection tool which is discussed further in section 3.4. 
 
3.3.2.5    Data collection process 
 
Three research assistants were recruited to collect both the primary data and secondary 
data. These assistants were nurses with extensive experience in the provision of 
PMTCT services and data collection. The researcher trained them for two days prior to 
commencement of data collection in order to standardise the data collection process. 
The topics covered during the training included how to conduct structured interviews 
and document reviews, PMTCT and ethical issues. They were trained adequately on all 
of the rights of respondents and the signing of informed consent by each interviewee 
was mandatory before data collection could commence. The theoretical training was 
followed by rehearsals and role play sessions until they mastered the required interview 
skills. The training helped them to avoid losing meaningful information and to capture 
the verbatim statements of respondents. The research assistants were fluent both in 
English and in Amharic. They administered the structured interview in Amharic and 
collected data from patients’ records in English. The researcher supervised the data 
collection procedures and could assist if and when necessary because he is well versed 
in both Amharic and English.  
 
The researcher translated the Amharic verbatim statements into English and then a 
professional Amharic-English translator checked the translations for accuracy. The 
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same procedure was followed when the researcher translated the Amharic direct 
quotations into English and the Amharic-English translator checked the translation as 
conveying the correct meanings. The actual data collection took place from May 2013 to 
November 2013. (Please see the letter from English-Amharic translator in Annexure 22 
of this thesis). 
 
3.3.3    Data analysis 
 
The choice of statistical methods to be used depends on the variables, sampling 
procedures and sample size of the study. Outcome variables could be one of three 
types: numerical, binary or ratio. In the case of numerical outcomes the mean, standard 
deviation, confidence intervals, p-values, analysis of variance (ANOVA), linear 
regression and multiple regressions can be applied. Binary outcome variables are 
characterised by samples where the value is one of the two alternatives such as yes/no 
responses. For this outcome proportions, probabilities, risks, odds rations (ORs), z-
tests, confidence intervals and logistic regressions were used. Two of the particular 
types of proportions that are relevant to health research are cumulative incidence (or 
risk) of a disease event and the prevalence of a disease. Cumulative incidence (or risk) 
is the probability that a disease occurs during a specified period of time. It is calculated 
by the new number of cases during a specified period of time divided by the number of 
persons initially disease-free and at risk of contracting the disease.  
 
On the other hand, prevalence is the burden of a disease at a particular time. It is 
calculated based on the number of existing cases among the whole population. Analysis 
of rate is used during longitudinal studies (Kirkwood & Sterne 2007:32, 130, 226). The 
likelihood of developing a particular disease, among those exposed to a factor, 
compared to the risk of the individual who has not been exposed, is measured by 
relative risk (RR). Hence, it is the ratio of two incidence rates. Odds ratio is a good 
estimate of relative risk when the disease is rare. Relative risk is the risk of disease in 
the exposed relative to the risk of disease in the un-exposed. The difference of this risk 
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among exposed to the un-exposed is attributable risk. In the presence of confounding 
variables these statistics may not reveal the true association. Confounding variables 
can be controlled by using matching and multiple logistic regression statistical 
calculations (Wassertheil-Smoller 2004:101). 
 
Statistical analysis of quantitative data can be descriptive or inferential. Descriptive 
analysis is concerned with the numerical description of a particular group or variable. In 
contrast, inferential statistics deal with statistical measures that can be used to infer 
results from a sample to estimate a parameter or the corresponding value of the 
population as a whole (Singh 2006:224).   
 
Both descriptive and inferential statistics are used in the analysis of this research such 
as the mean, relative risk and chi-square (X2) test to calculate the p-values and 
confidence intervals. A p-value of 0.05 and a confidence interval of 95% were used as 
cut off values for associations. Each independent and dependent variable was analysed 
using descriptive statistics before associations were calculated. The frequency of each 
independent variable among HIV-positive infants and HIV-negative infants was explored 
as well as the other outcome variables. Standard deviations and measures of central 
tendency (mean, median and mode) were used for HTC, ARV intervention and infant 
feeding practices and counseling. The number of women who underwent HTC before 
pregnancy and after pregnancy, the number of HIV-positive pregnant women receiving 
ARV prophylaxis at 14 weeks’ gestation and the number of mothers practicing exclusive 
breast feeding for the first six months are some of the areas where descriptive statistics 
were applied. The patients’ levels of satisfaction with PMTCT services were analysed 
using descriptive statistics.  
 
Different variables’ association with infants’ HIV status were explored using X2 test and 
RR. The proportion of mothers, using PMTCT services, whose own health improved 
were also explored. Both descriptive and analytical statistics were applied for analysing 
factors affecting the rate of MTCT and barriers and enablers influencing PMTCT service 
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utilisation. Mainly the Statistical Package for the Social Sciences (SPSS version 20.0) 
was used to aid for data analysis. Besides Epi info version 3.5.1 was used for 
calculating statistics that cannot be calculated by SPSS such as RR. Microsoft Excel 
2007 was used for plotting graphs. 
 
3.4    RELIABILITY OF THE STUDY 
 
Reliability is the consistency of measurement results in terms of persons, occasions, 
locations, and instruments. It should indicate the relative absence of unsystematic, 
random measurement error. Test-retest or repeated-measures reliability ensures that 
the tool measures stable results when applied twice or more frequently. The inter-rater 
reliability deals with the reliability of data recorded by two or more trained observers or 
data collectors. The data obtained by these different observers should provide 
consistent results (Stommel & Wills 2004:209-224).  
 
Reliability testing focuses on three aspects stability, equivalence and homogeneity. 
Stability is usually referred to as test-retest reliability and is concerned with the 
consistency of a repeated measure of the same attribute with the use of the same 
instrument. Equivalence focuses on the comparison of two versions of paper and pencil 
or two observers measuring the same event. Homogeneity is concerned with primarily 
paper and pencil tests in terms of correlation of various items in the instrument (Burns & 
Grove 2005:374-376). Prior to data collection, the structured interview schedule and 
document review checklist were pre-tested and revised based on identified 
shortcomings. The few shortcomings included that long sentences were shortened and 
that Amharic phrases familiar to the interviewed women were used, wherever possible. 
 
To ensure internal reliability Chronbach’s alpha coefficients were used. Chronbach’s 
Alpha calculation formula is: A=  K      (1-    K            ) 
                                                    K-1           K+K(K-1)r 
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Here K stands for number of items and r stands for the average correlation among the 
items. The Cronbach alpha “… measures the extent to which different subparts of an 
instrument are equivalent in terms of measuring the same critical attribute” (Polit & 
Hungler 2005:372).  It can range from +1 to -1.  A value close to 1 indicates a high 
degree of internal consistency or agreement among items.  
 
As this is a purposefully self-designed structured interview schedule and document 
review checklist, a Cronbach alpha of 0.7 was regarded as being acceptable (Burns & 
Grove 2005:374). The chronbach’s alpha for the different scales of data collection tool is 
presented in table 3.1. Acccordingly all the constructs had chronbach’s alpha above 0.7. 
 
To further ensure reliability of the tool, repeated measures of the same variables were 
done and the same results were obtained. To ensure interrater reliability, three data 
collectors were trained to obtain informed consent from the interviewees, to conduct 
structured interviews and to record the information accurately on the checklist in the 
same way.  
 
One data collector had experience of PMTCT services at a public hospital, one at a 
private hospital and the other one at a health center. During the training, they practiced 
to conduct interviews with each other until they mastered both the interviewing and the 
recording of the responses. The researcher was available during the data collection 
phase and checked the completed interview schedules and checklists at regular 
intervals. This enabled the researcher to identify and address any challenges the data 
collectors might have encountered.  
 
To further ensure interrater reliability, Cohen’s Kappa was computed. Cohen’s Kappa 
values of 0.41 to 0.60 can be considered moderate, values of 0.61 to 0.80 can be 
considered substantial and values of 0.80 to 1.00 are almost perfect (Stommel & Wills 
2004:216).  
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Cohen’s Kappa was used to assess the agreement between two or more data collectors 
for a categorical outcome (Marston 2010:126). Accordingly Cohen’s Kappa was 
calculated for the outcome variables. In this research the calculated Cohen’s Kappa 
values were above 0.81. Specifically for HIV status of the infant was 0.842 and patient 
satisfaction 0.909. 
 
Table 3.1 Chronbach’s alpha coefficients of the different sections of the data  
  collection tool 
Scale  Chronbach’s alpha Number of items 
HIV status of infants 0.706 4 
Health outcomes of the mothers 
used PMTCT service 
0.837 12 
Patient satisfaction 0.800 37 
HIV testing and counseling 0.803 7 
Antiretrovirals for prevention of 
mother to child transmission of HIV  
0.809 4 
Infant feeding counseling and 
practice 
0.742 4 
Factors affecting mother to child 
transmission of HIV 
0.768 7 
Factors affecting the utilisation of 
PMTCT services 
0.853 16 
 
 
3.5 VALIDITY OF THE STUDY 
 
A measurement is valid when it measures the characteristic or attribute that it intends to 
measure. Content validity is the most common approach to establish the validity of a 
measurement. Criterion validity is concerned with the use of external criteria to validate 
a given measurement instrument. The other one is construct validity which measures 
the meaning of the concept that it is intended to measure (Stommel & Wills 2004:209-
224). Content validity deals with adequate coverage of the topic under study by the 
measurement instrument. Its determination is primarily judgmental and intuitive. It can 
also be determined by the use of experts or panels but there is no numerical way to 
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express it. Criterion-related validity possesses qualities of relevance, free from bias and 
availability.  
 
Construct validity is the most complex and abstract form of validity measurement 
(Kothari 2004:73). Nevertheless content validity can be expressed numerically using the 
content validity index (CVI). Experts rate the content relevance of each item using four 
point rating scale. 1=not relevant; 2=unable to assess relevance without item revision or 
item is in need of such revision that it would no longer be relevant; 3=relevant but needs 
minor alteration; 4=very relevant and succinct. Experts must be also asked to add 
important areas not included in the instrument (Burns & Grove 2005:378). 
 
The tool was tested for face validity, content validity and construct validity. For content 
validity experts working in PMTCT services and those who undertake PMTCT research 
consulted to ensure that every item in the data collection tool relates to PMTCT 
services.  For face validity these experts had to agree that the interview schedule and 
checklist appeared to request information about PMTCT use. The data collection tool 
items were revised based on a review of the literature. Exploratory factor analysis was 
also applied to test construct validity. An appropriately defined population, a large 
sample size and a proportional stratified random sampling technique enhanced the 
external validity of the study, implying that the findings of this study could be 
generalised to the population of mother-infant pairs using PMTCT services in Addis 
Ababa.  
 
3.6    ETHICAL CONSIDERATIONS 
 
Ethical considerations relate to respondents’ (patients’) rights.  The discussion of these 
respondents’ rights will address autonomy, anonymity, confidentiality, privacy and 
justice including beneficence (or the absence of maleficence). 
 
3.6.1   Ethical issues relating to patients’ rights 
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Ethical research throughout the world is informed by principles of respect for persons, 
beneficence/non-maleficence and justice. These principles help to protect humans’ 
rights. These rights are self-determination, privacy, anonymity and confidentiality, fair 
treatment and protection from discomfort and harm. Respect for persons is based on 
the fact that individuals know what works for them, emphasising the importance of 
autonomy. Researchers are required to respect the individuals’ willingness to participate 
or not to participate in the research. To comply with this principle, the requirement for 
informed consent and confidentiality must be met. In case of beneficence, researchers 
and health care providers must act in ways that benefit the health and wellbeing of the 
research participants. On the one hand, the principle of non-maleficence requires the 
obligation to do no harm. It emphasises minimising potential harms. The principle of 
justice is concerned with equality and fairness in determining who receives the benefits 
and who bears the burden of research (Marshall 2007:7).  
 
Institutional review boards (IRB) help to ensure that ethical principles are applied, 
appropriate methods followed and the potential benefits of the investigation are greater 
than the risks. IRBs have the authority to approve, require modification or disapprove 
research. IRB reviews assess benefit/risk analysis, informed consent process, the 
selection of subjects, privacy and confidentiality. IRBs have the responsibility to ensure 
that the rights of persons to decide whether or not to participate is respected and they 
are not coerced to participate in any way. Besides the IRB ensures that informed 
consent is obtained, implying that the potential study participant/respondent has access 
to all relevant information about the study and about his/her participation in the study 
and knows who has the right to access his/her records (Lachman 2006:52). 
 
The informed consent should have specific information and be understood by the 
research participant. For this purpose both written and oral information should be 
provided to the research participant. The information should be clear enough to be 
understood by the potential participants/respondents. There are certain groups of 
persons who are unable to provide consent such as children, permanently incapacitated 
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adults and persons temporarily unable to consent due to emergencies or illnesses. The 
general rule for children, who are legally unable to consent, is that their parents or 
guardians can consent for their participation in research (Holm 2007:52) but that the 
child’s assent should be obtained, where possible to do so. 
 
3.6.1.1    Ensuring autonomy  
 
In this research people’s autonomy was respected by ensuring that every woman 
participated in the research voluntarily and that no woman was coerced into signing 
consent, being interviewed or answering any specific question.  The women were 
informed that they could terminate the interview at any stage and could refuse to 
answer specific questions without incurring any negative consequences whatsoever. 
The information sheet and the consent form informed every potential respondent about 
the specific objectives of the study and the method of data collection. Every woman was 
granted sufficient time to read the information sheet, ask any questions, and make her 
own independent decisions as to whether or not to agree to be interviewed. All women 
were re-assured that their treatment, and the treatment of their babies, would not be 
affected in any way whatsoever by their decisions to participate in the study or not to do 
so. The women’s rights to self-determination were respected because no one was 
coerced to agree to be interviewed, to answer specific questions or to complete the 
interview. The women’s decisions were respected at all times. 
 
There was no compensation or incentive for participating in this research. Participation 
was voluntary and every woman’s choice to participate or not to do so was respected 
and did not influence her treatment, or the treatment of her baby, in any way 
whatsoever. No costs were incurred by participating women as they were recruited at 
health care facilities and the interviews were conducted at convenient places, 
determined by each woman’s preference. 
 
3.6.1.2      Ensuring anonymity, confidentiality and privacy 
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The women were re-assured about anonymity because no names were mentioned on 
any documents and no one would be able to connect any informed consent form with 
any specific completed interview schedule and/or checklist. The women were informed 
that their signed consent implied consent to be interviewed, and consent to access the 
health records of both the mothers and their babies, implying full disclosure of the 
nature of the study and the data collection methods.  
 
As the nature of the study required that the information obtained during the structured 
interview had to be correlated with information from the mother’s and from the baby’s 
medical records, the researcher kept a list correlating each interviewed woman’s 
number (ranging from 1 to 384) with her medical file number and with the baby’s clinic 
chart number.  This list was kept locked up and only the researcher had access to it.  
This list was kept in case any audits might be required to confirm the data entries or in 
case any health facility might query the results of the study’s findings.  Subsequent to 
the acceptance of the research report this list will be destroyed with the completed 
interview schedules and the completed checklists (pertaining to the mothers’ and 
babies’ medical files/charts). 
 
The women’s right to privacy was respected because the interviews were conducted in 
a private room at the health facility or at any venue preferred by a specific woman and 
at a preferred time specified by her.   
 
Confidentiality was maintained because only the researcher and statistician and the 
study’s supervisor had access to the completed interview schedules and checklists. The 
data were entered into a secure computer accessible to the researcher and the 
statistician only and protected by a secure password known only to these two persons.  
Subsequent to acceptance of the research report, the completed interview schedules 
and checklists and the data entered on the computer will be destroyed. 
 
87 
 
3.6.1.3     Ensuring justice and beneficence/non-maleficence  
 
The appointment time and place for each interview could be specified by the woman 
concerned and this was respected. All women were contacted in the same way. No 
harm was inflicted on any woman as only interviews were conducted and data were 
obtained from the mothers’ and from the babies’ files. (No tests whatsoever were 
performed to supply data for this study). Potential benefits (beneficence/non-
maleficence) could result from the implementation of recommendations based on the 
study’s findings.  If more women could access and utilise the available PMTCT services 
before, during and after their pregnancies, this could help to reduce the rate of MTCT in 
Addis Ababa, enhancing the wellbeing of mothers and babies. 
 
3.6.2 Ethical issues related to sampling 
 
Fair treatment of respondents included that probability sampling ensured that every 
respondent was selected by chance, not by choice. Accordingly the sample was 
representative of the target population of women who utilised PMTCT services in Addis 
Ababa. All scientific procedures were followed appropriately. Only women who signed 
voluntary consent to participate in the study were interviewed.   
 
3.6.3 Ethical issues pertaining to the researcher’s conduct 
 
All references were appropriately acknowledged and a complete list of references is 
included in the report. Statistics were calculated and interpreted with the assistance of a 
statistician.  The researcher and the statistician independently entered the coded data 
onto the SPSS program and compared their data entries.  Any discrepancies were 
investigated and addressed.  This enhanced the accuracy of the data entered and 
helped to avoid wrong data entries and incorrect conclusions.  
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The information sheet and informed consent form (see Annexure 3, 4, 5 and 6) informed 
each potential respondent about the specific objectives of the study and that interviews 
will be conducted with the respondents, and that information from the mothers’ medical 
records and from the babies’ charts will comprise data for this study.  Mothers provided 
consent both for themselves and on behalf of their babies. Ethical clearance, once 
obtained from the Higher Degrees Committee, Department of Health Studies, University 
of South Africa, was requested from the Addis Ababa City Administration Health Bureau 
Ethics Committee. Finally the head of each selected hospital and health center granted 
approval before the commencement of data collection at any facility.  Dates for data 
collection at each site were arranged with the person in charge of the specific facility. 
 
3.7 SUMMARY  
 
This chapter discussed the research design and method. The quantitative approach and 
why it has been chosen was discussed in detail.  The selection of a retrospective cohort 
design was justified. Stratified random sampling technique, structured interview 
schedule and document review issues were addressed. The characteristics of the data 
collection tools were explained. This was augmented by proper data analysis 
applications and explanations of the underlying rationale for adopting specific data 
analyses. Reliability and validity of the instruments and sampling procedure were also 
discussed. Finally the ethical procedures that were followed to protect the rights of 
respondents were explained as well as the IRB review and the balance of risks and 
benefits.  
 
The next chapter will present the data analysis and discussion of the study’s findings. 
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CHAPTER 4 
 
ANALYSIS AND DISCUSSION OF RESEARCH FINDINGS 
 
4.1 INTRODUCTION 
This chapter discusses the research findings based on the quantitative data analysis. 
Before statistical tests were applied each variable was analysed using descriptive 
statistics in the case of continuous variables and summary statistics in the case of 
categorical variables. Variables related to the mothers and infants were analysed and 
discussed. The findings address the objectives of the study, namely to: 
• identify factors affecting the utilisation of PMTCT services in Addis Ababa; 
• evaluate PMTCT services in Addis Ababa; 
• assess patients’ satisfaction levels with PMTCT services in Addis Ababa; 
• examine the health outcomes of mothers using PMTCT services in Addis Ababa; 
• describe the HIV status of infants whose HIV-positive mothers used PMTCT 
services in Addis Ababa; 
• identify factors affecting the HIV status of infants in Addis Ababa; 
• make recommendations to enhance women’s utilisation of PMTCT services in 
Addis Ababa (to be addressed in chapter 5). 
 
The total sample size comprised 384 mother-infant pairs (N=384) for this study.  All 
responses that did not total 384 are indicated by n, and frequencies of responses within 
any total (N or n) are indicated by f. 
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4.2 RESPONDENTS’ SOCIO-DEMOGRAPHIC CHARACTERISTICS AND 
IMMUNOLOGICAL CONDITIONS 
 
This section presents the socio demographic characteristics of the mothers. The ages, 
marital status, religious affiliations, income and educational levels are discussed of the 
384 mothers who used PMTCT services in Addis Ababa and who participated in this 
study. 
Table 4.1: Respondents’ socio demographic characteristics and CD4 counts 
(N=384) 
Socio-demographic 
characteristic 
Number Percentage (%) 
Age of the mother 
16-20 5 1.3 
21-25 92 24.0 
26-30 180 46.9 
31-35 93 24.2 
36-40 14 3.6 
Marital status 
Never married 10 2.6 
Live in union 10 2.6 
Married 340 88.5 
Separated 21 5.5 
Divorced  2 0.5 
Widowed 1 0.3 
Educational level 
Never attended school 22 5.7 
Grades 1-6 66 17.2 
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Grades 7-8 95 24.7 
Grades 9-12 145 37.8 
University/college 56 14.6 
Religion   
Christian 311 81.0 
Muslim 73 19.0 
Baseline CD4 count   
<350cells/mm3 267 69.5 
≥350cells/mm3 117 30.5 
Most recent CD4 count   
<350cells/mm3 224 58.3 
≥350cells/mm3 160 41.7 
 
4.2.1    Respondents’ ages and marital status 
 
At enrollment in the PMTCT programme, 46.9% (f=180) of the mothers were 26-30 
years of age while 24.2% (f=93) were 31-45 years old and 24.0% (f=92) fell into the age 
group of 21-25. Only 1.3% (f=5) of the mothers were 20 years old or younger.  
 
Most respondents were married (88.5%; f=340) but 5.5% (f=21) were separated, 2.6% 
(f=10) had never been married, 2.6% (f=10) lived with their partners, 0.5% (f=2) were 
divorced and 0.3% (f=1) widowed.  
 
A study conducted in Ethiopia reported that out of 418 pregnant women, 91.4% were 
married, 5.5% were single and 3.1% were divorced (Moges & Amberbir 2011:109). 
Another Ethiopian study reported that all women who attended ANC clinics and 
participated in that research project were married (Adedimeji et al 2012:3). At Dilchora 
hospital, in eastern Ethiopia, out of 234 ANC attendees who accepted HIV testing, 
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98.3% were married (Demissie et al 2009:143). Those studies’ findings were similar to 
the current study’s finding, indicating that the majority of pregnant Ethiopian women, 
who used PMTCT services, were married. 
 
4.2.2 Respondents’ religious affiliations and educational levels 
 
Out of the 384 mothers who participated in this study, 81.0% (f=311) were Christians 
and 19.0% (f=73) were Muslims.  
 
Of the women who used PMTCT services, 37.8% (f=145) attained grades 9-12; 24.7% 
(f=95) attained grades 7-8, 17.2% (f=66) attained grades 1-6. Those who attended 
university/college level education comprised 14.6% (f=56) and those who never 
attended school were 5.7% (f=22). 
 
4.2.3   Respondents’ incomes compared to their educational levels 
 
The average monthly income of the women was 2533.7 birr per month but it ranged 
from 100 to 9200 birr (when 1USD was equivalent to 19birr). Those who never attended 
school earned on average 1106.8 birr per month (95%CI=782.1-1431.5). Mothers who 
attended grade 1-6 earned on average 1421.3 birr per month (95%CI=1080.6-1761.9). 
PMTCT service users who attained grades 7-8 earned on average 1923 birr per month 
(95%CI=1545.5-2300.5). Mothers who attained grades 9-12 earned on average 2075.3 
birr per month (95%CI=1632.3-3313.6). Those mothers, who used PMTCT services and 
who had attended university/college level education, earned on average 4304.3 birr per 
month (95%CI=3807.8-4800.7). This shows that as the mothers’ educational levels 
increased, their monthly incomes also increased. Since the women’s educational levels 
had more than two categories, the analysis of variance (ANOVA) test was used to 
determine whether any significant difference of monthly incomes existed among women 
with different levels of education. Accordingly, the relationship is statistically significant 
at 0.05 P value using ANOVA (P<0.01). The finding implies that those women with 
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higher levels of education were better positioned to afford costs related to PMTCT 
services and other associated expenses due to their relatively higher incomes, 
compared to the incomes of women with lower levels of education. 
  
Table 4.2:  ANOVA of respondents’ educational levels versus monthly incomes  
    Sum of 
squares 
Df Mean square F Sig 
Between 
groups 
365437119.3 4 91359279.82 27.307 0.000 
Within groups 1267988073 379 3345614.969   
Total 1633425191 383    
 
4.2.4   Respondents’ baseline and most recent CD4 counts 
 
At baseline 69.5% (f=267) of the women who participated in the study had CD4 counts 
of 350cells/mm3 or less while 30.5% (f=117) had CD4 counts greater than 
350cells/mm3. The most recent CD4 counts of less than or equal to 350cells/mm3 
decreased to 58.3% (f=224) from the initial 60.5% (f=267). On the other hand, women 
with CD4 counts of greater than 350cells/mm3 increased to 41.7% (f=160) from the 
initial 30.5% (f=117). 
  
4.3  FACTORS AFFECTING THE UTILISATION OF PMTCT SERVICES IN ADDIS  
 ABABA         
 
Out of the study’s 384 respondents, 84.9% (f=326) knew that they were HIV-positive 
before presenting at ANC clinics whereas 15.1% (f=58) were unaware of their HIV-
positive status. Most of the women (89.1%; f=342) disclosed their HIV status to at least 
one other person but the remaining 10.9% (f=42) did not do so. The respondents’ 
reported partner sero-concordant HIV status was 81.5% (f=313), implying that 81.5% of 
the respondents’ partners were also HIV-positive.  
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Since factors affecting the utilisation of PMTCT services are contextualised within the 
HBM’s major tenets, the rest of the findings in this section will be presented according to 
perceived susceptibility, perceived severity and perceived barriers.   
 
4.3.1 Perceived susceptibility   
 
In this study, perceived susceptibility implied pregnant women’s beliefs about being 
infected with HIV and their beliefs about PMTCT. The pregnant women’s beliefs about 
being infected with HIV were manifested by seeking HIV diagnosis and utilising PMTCT 
services when HIV-positive. Since the respondents of this study were HIV-positive, their 
beliefs about being infected with HIV were assessed based on their knowledge of their 
HIV-positive status when presenting at ANC clinics. Accordingly this knowledge was 
assessed in relation to the respondents’ educational level, marital status and 
employment status.  
 
4.3.1.1 Educational level versus knowledge of HIV status of the mothers at 
presentation at ANC clinics 
 
Before presenting at the ANC clinic, of those  
• 22 women who never attended school, 81.8% (f=18) knew their HIV status and 
four (18.2%%) of them did not; 
• 66 who had attained grades 1-6, 80.3% (f=53) knew their HIV status and 13 
(19.7%) did not; 
• 95 women who attained grades 7-8, 77.9% (f=74) knew their HIV status and 21 
(22.1%) did not; 
• 145 women who attained grades 9-12, 88.3% ((f=128) knew their HIV status and 
11.7% (f=17) did not; and 
• 56 women who attended university/college education, 94.6% (f=53) knew their 
HIV status and 5.4% (f=3) did not.  
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The highest percentage of women who knew their HIV status before presenting for ANC 
were those who had attained university/college level education and the lowest 
percentage were those who attained grades 7-8. Both educational level and knowledge 
of HIV status are categorical variables, thus X2 tests were used. The observed 
frequency (OF) was smaller than the expected frequency (EF) of mothers who had 
never attended school, attained grades 1-6 and grades 7-8 with known HIV status at 
presentation for ANC. On the other hand the OF was higher than the EF for mothers 
who attained grades 9-12 and university/college level education with known HIV status 
at presentation for ANC. Hence, there was a statistically significant difference between 
educational level and HIV status at presentation for ANC at p-value of 0.05 using X2 test 
(P=0.035). These findings imply that at high levels of educational attainment, women 
tended to know their HIV-positive status before coming to ANC clinics. Nevertheless 
Cramer’s V showed only a weak association (V=0.164).   
 
Table 4.3: Observed and expected frequencies of educational level versus HIV 
status at presentation at ANC clinics (N=384) 
 
Educational level  HIV status at presentation 
for ANC 
Total 
Known Unknown 
 No schooling 
Count 18.0 4.0 22.0 
Expected Count 18.7 3.3 22.0 
 Grade 1-6 
Count 53.0 13.0 66.0 
Expected Count 56.0 10.0 66.0 
 Grade 7-8 
Count 74.0 21.0 95.0 
Expected Count 80.7 14.3 95.0 
 Grade 9-12 
Count 128.0 17.0 145.0 
Expected Count 123.1 21.9 145.0 
 University/College 
Count 53.0 3.0 56.0 
Expected Count 47.5 8.5 56.0 
Total 
Count 326,0 58.0 384.0 
Expected Count 326.0 58.0 384.0 
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Table 4.4: Chi-square test:  educational level versus HIV status at presentation at 
ANC clinics (N=384) 
 
 Value df Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 10.321 4 .035 
N of Valid Cases 384   
 
 
A study conducted in northwestern Ethiopia reported the educational level of pregnant 
women attending an ANC clinic where HCT and PMTCT services were provided. Out of 
418 pregnant women, 46.7% were unable to read and write, 9.8% had passed grades 
1-6, 7.2% attained grades 7-8, 19.1% attained grades 9-12 and 11.5% progressed 
beyond grade 12 (Moges & Amberbir 2011:109). A study conducted in four SSA 
countries (Burkina Faso, Kenya, Malawi and Uganda) investigated the correlation 
between educational level and HCT. Those who had not been tested for HIV, were 
those who had lower levels of education. Women in the highest educational levels were 
more likely to be tested at the VCT sites while women with lower educational levels 
were more likely to get tested at PMTCT sites (Obermeyer, Neuman, Hardon, Desclaux, 
Wanyenzes, Ky-Zerbo, Cherutich & Namakhoma 2013:1113-1116). 
 
A systematic review of research reports identified women’s educational levels and low 
socio-economic status as posing barriers to accessing PMTCT services in India (Darak 
et al 2012:4). Another study from India also documented factors associated with women 
who discontinued using PMTCT services. A woman with less than graduate level 
education was 6.32 times more likely to discontinue using PMTCT services compared to 
a woman with graduate level education. A woman from a poor family was 1.61 times 
more likely to discontinue using PMTCT services compared to a woman form a middle 
income or a rich family in India (Panditrao et al 2011:595).  
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Thus the current study’s findings, indicating that women with higher education levels 
were more likely to access and utilise PMTCT services in Addis Ababa, are supported 
by other studies’ findings from Ethiopia, SSA and India. 
 
4.3.1.2 Respondents’ marital status versus knowledge of their HIV status when 
presenting at ANC clinics 
 
Most of the women, utilising PMTCT services, were married (88.5%; f=340), 5.5% 
(f=21) were separated, 2.6% (f=10) lived with their partners, 2.5% (f=10) had never 
been married while 0.5% (f=2) were divorced and only one (0.3%) was a widow. The 
following women knew their HIV status before attending the ANC clinic (classified 
according to marital status): 
• 100.0% (1 out of 1) who were widowed; 
• 90.0% (9 out of 10) who lived with their partners without being married; 
• 80.0% (8 out of 10) who had never been married; 
• 76.6% (294 out of 340) who were married;  
• 66.7% (14 out of 21) who were separated; 
• 100.0% (0 out of 2) who were divorced.  
 
Women who knew their HIV status before presenting at ANC clinics could start 
using PMTCT services timeously and use ARVs as prescribed. If pregnant women 
do not know their HIV status early, they might fail to start PMTCT services timeously 
for the unborn baby to derive maximum protection from being born HIV-infected. 
The chi square test showed that the OF was smaller than the EF for mothers who 
had never been married, separated and divorced with known HIV status at 
presentation for ANC. However, the OF was higher than the EF for mothers who 
lived “in union” (with their male partners without being married), married and 
widowed for known HIV status at presentation for ANC. This showed that the 
presence of partners, either in the form of marriage or living in union, influenced 
women’s knowledge of their HIV status at presentation for ANC and it is statistically 
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significant at a p value of 0.05 as indicated by the chi square (X2) test (p=0.003).The 
strength of association using Cramer’s V between these two variable was weak 
(V=0.216). Therefore this finding implies that women who had male partners (being 
married, widowed or living in union) were less likely than other women (who were 
unmarried and not living with male partners) to know their HIV status when they 
presented for ANC.  Since knowledge of HIV status is an initial step towards using 
ARVs for PMTCT, women’s knowledge of their HIV status played a role in their 
utilisation of PMTCT services because only women who knew that they were HIV-
positive could commence using those services. 
 
Table 4.5: Observed and expected frequencies of marital status versus HIV    
status at presentation at ANC clinics (N=384) 
 
Marital status  HIV status at 
presentation for ANC 
Total 
Known Un-
known 
 
Never 
married 
Observed count 8.0 2.0 10.0 
Expected Count 8.5 1.5 10.0 
 Living in 
union 
Observed count .09 1.0 10.0 
Expected Count 8.5 1.5 10.0 
 Married 
Observed count 294.0 46.0 340.0 
Expected Count 288.6 51.4 340.0 
 Separated 
Observed count 14.0 7.0 21.0 
Expected Count 17.8 3.2 21.0 
 Divorced 
Observed count 0 2.0 2.0 
Expected Count 1.7 .3 2.0 
 Widowed 
Observed count 1.0 0 1.0 
Expected Count .8 .2 1.0 
Total 
Observed count 326.0 58.0 384.0 
Expected Count 326.0 58.0  384.0 
 
 
99 
 
Table 4.6: Chi-square test: respondents’ marital status versus HIV status when 
presenting at ANC clinics (N=384) 
 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 17.909 5 .003 
N of Valid Cases 384   
 
A study which was conducted in Kenya had reported findings about married women’s 
experiences of HIV testing at ANC clinics. A total of 2 700 mothers were enrolled in the 
study and 86.2% of them were married. Of these 2 700 mothers, 92.1% reported getting 
their HIV-1 test results during pregnancy. Women who had not been tested for HIV 
during pregnancy were less likely to be married than those who had been tested 
(Kinuthia, Kiarie, Farquhar, Richardson, Nduati, Mbori-Ngacha & John-Stewart 2011:3). 
A Tanzanian study reported a different finding indicating that VCT attendance was 
higher among those women who had never been married (49%) and those who had 
been separated or divorced (49%). VCT desire was also high among those with recent 
marital status changes (40%) (Wringe, Isingo, Urassa, Mailseli, Manyalla, Changalucha, 
Mngara, Kalluvya & Zaba 2008:321-322). Thus this study from Kenya produced 
different result than those reported by the current study. 
 
4.3.1.3 Respondents’ employment status versus their knowledge of their HIV 
status at presentation at ANC clinics 
 
Out of this study’s respondents, 39.6% (f=152) were employed full time, 7.3% (f=28) 
had part time employment, 19% (f=73) were self-employed and 34.1% (f=131) were 
unemployed. Out of the 73 self-employed women 91.8% (f=67) knew their HIV status 
before attending the ANC clinic while 82.9% (f=126) of those who were employed full 
time had such knowledge. Although 88.5% (f=116) of the unemployed women knew 
their HIV status before presenting at the ANC clinic, only 60.7% (f=17) of the women 
who had part time employment were aware of their HIV status at the same stage. The   
highest percentage of self-employed women knew their HIV status before presenting at 
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the ANC clinic, and the lowest percentage were part-time employed women. The chi-
square test showed an OF which was smaller than the EF for full time and part-time 
employed women with known HIV status at presentation for ANC. Nevertheless, the OF 
was higher than the EF of self employed and unemployed women with known HIV 
status at presentation for ANC by 5 and 4.8 respectively. This was statistically 
significant at 0.05 cut off p value using X2 test (P=0.001). X2 test was used to cross 
tabulate employment status and HIV status at presentation for ANC because both are 
categorical variables. Self employed and unemployed women benefited more from the 
PMTCT programme by knowing their HIV status earlier than the employed women. The 
strength of association was weak using Cramer’s V (V=0.212). 
 
Table 4.7:  Observed and expected frequencies of employment status versus HIV 
status at presentation at ANC clinics (N=384) 
 
Employment status  HIV status at 
presentation for ANC 
Total 
Known Unknown 
 Full time employed  
Observed 
count 126.0 26.0 152.0 
Expected 
Count 129.0 23.0 152.0 
 Part-time employed 
 Observed count 17.0 11.0 28.0 
 Expected Count 23.8 4.2 28.0 
 Self-employed 
 Observed count 67.0 6.0 73.0 
 Expected Count 62.0 11.0 73.0 
 Unemployed 
 Observed count 116.0 15.0 131.0 
 Expected Count 111.2 19.8 131.0 
Total 
 Observed count 326 58 384 
 Expected Count 326.0 58.0 384.0 
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Table 4.8: Chi-square test: respondents’ employment status versus HIV status at 
presenting at the ANC clinic (N=384) 
 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-
Square 
17.306a 3 .001 
N of Valid Cases 384   
 
A study conducted in northwestern Ethiopia reported different findings as to women’s 
employment status. Out of 418 women who participated in that study, 3.6% were 
government employees, 7.7% private employees, 62.2% housewives, 3.3% day 
labourers, 2.6% housemaids and 6.9% merchants but most women were unemployed 
(Moges & Amberbir 2011:109). A Kenyan study with 2 700 respondents, reported that 
70.3% were unemployed and that 20 had known that they were HIV-1 infected prior to 
their pregnancies. As many as 92.1% reportedly received their HIV-1 results during 
pregnancy. There was no significant difference in employment status between HIV 
tested and untested respondents (Kinuthia et al 2011:3). 
 
Other studies reported different findings pertaining to women’s employment status and 
their knowledge of their HIV status from those reported by the current study.  However, 
it should be remembered that Addis Ababa is an urban environment while the other 
studies might have been conducted in rural areas and that the association (Cramer’s V) 
was weak. 
 
4.3.2 Perceived severity 
 
Perceived severity implies that the HIV-positive pregnant woman needs to consider the 
consequences of HIV for herself and for her unborn baby. She could transmit HIV to her 
sexual partner if he is uninfected. The partner should be tested for HIV to know whether 
or not he is HIV-positive and to plan appropriate preventive actions. The HIV status of 
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the respondents’ partners, versus awareness of respondents’ partners that the pregnant 
women were using PMTCT services, was discussed in this construct. The partner’s HIV 
status was associated with the awareness of his partner’s utilisation of PMTCT services. 
 
4.3.2.1 HIV status of respondents’ partners versus awareness that the pregnant 
women were using PMTCT services  
 
Reportedly 81.5% (f=313) of the 384 of the respondents’ partners were HIV-positive, but 
7.3% (f=28) were HIV-negative and the HIV status of 11.2% (f=43) was unknown. As 
many as 88.5% (f=340) of the 384 respondents indicated that their partners knew that 
they were using PMTCT services but the partners of 11.5% (f=44) did not know. Out of 
313 partners who were HIV-positive, 97.8% (f=306) were aware of their partners’ 
utilisation of PMTCT services while 2.2% (f=7) were unaware of this fact. Most of the 28 
HIV-negative partners (92.9%; f=26) were reportedly aware of the women’s utilisation of 
PMTCT services but 7.1% (f=2) were unaware of this fact. Only 18.6% (f=8) of the 
women’s 43 partners with unknown HIV status knew about the women’s utilisation of 
PMTCT services and 81.4% (f=35) did not have this knowledge.  
 
Thus 97.8% (f=306) of the respondents’ partners whose HIV status was positive, were 
aware that their partners used PMTCT services. However, only 18.6% (f=8.) of those 
partners with unknown HIV status were aware that the respondents used PMTCT 
services. Among the 28 HIV-discordant couples the majority of the male partners 
(92.9%; f=26.) knew about the respondents’ utilisation of PMTCT services. The chi-
square test shows that the OF was higher than the EF by 28.9 among HIV-positive 
partners who knew that their HIV-positive partners used PMTCT services. The OF was 
also higher than the EF of HIV-negative partners by 1.2 among those partners who 
knew that their HIV-positive partners were using PMTCT services.  
 
On the other hand, the OF was lower than the EF of partners with unknown HIV status 
by 30.1 among those partners who knew their partners were using PMTCT services. 
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This finding is also statistically significant, using the chi-square test (P<0.01). Cramer’s 
V shows a strong association between a partner’s HIV status and his awareness that 
his partner (the pregnant woman) utilised PMTCT services (V=0.781), since Cramer’s V 
approached 1. This finding indicates that most respondents’ HIV-positive partners knew 
about their PMTCT service utilisation, while few partners from HIV discordant couples 
were aware of this fact. 
 
 
 
 
 
 
Figure 4.1: Partners’ HIV status versus their awareness of PMTCT service 
utilisation (N=384) 
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Table 4.9: Observed and expected frequencies of partners’ HIV status versus their 
awareness of the respondents’ utilisation of PMTCT services (N=384) 
 
Partner HIV status  Knowledge of 
partner about use 
of PMTCT service 
Total 
  Yes No 
 HIV-positive 
 Observed count 306.0 7.0 313.0 
 Expected Count 277.1 35.9 313.0 
 HIV-negative 
 Observed count 26 2.0 28.0 
 Expected Count 24.8 3.2 28.0 
 Unknown 
status 
 Observed Count 8.0 35.0 43.0 
 Expected Count 38.1 4.9 43.0 
Total  
Observed Count 340 44 384 
Expected Count 340.0 44.0 384.0 
 
 
Table 4.10: Chi square test: HIV status of partners versus their awareness that 
respondents were using PMTCT services  
 Value Df Asymp. Sig. (2-
sided) 
Pearson Chi-Square 234.058 2 .000 
N of Valid Cases 384   
 
A systematic literature review identified three reports indicating that the lack of support, 
especially among women having HIV-uninfected partners, was one of the factors 
preventing women from using PMTCT services (Darak et al 2012:9). A study from India 
reported that a woman, whose partner’s HIV status was negative or unknown, was 2.69 
times more likely to discontinue using PMTCT services than a woman whose partner 
was HIV-positive (Panditrao et al 2011:595). An Ethiopian study interviewed 107 HIV-
positive women attending ANC. Out of the respondents whose partners’ HIV status was 
known, 33.6% had disclosed their HIV status to their partners but only 20.6% of women 
whose partners’ HIV status was negative had shared this information with their partners 
(Sendo, Cherie & Erku 2013:2-6). Thus fewer women seemed to disclose their HIV-
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positive status to HIV-negative husbands than to HIV-positive husbands, similar to this 
study’s findings. 
 
4.3.3 Perceived barriers 
 
Perceived barriers imply obstacles that could impact negatively on women’s utilisation 
of PMCT services. Different variables could obstruct the use of PMTCT services. The 
variables addressed in this section include marital status versus disclosure of HIV 
status, stigma and discrimination versus most recent CD4 count and employment status 
versus monthly income.  
 
4.3.3.1 Marital status versus disclosure of HIV status 
 
As to disclosure of HIV status, 89.1% (n=342) of the current study’s respondents, had 
disclosed their HIV status to a third party whereas 10.9% (f=42) did not do so. Of the 
married women, 91.2% (f=310) had disclosed their HIV status to a third party while 
90.0% (f=9) of those who had never been married, and 70.0% (f=7) of those living with 
their partners, 66.7% (f=14) of those who had been separated from their partners, and 
50% (f=1) of the divorcees had done so. The percentage of married women who had 
disclosed their HIV status was the highest. The chi-square test also shows that the OF 
was higher than the EF of married women by 7.2 among those who had disclosed their 
HIV status to a third a person. The OF was higher than the EF by 0.1 among never 
married and widowed and those who disclosed their HIV status to a third a person. On 
the other hand, the OF was lower than the EF by 0.8 among women who were divorced, 
by 1.9 among women living in union and by 4.7 among those women who had been 
separated and disclosed their HIV status to a third person. This was statistically 
significant at 0.05 p value using the chi-square test (P=0.002). Both marital status and 
disclosure of HIV status are categorical variables. Cramer’s V indicated that the 
association was weak (V=0.225) between the respondents’ marital status and the 
disclosure of their HIV status to other persons.  
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Table 4.11: Observed and expected frequencies of marital status of women 
versus their HIV status disclosure to a third person (N=384) 
 
Marital status  Disclosure of HIV 
status to a third 
person 
Total 
Yes No 
 
Never 
married 
 Observed count 9.0 1.0 10.0 
 Expected Count 8.9 1.1 10.0 
 Live in 
union 
 Observed Count 7.0 3.0 10.0 
 Expected Count 8.9 1.1 10.0 
 Married 
 Observed count 310.0 30.0 340.0 
 Expected Count 302.8 37.2 340.0 
 Separated 
 Observed count 14.0 7.0 21.0 
 Expected Count 18.7 2.3 21.0 
 Divorced 
 Observed count 1.0 1.0 2.0 
 Expected Count 1.8 .2 2.0 
 Widowed 
 Observed count 1.0 0 1.0 
 Expected Count .9 .1 1.0 
Total 
 Count 342 42.0 384.0 
 Expected Count 342.0 42.0 384.0 
 
 
Table 4.12:  Respondents’ marital status versus disclosure of their HIV-positive 
status (N=384) 
 Value Df Asymp. Sig. (2-
sided) 
Pearson Chi-Square 19.368 5 .002 
N of Valid Cases 384   
 
A study conducted in southwestern Ethiopia determined the rate, barriers and outcomes 
of HIV-positive status disclosure among sexual partners. Only 6% of that study’s 
respondents had disclosed their HIV status to their sexual partners. Women who had 
non-regular sexual partners were less likely to disclose their status than women with 
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regular sexual partners (Kassaye, Lingerh & Dejene 2005:128). Another study 
conducted in Addis Ababa reported similar findings as to disclosure of HIV status. In 
that study 107 HIV-positive pregnant women were interviewed. All those women were 
married, had one regular sex partner and 73% had disclosed their HIV status to their 
sexual partners. Positive outcomes, cited by the women, due to disclosure of their HIV-
positive status, included increased support, less anxiety and enhanced intentions to 
utilise PMTCT services (Sendo et al 2013:2-4). A Ugandan study reported lower HIV 
disclosure rates. That study’s sample comprised 105 men and 298 women of whom 
48.7% were married, 14.7% were single and 8.9% were separated or divorced. Only 
48.9% had disclosed their HIV status to their sex partners. Factors associated with a 
reduced likelihood of disclosure included having an unstable relationship and changing 
one’s sexual partners (Osinde, Kakaire & Kaye 2012:62-63). 
 
4.3.3.2 Stigma and discrimination versus most recent CD4 count 
 
As to perceived stigma, in the current study, 9.6% (f=37) of the women agreed that 
some people were afraid to touch them once their HIV-positive status had become 
known but 90.4% (f=347) disagreed with this statement. In a similar trend, 92.2% 
(f=354) of the respondents disagreed that some people physically backed away once 
they learned that the woman was HIV-positive while 7.9% (f=30) of them agreed. In 
response to a related question, 81.3% (f=312) disagreed that some people acted as if 
HIV was the affected person’s own fault and 18.8% (f=72) agreed. As many as 87.8% 
(f=337) of the women disagreed and 12.2% (f=47) agreed that people were perceived to 
be uncomfortable once they learned about the woman’s HIV-positive status.  
 
Of the respondents 92.1% (f=352) of respondents disagreed that some people 
physically backed away once they knew that these women were HIV-positive. Women 
(f=30) who agreed that some people physically backed away once they learned the 
woman was HIV-positive, had a mean most recent CD4 count of 380cells/mm3. 
However, a mean most recent CD4 count of 348cells/mm3 was recorded for the 354 
108 
 
women who disagreed with this statement. The difference of these two groups of 
respondents’ most recent CD4 counts was not statistically significant using Z-test at 
0.05 p value (P=0.0309; 95%CI=-29, 93). Hence, the women’s most recent CD4 counts 
were not associated with whether or not people were perceived to physically back away 
once they learned that the women was HIV-positive.  
 
Internalised stigma was reported by 66.7% (f=256) of the respondents as they 
sometimes felt worthless because they had HIV and 33.3% (f=128) did not have such 
feelings. Reportedly 60.7% (f=233) of the women felt guilty because they had HIV and 
39.3% (f=151) did not have such guilt feelings. During the 12 months preceding the 
interview, 36.7% (f=141) of the women avoided friends and/or family members because 
of their HIV status. The most recent mean of CD4 counts of those 256 women who 
agreed that they sometimes felt worthless was 332cells/mm3 while the most recent 
mean of the CD4 count of 388cells/mm3 was recorded for women who disagreed with 
this statement.  This difference was statistically significant using the Z test at 0.05 P 
value (P=0.001; 95%CI=-90,-22). This difference is also shown in box plots (see figure 
4.2). Therefore, those women who experienced internalised stigma and sometimes felt 
worthless had lower mean most recent CD4 counts than those who did not face such 
internalised stigma.  
 
Regarding discrimination during the 12 months preceding the interview, 4.2% (f=16) of 
the women avoided social events, 3.6% (f=14) had been abandoned by their partners, 
1.8% (f=7) had been abandoned by other family members, 5.7% (f=22) had been 
verbally abused and 3.4% (f=13) had been physically assaulted, 2.3% (f=9) had lost 
their jobs, 1% (f=4) had been expelled from their homes and 1.6% (f=6) had lost their 
property. No woman had been denied health services during the preceding 12 months 
because of her HIV status. Discrimination was reported by 5.7% of those women who 
had encountered verbal abuse.  
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Those 22 women who had experienced verbal abuse, had a recent mean CD4 count of 
389cells/mm3 and for the 362 women who did not face verbal abuse their most recent 
mean CD4 count was 348cells/mm3. This difference of most recent CD4 count mean 
was not statistically significant using the Z-test at 0.05 p value (P=0.257; 95% CI=-
30,111). Thus the most recent CD4 count was not associated with whether or not 
women had experienced verbal abuse.  
  
 
 
Figure 4.2: Box plots for women’s feeling of worthlessness due to HIV-positive 
status versus most recent CD4 counts (N=384)  
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Table 4.13: Stigma and discrimination among the women who used PMTCT 
service (N=384) 
 
Perceived stigma 
 Agree Disa-
gree 
Total 
Some people are afraid to touch me once they know I 
have HIV  
% 9.6  90.4  100  
f 37 347 384 
Some people have physically backed away from me 
once they learned I have HIV  
% 7.9  92.1  100  
f 30 352 382 
Some people act as if it is my fault I have HIV  % 18.8  81.3  100  
f 72 312 384 
People seem uncomfortable being around me once they 
learn I have HIV  
% 12.2  87.8  100  
f 47 337 384 
Internalised stigma 
 I sometimes feel worthless because I am HIV-positive  % 66.7  33.3  100  
f 256 128 384 
I feel guilty because I have HIV  % 60.7  39.3  100  
f 233 151 384 
In the past 12 months, I have  found myself avoiding or 
isolating myself from friends or family because of my 
HIV status  
% 36.7  63.3  100  
f 141 243 384 
Enacted stigma (discrimination) 
 In the past 12 months, have you faced any of the following? 
Exclusion from social events % 4.2  95.8  100  
f 16 368 384 
Abandonment by partner % 3.6  96.4  100  
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f 14 370 384 
Abandonment by other family members % 1.8  98.2  100  
f 7 377 384 
Verbal abuse or ridicule % 5.7  94.3  100  
f 22 362 384 
Physical assault % 3.4  96.6  100  
f 13 371 384 
Being fired from work % 2.3  97.7  100  
f 9 375 384 
Being expelled from home % 1.0   99.0  100  
f 4 380 384 
Had property taken away % 1.6  98.4  100  
f 6 378 384 
Denied health services % 0   100  100  
f 0 384 384 
 
 
A review of published research reports from SSA revealed that stigma continued to 
influence the effective implementation of PMTCT programmes. That review evaluated 
studies from 12 African countries, and identified stigma as a barrier affecting the uptake 
of PMTCT interventions in all reviewed qualitative studies. Two quantitative studies also 
reported that stigma, including self-stigma, adversely affected women’s utilisation of 
PMTCT services. Discrimination directed specifically at pregnant HIV-positive women 
was described in one qualitative study from Kenya. Blame for potentially dying and 
leaving an orphaned baby was a form of discrimination which resulted in a barrier to the 
utilisation of PMTCT services by some pregnant SSA women (Gourlay, Birdthistle, 
Mburu, Lorpenda & Wringe 2013:4-6).  
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A Kenyan study determined the relative role of stigma versus health system factors in 
influencing the non-utilisation of PMTCT interventions. The 2 700 mothers who 
participated in that study would not buy food from a vendor who was visibly sick. 
Internal and enacted stigma did not differ between tested and untested mothers. 
Overall, health system factors rather than stigma, were identified as barriers affecting 
the utilisation of PMTCT services (Kinuthia et al 2011:3-8). A systematic review from 
low and middle income countries reported that social norms and stigma were identified 
as obstacles preventing the utilisation of PMTCT interventions and HIV testing (Car, 
Brusamento, Elmoniry, Velthoven, Pape, Welch, Tugwell, Majeed, Rudan, Car & Atun 
2013:12). 
 
A South African study examined perceived stigma among patients receiving ART. At 
baseline 735 treatment naïve patients were included in the study and follow-up 
assessments were done at six and 12 months. Internalised stigma had decreased from 
baseline to six months up to 12 months of follow-up time. Whereas discrimination 
experiences increased during these follow up periods, CD4 cell counts increased from 
baseline to six months and up to 12 months during the follow-up period. Univariate 
analysis also showed that lower CD4 cell counts were associated with internalised 
HIV/AIDS stigma. Likewise multivariate analysis showed that persistent lower CD4 cell 
counts were predictors of internalised HIV/AIDS stigma (Peltzer & Ramlagan 2011:60-
64). 
 
Another study from the USA investigated the number of missed visits to health care 
facilities in relation to stigma and CD4 count decline. At baseline 215 HIV-infected 
patients were identified but later on 75 patients were included as they met all the 
sampling criteria. The number of missed visits was associated with a decline in CD4 
count. For each 10% increase in the number of missed visits, the CD4 count decreased 
by >50cells/mm3 from baseline (Walburn, Swindells, Fisher, High & Islam 2012:780-
784). 
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4.3.3.4 Employment status versus monthly income  
 
Self-employed women earned the highest incomes of 3 747 birr per month on average 
in the current study. The average monthly income of fully employed women was 2 909 
birr per month. The lowest earners were part-time employed women who got 919 birr 
per month on average while unemployed women reported average incomes of  1 767 
birr per month, in the form of partner or family support. As employment status had more 
than two categories, ANOVA was the best statistical test to compare differences in 
monthly incomes of the respondents. The monthly income difference was statistically 
significant at 0.05 P value using ANOVA (P<0.01). The monthly median income 
difference is portrayed in the box plots of figure 4.3.  
 
 
 
Figure 4.3:  Box plots of employment status versus monthly incomes of the 
women in birr (N=384) 
 
114 
 
Table 4.14: ANOVA of respondents’ employment status versus their monthly 
incomes (N=384) 
 
 Sum of Squares df Mean Square F Sig. 
Between 
Groups 
278979995.794 3 92993331.931 26.090 .000 
Within Groups 1354445196.703 380 3564329.465   
Total 1633425192.497 383    
 
 
A study conducted in Arba Minch, Ethiopia, showed low levels of household incomes, 
similar to the current study’s findings. The majority were not self-employed nor 
employed formally. The average reported household income was 727 birr with the 
highest being 7 168 birr. This low socio-economic status of the women could pose a 
barrier to women’s utilisation of PMTCT services (Adedimeji et al 2012:3-4). A Ugandan 
study showed that economic constraints were barriers to accessing PMTCT services. 
Costly transportation was cited by 42 out of 45 respondents as a barrier to enrolling in 
PMTCT programmes in that study. Other financial constraints included the cost of the 
food while waiting to be seen by healthcare providers and the cost of nutritious foods 
that patients on HAART should eat. Many women indicated that they were economically 
dependent on their husbands, limiting these women’s control over their treatment 
seeking decisions and their ability to begin with and adhere to HAART (Duff, Kipp, Wild, 
Rubaale & Okech-Ojony 2010:4). 
 
4.4 PROCESS OF PMTCT SERVICES IN ADDIS ABABA 
 
PMTCT services were evaluated according to the process construct of Donabedian’s 
model. According to this model process encompasses the following healthcare 
activities: HIV testing and counseling of pregnant women, ARVs for PMTCT, infant 
feeding counseling and practices and factors affecting the rate of MTCT.  
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4.4.1    HIV testing and counseling services provided to pregnant women 
 
All 384 (100%) respondents of this study had received pre-test information during HIV 
testing and counseling. Out of 326 women who knew their HIV status before presenting 
at the ANC clinic, 58.9% (f=192) had received the pre-test information during group 
sessions, 20.2% (f=66) got pre-test information in the form of couples’ counseling and 
38.7% (f=126) received individual counseling. Group sessions were the most frequently 
employed method of providing pre-test information to women who knew their HIV status 
before presenting at the ANC clinic.  
 
On the other hand, out of the 58 women, who had been tested for HIV when presenting 
themselves at the ANC clinics, 6.9% (f=4) attended group sessions before HIV testing, 
20.7% (f=12) had couples’ counseling and 72.4% (f=42) received individual counseling. 
Thus individual counselling was the most frequently used approach for providing 
counselling to this group of women. The national HIV counseling and testing guideline 
indicates that no HIV test should be provided without pre-test counseling. The pre-test 
session can be provided to individuals, couples or groups (FMOH/HAPCO 2007:10). 
 
Almost all women (97.7%; f=375), mentioned that they could ask questions during the 
pre-test session and 99.0% (f=380) were informed that they had the right to say “no” to 
HIV testing. Similarly, 99.7% (f=383) of the women received HIV counseling after testing 
had been completed and the same number of women believed their privacy had been 
maintained during testing and counseling. Additionally, 99.5% (f=382) of the women 
also believed that confidentiality had been maintained during HIV testing and 
counseling. 
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Table 4.15: HIV testing and counseling services provided to pregnant women 
(N=384) 
 
Able to ask questions during the 
HIV pre-test information session   
 Yes  No  Total  
% 97.7 2.3 100 
f 375 9 384 
Informed by the nurses/midwives, 
during the pretest information 
session, that they had the right to 
say “no” to HIV testing    
% 99.0 1.0  100  
f 380 4 384 
Received counseling after the HIV 
testing had been completed.    
% 99.7 0.3  100  
f 383 1 384 
Privacy maintained during HIV 
testing and counseling 
% 99.7 0.3  100  
f 383 1 384 
Confidentiality maintained during 
HIV testing and counseling. 
% 99.5  0.5  100   
f 382 2 384 
Disclosed HIV status to at least 
one other person 
% 89.1  10.9  100  
f 342 42 384 
 
A Ugandan study on 30 women also reported that most HIV-positive women were given 
sufficient time to ask questions during post-testing counseling. Most women had also 
learned about HIV counseling and testing during their previous visits to the health 
facilities (Rujumba, Neema, Tumwine, Tylleskar & Heggenhougen 2013:8-11). Similar 
findings were also reported from four African countries indicating that HIV-positive 
women were given time to ask questions during counseling sessions, 92% of those 
women were asked if they would agree to HIV testing and 84% of them were informed 
they had the right to refuse HIV testing. Most of those women (85%) reported that the 
health workers and counselors kept their HIV test results confidential. However, 79% of 
those women did not disclose their HIV status to any third party (Hardon, Vemooij, 
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Bongololo-Mbera, Cherutich, Desclaux, Kyaddondo, ky-Zerbo, Neuman, Wanyenze & 
Obermeyer 2012:6-9). A study conducted in Vietnam documented a different finding. It 
included 1 108 women in the study and only 38.6% of those Vietnamese women got 
pre-test counselling while only 7.5% received post-test counseling. The study further 
recommended that HIV counseling and testing could be enhanced if PMTCT services 
were integrated into ANC services at primary level health facilities (Hahn, Gammeltoft & 
Rasch 2011:5-8).  
 
 
 
Figure 4.4: Methods of HIV information provided before HIV testing  (N=384) 
 
 
4.4.2 Antiretrovirals for the prevention of mother-to-child transmission of HIV 
 
Out of 384 women who participated in the current study, 14.3% (f=55) received ARV 
prophylaxis and 85.7% (f=329) received ART for PMTCT. Out of those 55 mothers who 
had received ARV prophylaxis, 25.5% (f=14) started taking ARVs when their CD4 
counts were below 350cells/mm3 and 74.5% (f=41) started the prophylaxis when their 
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CD4 counts were equal to or above 350cells/mm3.  However, 25.5% (f=14) of this 
study’s respondents on ARV prophylaxis were in fact eligible for ART, because their 
CD4 counts were equal to or below 350cells/mm3.  
 
There were 329 patients on ART, of whom 79.6% (f=262) had CD4 counts of 
<350cells/mm3 and 20.4% (f=67) had CD4 counts of ≥350cells/mm3.  Some patients 
(20.4%; f=67) taking ART, had initiated treatment before they were eligible to do so in 
terms of their CD4 counts.  
 
Out of 276 patients with CD4 counts of less than 350cells/mm3, 5.1% (f=14) were taking 
ARV prophylaxis and 94.9% (f=262) were receiving ART. Out of those 108 patients with 
CD4 counts of ≥350cell/mm3, 38.0% (f=41) were taking ARV prophylaxis and 62.0% 
(f=67) were taking ART.  
 
As shown in table 4.16, 19.8% (f=76) of 384 women who participated in the current 
study, were in WHO stage I, 54.2% (f=208) in WHO stage II, 24.2% (f=93) in WHO 
stage III and 1.8% (f=7) were in WHO stage IV when they started taking ARVs for 
PMTCT. Out of those 76 respondents who were in WHO stage I, 47.4% (f=36) were 
receiving ARV prophylaxis and 52.6% (f=40) were receiving ART. Out of 208 patients in 
WHO stage II, 7.2% (f=15) were receiving ARV prophylaxis while 92.8% (f=193) 
received ART. Of those 93 patients in WHO stage III, 4.3% (f=4) were receiving ARV 
prophylaxis and 95.7% (f=89) ART. Finally of the seven patients in WHO stage IV, 
100.0% (f=7) were taking ART. Ethiopia adopted the WHO 2010 ART guidelines during 
the implementation of this study that recommends the provision of ART at WHO stage 
III and IV irrespective of CD4 count (WHO 2010b). The revised WHO (2013:94) 
guideline also recommends the initiation of ART among PLHIV with clinical stage of III 
or IV regardless of CD4 cell count. The WHO 2010 guideline recommends that all 
patients should start ART at less than 350 CD4 cell counts.  However, the WHO 2013 
guideline suggests that this should be implemented for all persons with CD4 cell counts 
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below 500, irrespective of WHO stage (WHO 2013:94), but this had not been 
implemented in Ethiopia during the data collection phase of this study.  
 
Only 13.0% (f=50) of the 384 respondents had received ARVs at the ANC clinic, with 
94.0% (f=47) of them receiving ARV prophylaxis and 6.0% (f=3) ART. Most respondents 
(85.2%; f=327) received their ARVs from the ART the clinic, but 1.8% (f=7) did so in the 
delivery ward.  
 
Table 4.16: CD4 count and WHO stage when ARVs were commenced (N=384) 
 
CD4 count when 
ARVs were 
commenced 
 ARV 
Prophylaxis 
ART Total 
<350 cells/mm3 % 5.1  94.9  100  
f 14 262 276 
≥350 cells/mm3 % 38.0  62.0  100  
f 41 67 108 
WHO stage when ARVs were commenced 
WHO stage I % 47.4  52.6  100  
f 36 40 76 
WHO stage II % 7.2  92.8  100  
f 15 193 208 
WHO stage III % 4.3  95.7  100  
f 4 89 93 
WHO stage IV % 0  100  100 
f 0 7 7 
Total % 14.3  85.7  100  
f 55 329 384 
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Similar findings had been reported from a study conducted in Uganda indicating that 
85.8% of the women with low CD4 counts (<350 cells/mm3) received HAART 
(Namuwaya et al 2011:72). Thus the Ugandan study, and the current study conducted 
in Addis Ababa, Ethiopia, indicate that most respondents’ treatments complied with the 
WHO (2013) guideline. 
 
However, a study conducted in Burkina Faso reported that out of 581 women, 55.6% 
were on monotherapy and 44.4% were on triple therapy. Among those in WHO stage I, 
64.0% were receiving short course ART (ARV prophylaxis) during the perinatal period 
and 23.0% were receiving HAART. Among respondents in WHO stage II, 24.7% were 
receiving short course ART and 54% were receiving HAART. Among those on WHO 
stage III and IV, 11.3% were receiving short course ARVs and 23% were receiving 
HAART. Among those with CD4 count <200cells/mm3, 9.7% were receiving short 
course ARVs and 51.0% were receiving HAART (Kouanda et al 2010:846).  Thus the 
Burkina Faso study’s findings indicated that respondents in that survey were not treated 
according to the WHO’s (2013) guidelines. 
 
4.4.3 Infant feeding options 
 
In the current study, respondents had been counseled on average 3.46 times by 
healthcare providers about infant feeding, ranging from 0 to 10 times. Out of 384 
respondents, only 0.5% (f=2) reportedly received no such counseling. As to specific 
kinds of counseling, 83.0% (f=319) of the women had been counseled on exclusive 
breast feeding during the first six months of life, 11.0% (f=42) had been counseled on 
mixed feeding and 5.5% (f=21) had been counseled on replacement feeding. Most 
women (87.0%; f=334), were using exclusive breast feeding during the first six months 
of their babies’ lives. Only 2.9% (f=11) of the respondents gave their infants mixed 
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feeding and 10.0% (f=39) used replacement feeding such as cow’s milk, milk powder 
and porridge.  
 
During the course of infant feeding, most respondents (85.4%; f=328) received follow-up 
advice from health care providers. Of these 328 women, 0.9% (f=3) received follow up 
advice from health officers, 0.6% (f=2) from medical doctors and 98.5% (f=323) from 
nurses, rendering nurses the most important source of information concerning infant 
feeding.  Out of 384 respondents, 9.9% (f=38) received follow-up counselling from 
family members, 1.0% (f=4) from community volunteer workers and 3.6% (f=14) 
received no follow-up counselling. 
 
Table 4.17: Infant feeding counseling and practices (N=384) 
 Exclusive 
breast 
feeding 
Mixed 
feeding 
Replacement 
feeding 
None Total 
Infant 
feeding  
counseling 
% 83.1  11.0  5.5  0.5  100  
f 319 42 21 2 384 
Infant 
feeding 
practice 
% 87.0  2.9  10 .2 0  100 
f 334 11 39 0 384 
People who undertook follow up of the mother during infant feeding period 
 Healthcare 
provider 
Community 
volunteer 
Family 
member 
No body Total 
 % 85.4  1  10  3.6  100  
f 328 4 38 14 384 
 
The demographic health survey of Ethiopia also shows that breast feeding is a common 
practice in Ethiopia with 98% of mothers who breastfeed their babies at some stage and 
52% of them practicing exclusive breast feeding during the first six months of their 
babies’ lives. Reportedly, 51% of children aged 6-9 months in Ethiopia are eating 
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supplementary food (CSAE/ICFI 2012:119). However, a study from the Gurage zone of 
Ethiopia showed that 60% of the women used replacement breast feeding as an option 
for PMTCT. Only 24% of them indicated exclusive breast feeding as an option. The 
remaining 16% indicated mixed feeding and did not know what to feed their infants 
(Belachew & Jira 2007:41-42).   
 
A South African study reported similar findings showing that different kinds of infant 
feeding options were introduced to the mothers (Laher et al 2012:93). Another study 
conducted in South Africa also indicated that HIV-positive mothers were likely to 
practise exclusive breast feeding during the first six months of their infants’ lives after 
the introduction of the PMTCT programme (Goga et al 2012:15). 
 
Thus studies from Ethiopia and South Africa seem to confirm the current study’s 
findings that most HIV-positive mothers using PMTCT services, employed exclusive 
breast feeding during the first six months of their babies lives. 
 
4.5  OUTCOMES OF PMTCT SERVICES 
 
PMTCT outcomes were examined in terms of the components of Donabedian’s Model. 
Outcomes in this model refer to changes in individuals and populations that can be 
attributed to health care interventions. The different outcomes of PMTCT addressed in 
this section include:  
• patients’ satisfaction levels with PMTCT services,  
• health status of the mother and  
• HIV status of the infant.  
 
Factors affecting MTCT are also discussed in this section to ensure continuity of 
information related to the infant.  
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4.5.1 Patients’ satisfaction levels with PMTCT services in Addis Ababa. 
 
The domains used to assess the mothers’ satisfaction levels included their expectations 
about the infrastructure, accessibility and availability of PMTCT services, the 
affordability of PMTCT services and patients’ perceptions about the nurses/midwives. 
Patient satisfaction data can be analysed by the percentage of responses under each 
category of agreement or disagreement. Another way of reporting patient satisfaction is 
by adding the percentages of responses for the two top categories and considering this 
number to indicate the satisfaction of the patients. Patient satisfaction could also be 
analysed using a single mean score based on all response categories. It also facilitates 
a comparison of satisfaction across different components (Press 2006:111-113). 
 
A Likert scale was used to assess the level of agreement. The scale ranged from 
strongly agree to strongly disagree. At the beginning of each component’s analysis, 
percentages and numbers are presented for each category of responses. Then the 
‘strongly agree’ and ‘agree’ answers were added to identify the number of satisfaction 
responses. Likewise the responses of ‘strongly disagree’ and ‘disagree’ were added to 
identify the number of dissatisfaction responses. The mean scores were calculated to 
identify components with which patients were satisfied or dissatisfied. Accordingly a 
scale had been used indicating 1 being the lowest level of satisfaction and 5 the highest 
level of satisfaction.  
 
Out of all the components considered the lowest mean score of 3.29 was obtained for 
accessibility and availability of PMTCT services. The highest mean score of 3.67 was 
obtained for expectations about the infrastructure. Each component with a high mean 
score of satisfaction was analysed in relation to the women’s most recent CD4 count 
and WHO stage using ANOVA, chi-square tests and Cramer’s V.  
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4.5.1.1 Expectations about the infrastructure 
 
Eight Likert scale type questions pertained to the women’s expectations about the 
infrastructure. Most women were satisfied with the cleanliness and the attractiveness of 
the health facility as 92.5% (f=355) were satisfied, 2.3% (f=9) were uncertain, and 5.2% 
(f=20) were dissatisfied. Most respondents (89.3%; f=343) considered the waiting room 
to be comfortable but 1.6% (f=10) were uncertain and 8.1% (f=31) disagreed. As can be 
seen from Table 4.18, the respondents were satisfied with the infrastructure except for 
the health facility’s wheelchair friendliness. In response to this question, 44.3% (f=170) 
agreed, 16.4% (f=63) were uncertain, and 39.3% (f=151) disagreed that the facility had 
was wheelchair-friendly.  
 
The lowest mean score of 3.11 (out of 5.0) was obtained for the health facility’s 
wheelchair friendliness. The highest mean score of 4.29 was obtained for the health 
facility’s cleanliness and attractiveness. The overall mean score of expectations about 
the infrastructure was 3.67, implying that the patients were satisfied with this aspect. 
Patients’ satisfaction levels were further analysed in relation to their most recent CD4 
counts, revealing that the: 
• patients who strongly agreed that the health facility was clean and attractive, had 
a mean CD4 count of 318cells/mm3  
• satisfied patients’ mean CD4 count was 364cells/mm3 
• dissatisfied patients’ mean CD4 count was 505cells/mm3  
• strongly dissatisfied patients’ mean CD4 count was 473cells/mm3 
The dissatisfied patients had higher most recent mean CD4 counts. This difference was 
also statistically significant using ANOVA (P<0.01). However the post hoc Bonferroni 
test does not show any significant difference of the most recent mean CD4 counts 
among strongly satisfied and strongly dissatisfied patients (P=0.076; 95%CI= -317, 8).  
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Table 4.18:  Expectations about the health facility’s infrastructure (N=384) 
 Expectations 
about the 
infrastructure 
 Strong. 
agree 
Agree Uncert. Disag. Strongly 
disagree 
Total Mean 
score 
Facility was  
clean and 
attractive 
% 43.8  48.7  2.3 3.1  2.1  100  4.29 
F 168 187 9 12 8 384 
Comfortable 
waiting room 
% 17.4  71.9  2.6 6.8  1.3  100  3.97 
F 67 276 10 26 5 384 
Adequate 
seats in  
waiting room 
% 15.1  66.1  4.4  13  1.3  100 3.81 
f 58 254 17 50 5 384 
Clean toilets 
in good, 
working order 
% 8.9  50.3  10.4  26.6  3.9  100  3.34 
 f 34 193 40 102 15 384 
Safety of the 
health facility  
% 23.7  62.2  4.4  9.6  0   100  4.00 
f 91 239 17 37 0 384 
Wheelchair 
friendliness 
% 7.6  36.7  16.4  37.5  1.8  100  3.11 
f 29 141 63 144 7 384 
Visible direc-
tions for 
patients  
% 11.7  55.5  7.8  23.2  1.8  100  3.52 
f 45 213 30 89 7 384 
8. Visible  
name and 
contact details 
of the person 
in charge 
% 4.7  54.9  9.9  26  4.4  100 3.29 
f 18 211 38 100 17 384 
Overall mean 
score 
  3.67 
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Thus patients’ high levels of satisfaction with the health facility’s cleanliness and 
attractiveness were not related to their most recent mean CD4 counts. However, the 
dissatisfied patients had slightly higher CD4 counts than the satisfied patients.  
 
Among strongly satisfied patients with the health facility’s cleanliness and 
attractiveness, 16 were in first, 112 in second, 40 in third and none in the fourth WHO 
stage. Among satisfied patients 55 were in first, 79 in second, 50 in third and 3 in the 
fourth WHO stage. Among dissatisfied patients, 9 were in first, 2 in second, 1 in third 
and none in the fourth WHO stage. Among strongly satisfied patients, 3 were in first, 4 
in second, 1 in third and none in the fourth WHO stage. As the respondents’ clinical 
condition worsened, the number of satisfied patients decreased. This was also 
statistically significant using Chi-square test (P<0.01). However, Cramer’s V only 
showed a weak association (V=0.235). 
 
An Ethiopian study reported similar findings as to patients’ satisfaction with the 
cleanliness of the health facilities. Satisfaction levels of patients were assessed at six 
hospitals and six health centers. The mean score of patients’ satisfaction with health 
facilities’ cleanliness ranged from 76.50% to 90.57% (Bekele, Taye, Mekonnen, Girma, 
Gegefu, Mekonnen & Dejene 2008:44). 
 
A study from Kenya also reported similar findings as overall satisfaction with ANC 
services was high. As many as 96% of the women participating in the Kenyan study, 
who attended a fully integrated ANC clinic, and 97% of women, who attended a non-
integrated ANC clinic, were either satisfied or very satisfied. However, 79% of HIV-
infected women were very satisfied with the fully integrated ANC clinic’s services ((Vo et 
al 2012:1444). A Zambian study also reported that 76.7% of the health care providers 
rated the clinic’s infrastructure as being good or very good and 65.1% rated PMTCT 
services the same way (Kim, Banda, Hiner, Tholandi, Bazant, Sarkar, Andrade & 
Makwala 2013:4).  
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4.5.1.2   Accessibility and availability of PMTCT services 
 
Patients’ satisfaction levels with the accessibility and availability of PMTCT services 
were assessed based on responses to five questions. Concerning the time taken by 
patients’ to reach the health facility, 89.1% (f=342) agreed, 0.3% (f=1) were uncertain 
and 10.7% (f=41) disagreed that it took them more than 30 minutes to reach a health 
care facility. Reportedly the current study’s respondents had to wait on average 80.87 
minutes before receiving PMTCT services. After being attended to at the clinic, patients 
waited on average a further 22.28 minutes at the pharmacy to get their prescribed 
medications. Similarly 82.6% (f=317) of the respondents agreed, 0.8% (f=3) were 
uncertain and 16.7% (f=64) disagreed that the health facility rendered services during 
convenient hours. Respondents indicated their levels of agreement with the statement 
“sometimes I cannot get the prescribed medicines because of shortages (‘stock-outs’)” 
as  
• 5.5% (f=21) strongly agreed,  
• 28.9% (f=111) agreed,  
• 3.1% (f=12) were uncertain,  
• 56% (f=215) disagreed and  
• 6.5% (f=2%) strongly disagreed.  
 
Thus 34.4% (f=132) indicated that medicines were sometimes unavailable at clinics.  
This could have serious impacts on the treatment outcomes of the women using 
PMTCT services, as treatment interruptions could impact negatively on the 
immunological and clinical outcomes as well as on the HIV status of their babies.  
Unavailable ARVs could annul the entire PMTCT programme’s objectives. 
 
Responses to the statement “I can reach a referral hospital when necessary” were that: 
• 93.0% (f=357) agreed 
• 1.6% (f=6) were uncertain   
• 5.5%; f=21) disagreed.  
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Patients’ responses to the statement “there is a visible suggestion box in the health 
facility to voice my opinions and concerns anonymously” were diverse because 73.2% 
(f=281) agreed, 2.3% (f=9) were uncertain, 24.5% (f=94) disagreed.  
 
A lowest mean score of 1.77 (out of 5) was obtained for the statement indicating that it 
took patients more than 30 minutes to reach the health facilities. The highest mean 
score of 4.07 was obtained in response to the statement that patients could reach a 
referral hospital when necessary. The overall mean score for accessibility and 
availability of PMTCT services was 3.29. The patients who were strongly satisfied with 
reaching a referral hospital when necessary, had a mean most recent CD4 count of 
423cells/mm3. The satisfied patients’ mean most recent CD4 count was 335cells/mm3, 
while it was 306cells/mm3 among dissatisfied patients and 350cells/mm3 among strongly 
dissatisfied patients. Those patients who were strongly satisfied with the accessibility 
and availability of a referral hospital had higher most recent CD4 counts than other 
patients.  This finding was statistically significant at 0.05 P value by ANOVA (P=0.001). 
(As CD4 count is a continuous variable and satisfaction level is a categorical variable 
with more than two categories, ANOVA was the preferred statistical test to use for these 
calculations).  
 
Out of 74 respondents who were strongly satisfied with the accessibility of the referral 
hospital when necessary, 43.2% (f=32) were in first, 39.2% (f=29) in second, 17.6% 
(f=13) in third and none in fourth most recent WHO stage. Among 283 satisfied patients, 
18% (f=51) in first, 54.1% (f=153) in second, 26.5% (f=75) in third and 1.4% (f=4) in 
fourth most recent WHO stage. Among 20 dissatisfied patients, 5% (f=1) was in first, 
60% (f=12) in second, 35% (F=7) in third and none in fourth most recent WHO stage. 
As their clinical conditions worsened, the number of satisfied patients decreased. This 
was also statistically significant at 0.05 P value using the chi-square test (P=0.002). 
Nevertheless, Cramers’ V showed a weak association (V=0.162). 
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Table 4.19: Accessibility and availability of PMTCT services (N=384) 
Accessibility  
of the 
PMTCT 
services 
 Strong. 
agree 
Agree Uncert. Disagree Strong. 
disagree 
Total Mean 
score 
Requiring 30+ 
minutes to 
reach the 
health facility 
% 49.0 40.1 0.3  6.8  3.9  100.1  1.77 
f 188 154 1 26 15 384 
Convenient 
hours of 
health facility  
% 15.1  67.4  0.8  3.6  13.0  99.9  3.68 
f 58 259 3 14 50 384 
Medicine  
shortages at 
times 
% 5.5  28.9  3.1  56.0  6.5  100  3.29 
f 21 111 12 215 25 384 
Able to reach  
referral hos-
pital when 
necessary 
% 19.3  73.7  1.6  5.2  0.3  100.1  4.07 
f 74 283 6 20 1 384 
Suggestion 
box to voice 
opinions and 
concerns 
anonymously 
% 22.4  50.8  2.3  17.4  7.0  99.9  3.64 
F 86 195 9 67 27 384 
Overall mean 
score 
  3.29 
 
This finding is in line with another study conducted in Addis Ababa, Ethiopia, which 
showed that 91.4% of pregnant women who used PMTCT services, reported that they 
understood the information received and 89.8% of them were satisfied with their 
counseling sessions. The average waiting time at these ANC clinics was 39.8 minutes 
(Ismail & Ali 2011:129-130). A study conducted at the Jimma Referral Hospital, in 
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Ethiopia, reported similar findings. Out of that study’s 422 participants 19% were very 
satisfied and 36% were satisfied with the availability of medicines. However, regarding 
the overall waiting time, only 3.1% were very satisfied and 44.5% were satisfied 
(Assefa, Mosse & Michael 2011:105). A study from Uganda reported that the long 
waiting times (averaging four hours) at clinics posed major barriers for Ugandan women 
to continue using HAART for PMTCT (Duff et al 2010:5). 
 
4.5.1.2 Affordability of PMTCT services 
 
Respondents’ responses were documented for seven questions about the affordability 
of PMTCT services. Although 61.2% (f=235) respondents agreed that they could afford 
to pay the fees for the PMTCT services, 26.6% (f=102) disagreed with this statement.  
Patients were asked whether they received health care at the clinic if they could not pay 
the requested sum of money.  Although 85.7% (f=329) agreed, 1.8% (f=7) were 
uncertain and 12.5% (f=48) disagreed. Patients rated their level of agreement with the 
care received as being worth the money they paid as follows:   
• 87.3% (f=335) agreed 
• 2.6% (f=10) were uncertain and  
• 10.2% (f=39) disagreed.  
 
In response to another statement that the treatment was of an acceptable quality, 
96.9% (f=372) of the respondents agreed and 2.3% (f=9) strongly disagreed. Only 4.2% 
(f=16) of the respondents agreed that the healthcare workers discriminated against 
patients according to race, according to age (3.1%; f=12) and according to status (6.8%; 
f=26).  
 
The average most recent CD4 count of those patients who were very satisfied with the 
quality of the treatment received was 380cells/mm3, among satisfied patients it was 
335cells/mm3, among dissatisfied patients 422cells/mm3 and among very dissatisfied 
patients it was 669cells/mm3. Those very dissatisfied patients had higher CD4 counts 
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than others and this was statistically significant at 0.05 P value using ANOVA 
(P=0.002). The post hoc Bonferroni test showed the significant CD4 count difference 
was found between the groups of satisfied patients and very dissatisfied patients 
(P=0.036; 95%CI=12, 655).  
 
Among very satisfied patients (with treatment being of an acceptable quality, 27 were in 
first, 40 in second, 25 in third and none in fourth WHO stages. Among satisfied patients, 
55 were in first, 153 in second, 68 in third and 4 in the fourth WHO stages. Among 
dissatisfied patients, none were in first, 4 in second, 3 in third and none in fourth WHO 
stages. Among very dissatisfied patients, 1 was in the first and second and none in third 
and fourth WHO stages.  
 
It appears that as the respondents’ clinical conditions worsened, the number of satisfied 
patients decreased. However, this was not statistically significant at 0.05 P-value using 
Chi-square test (P=0.06), but Cramer’s V showed a weak association (V=0.133). 
 
A study, conducted at Felege Hiwot Hospital in Ethiopia, reported similar findings as to 
patients’ satisfaction levels with the affordability of HIV/AIDS clinical care. The study 
was conducted with an objective of assessing the quality of clinical care provided to 365 
PLHIV (respondents). Accordingly the mean satisfaction score was 3.2 out of 5 points 
(Alemayehu, Bushen & Muluneh 2009:360). A study from Uganda reported that 
transportation fees posed barriers to their respondents to access health facilities and to 
receive PMTCT services (Duff et al 2010:4). One study from Malawi reported that 
distances from the hospital and transportation costs constituted barriers to access to 
PMTCT services (O’Gorman, Nyirenda & Theobald 2010:3-6).  
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Table 4.20: Affordability of PMTCT services (N=384) 
Affordability 
of PMTCT 
service 
 Strong. 
agree 
Agree Uncert. Disagree Strong. 
disagree 
Total Mean 
score 
Health care 
received 
even if 
unable to pay  
% 37.8  47.9  1.8  10.7  1.8  100  4.09 
F 145 184 7 41 7 384 
Care  re-
ceived is 
worth the 
money paid 
% 16.1  71.1  2.6  3.4  6.8  100  3.86 
F 62 273 10 13 26 384 
Treatment is 
acceptable  
% 23.9  72.9  0.8  1.8  0.5  99.9  4.18 
F 92 280 3 7 2 384 
Healthcare 
workers dis-
criminate  
(race) 
% 1.3  2.9  2.3  70.6  22.9  100  4.11 
F 5 11 9 271 88 384 
Healthcare 
workers  dis-
criminate  
(age) 
% 0.8  2.3  1.3  69.8  25.8  100  4.17 
F 3 9 5 268 99 384 
Healthcare 
workers  
discriminate 
(status) 
% 0.8  6.7  1.8  64.8  26.6  100  4.10 
F 3 23 7 249 102 384 
I can afford to 
pay the 
PMTCT fees 
% 25.0  36.2  12.2  13.3  13.3  100  3.46 
F 96 139 47 51 51 384 
Overall 
mean score 
  3.57 
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4.5.1.4 Respondents’ perceptions about the nurses/midwives 
 
Perceptions of the respondents about the nurses/midwives were assessed by using 
eight questions.  Some respondents (51.6%; f=198) agreed that there were too few 
nurses/midwives at the clinics. In response to another question, 91.1% (f=350) agreed 
that they felt comfortable talking to the nurses/midwives. Most respondents (85.4%; 
f=382) agreed that the nurses/midwives treated the patients with respect. Again, 68.8% 
(f=264) of the respondents agreed that the nurses/midwives explained what was wrong 
with the patients and 96.9% (f=372) also agreed they could ask questions from the 
nurses/midwives without being afraid. Likewise, 96.4% (f=370) of the respondents 
agreed that they were pleased with the way they had been treated by the midwives at 
the health facilities but 32.6% (f=125) agreed that the nurses/midwives sometimes used 
words that the patients did not understand. However, some respondents (39.6%; f=152) 
agreed that the nurses/midwives ignored some of their questions. 
 
The lowest mean score of 2.63 was obtained for perceptions of the respondents about 
the number of nurses/midwives working at the clinics. The highest mean score of 4.35 
was obtained indicating that patients could ask the nurses/midwives questions without 
being afraid. The overall mean score for perception of patients about nurses/midwives 
was 3.62. The mean CD4 count among those patients who were very satisfied because 
they could ask nurses/midwives questions without being afraid was 354cells/mm3, 
among satisfied patients it was 349cells/mm3 and among dissatisfied patients it was 
356cells/mm3. There was no statistically significant difference in terms of most recent 
CD4 count among satisfied and dissatisfied patients at 0.05 P value using ANOVA 
(P=.655).  
 
Among very satisfied patients who could ask nurses/midwives questions without being 
afraid, 28 were in first, 99 in second, 31 in third and none in fourth WHO stages. Among 
satisfied patients, 56 were in first, 92 in second, 62 in third and 4 in fourth WHO stages. 
Among dissatisfied patients, 1 was in first, 7 on second, 3 in third and none in fourth 
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WHO stages. As the clinical condition worsened, the number of satisfied patients 
decreased. This was also statistically significant at 0.05 P value using Fisher’s exact 
test (P=0.014). Yet, Cramer’s V showed only a weak association (V=0.134). 
 
Another study from Ethiopia supports these findings. Among women who attended ANC 
clinics and used PMTCT services, 92.2% were comfortable with the counselors’ 
handling of and respect for their clients. Regarding competency, 91.5% of the clients 
reported that they were satisfied with the technical competencies of the counselors 
(Ismail & Ali 2011:129-130). Another study conducted in the northwestern part of 
Ethiopia also found that patients were satisfied with provider-patient interactions as the 
average satisfaction score was 4.4 out of 5 points (Alemayehu et al 2009:360). 
 
An Indian study also produced similar findings even though the patients’ satisfaction 
was measured with doctors’ services. The Indian respondents’ satisfaction levels with 
doctors’ services  were rated as excellent for the following factors: feeling at ease with a 
doctor (83.98%), able to tell the doctor one’s problems (92.19%), doctors’ listening to 
one’s problems (87.90%), doctors’ understanding of the patients’ complaints (95.31%), 
doctors’ effective explanations (93.34%) and doctors’ help to improve the women’s 
health (93.34%) (Kishor et al 2011:242).  
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Table 4.21: Respondents’ perceptions about the nurses/midwives (N=384) 
Patients’ 
perceptions
about 
nurses/mid-
wives 
(n/ms) 
 Strong
-ly 
agree 
Agree Uncer-
tain 
Disagree Strong-
ly dis-
agree 
Total Mean 
score 
Too few 
n/ms at the 
clinic 
% 28.1  23.4  9.4  35.2  3.9  100 2.63 
f 108 90 36 135 15 384 
Comfortable 
talking to  
n/ms  
% 15.1  76.0  0.8  8.1  0   100  3.98 
f 58 292 3 31 0 384 
N/ms  treat-
ing patients 
with respect 
% 13.3  72.1  1.0  13.0  0.5  99.9  3.85 
f 51 277 4 50 2 384 
N/ms explain 
what is 
wrong with 
patients 
% 7.6  61.2  1.3  29.4  0.5  100  3.46 
f 29 235 5 113 2 384 
Can  ques-
tion  n/ms  
without 
being afraid 
% 41.1  55.7  0.3  2.9  0  100  4.35 
f 158 214 1 11 0 384 
Pleased with 
the way the 
n/ms treated 
patients 
% 23.2  73.2  0.8  2.9  0   100.1  4.17 
f 89 281 3 11 0 384 
N/ms used 
difficult 
words 
% 3.1  29.4  7.8  55.2  4.4  99.9  3.28 
f 12 113 30 212 17 384 
N/ms 
ignored 
some 
questions 
% 2.9  36.7  5.7  47.1  7.6  100  3.20 
f 11 141 22 181 29 384 
Overall 
mean score 
 3.62 
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4.5.2     RESPONDENTS’ HEALTH OUTCOMES  
 
In this section health outcomes of the mothers were measured using CD4 counts, WHO 
stages and other illnesses diagnosed while using PMTCT services. The CD4 counts 
and the WHO stages as well as the most recent measurements, used to assess 
maternal health outcomes, were considered. Prescribed ARVs versus most recent CD4 
counts were analysed to evaluate the health outcomes of mothers who used PMTCT 
services. 
 
4.5.2.1 CD4 counts and WHO stages as measurements of respondents’ health  
   outcomes 
 
All the respondents (100%; N=384) who participated in this study had initial CD4 counts 
recorded, 87.8% (f=337) had second CD4 counts, 75.0% (f=288) had third CD4 counts, 
28.6% (f=110) had fourth CD4 counts, 10.9% (f=42) had fifth CD4 counts and 5,7% 
(f=22) had six CD4 counts recorded. This trend indicates that as time went on the 
percentage of women with successive CD4 counts decreased. As can be seen from 
figure 4.5, for those women who had six recorded CD4 counts, the mean CD4 count 
increased from 302.1cells/mm3 at the first count to 414cells/mm3 at the sixth count. 
Repeated measure ANOVA also showed an increase of CD4 count that was significant 
at 0.05 P-value (P=0.008). (Repeated measure ANOVA was used taking into 
consideration the comparisons of significant differences among the same group of 
people for measurements taken up to six times).  
 
At the beginning all the women, 100% (N=384), had their WHO staging recorded.  
However this decreased during subsequent visits:  
• during the second visit 92.4% (f=355)   
• during third visit 87.2% (f=335)  
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• during fourth visit 47.4% (f=182) 
• during fifth visit 34.1% (f=131) and  
• during six visit 31.3% (f=120) had their WHO staging recorded 
 
Like CD4 count, the percentage and number of women who had recorded WHO 
staging decreased at subsequent visits. However, during the second and 
subsequent WHO staging the percentage of women was higher than those with CD4 
counts. During the initial visit 53.9% (f=207) of the women were at WHO stage II and 
1.1% (f=4) were at WHO stage IV.  
 
During the second visit 56.1% (f=199) were at WHO stage II and 1.1% (f=4), were at 
WHO stage IV. The percentage for WHO stage I fluctuated during subsequent 
stages. As can be seen from table 4.23, the percentage of WHO stage IV increased 
from the first to sixth time staging whereas the percentage of women in WHO stage 
III increased form the second time staging onwards.  
 
If the clinical condition of the women who used PMTCT services improved, the 
percentage composition of women in WHO stage III and IV (advanced illness) 
should have decreased. Hence, maternal health status from WHO stage showed no 
marked improvement. This was the case because the CD4 count did not increase 
sufficiently (to at least 500) to restore the clinical health status of these women. 
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Figure 4.5: Mean CD4 count at six measurements  
 
Table 4.22: Repeated measures ANOVA of CD4 counts  
Source CD4 count Df F Sig 
CD4 count Linear 1 8.822 .008 
 
A Kenyan study analysed data from 434 women who completed PMTCT interventions. 
The percentage of women with CD4 counts of <250 cells per microliter decreased from 
23% at baseline to 5% at 24 weeks postpartum and this was significant (Okonji et al 
2012:251-254).  
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Table 4.23:  Respondents’ WHO stage at six different occasions 
  
WHO staging at 6 
different times 
 Percent and number of women in each 
WHO stage 
 
 
Total  WHO 
stage I 
WHO 
stage II 
WHO 
stage III 
WHO 
stage IV 
1 
 
% 21.4  53.9  23.7   
 
1.0 
 
100  
 
f 
82 207 91 4 
 
 
384 
2  
 
% 19.4  56.1  23.4  1.1  
 
100  
 
f 69 199 83 4 
 
355 
3 
 
 
% 17.6  56.7  24.2  1.5  
 
 
100  
 
f 
59 190 81 5 
 
 
335 
4  
 
 
% 28.0  41.8  26.9  3.3  
 
 
100  
 
 
f 51 76 49 6 
 
 
182 
5 
 % 
32.1  35.1  28.2  4.6  
 
 
100  
 
 
f 42 46 37 6 
 
 
131 
6  
 
 
% 30.8  35.8  29.2  4.2  
 
 
100  
 
 
f 37 43 35 5 
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A study from South Africa reported similar findings as to HIV infected women’s CD4 
counts during antenatal and post natal periods. Out of 1 369 pregnant women who had 
CD4 counts recorded during their antenatal period, 11.6% had CD4 count <200cells/ml 
140 
 
as compared to 6.02% of the 822 women at the post natal assessments. The results of 
both antenatal and post natal CD4 counts were found for 793 women of whom 9.96% 
had low CD4 counts during antenatal and 6.18% during post natal checks. However, a 
few (1.51%) of these women progressed from a high antenatal to a low post natal CD4 
counts (Lebon, Bland, Rollins, Coutsoudis, Coovadia & Newell 2007:1472-1473).  
 
A multi country study in Africa used CD4 counts and WHO stages to measure maternal 
health status. The findings related to the women’s CD4 counts were contrary to those of 
the current study’s findings while their findings concerning WHO stages supported the 
current study’s findings. The study reported that maternal CD4 counts declined at 12 
and 24 months after delivery, as 4.5% and 11.6% of women with enrollment CD4 count 
of >250cells/mm3 had CD4 counts that declined to <200cells/mm3. A total of 4.4% of of 
those women developed new WHO stage III and 0.4% of them developed new WHO 
stage IV (Ekouevi et al 2012b:4-6).  
 
4.5.2.2     ARVs used versus CD4 count in relation to maternal health outcomes  
 
The mean CD4 count increment was compared between those women who received 
ARV prophylaxis and those who were on ART. The mean CD4 count among those who 
received ARV prophylaxis increased from 471cells/mm3 at commencement of ARVs to 
480cells/mm3 most recently. This shows that the mean CD4 count of women receiving 
ARV prophylaxis increased on average only by nine cells/mm3 while among those 
women who received ART, the mean CD4 count increased from 267cells/mm3 at 
commencement of ARVs to 329cells/mm3 most recently, a mean CD4 count increase of 
62cells/mm3. Therefore the increment of CD4 counts among those women who 
received ART was almost seven times higher than those of women who received ARV 
prophylaxis. This finding indicates that ART had improved the immunity of the 
respondents compared to those respondents on ARV prophylaxis. Correlation analysis 
of the CD4 counts when ARVs started and the most recent CD4 counts was done by 
scatter plot and by calculating Pearson’s correlation coefficients. The scatter plot in 
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figure 4.6 shows a linear positive association. Pearson’s correlation coefficients were 
calculated because both the dependant and independent variables were continuous and 
followed normal distributions. Accordingly, as the CD4 count at the commencement of 
ARVs increased, the most recent CD4 count also increased. Similarly, when the CD4 
count at the commencement of ARVs decreased, the most recent CD4 count also 
decreased. This was statistically significant at 0.05 P value (r=0.613; P<0.01). Hence, 
the following linear regression model could predict the most recent CD4 count based on 
CD4 count when ARVs were commenced: 
• the most recent CD4 count = 154+0.665 (CD4 count when ARVs commenced) 
• thus when CD4 count at commencement of ARVs increased by 1cells/mm3, then 
the most recent CD4 count increased by 0.665cells/mm3.  
 
Table 4.24: Correlation of CD4 counts when ARVs were commenced versus the 
most recent CD4 counts (N=384) 
 
 CD4 count 
most recent 
CD4 count 
when 
antiretrovirals 
was 
commenced 
Most recent CD4 count 
 
Pearson Correlation 
 
1 .613** 
 Sig. (2-tailed) 
 
 
.000 
 N 
 384 384 
CD4 count when ARVs 
were commenced 
 
 
 
Pearson Correlation .613** 1 
 Sig. (2-tailed) .000  
N 384 384 
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Figure 4.6: Scatterplot: most recent CD4 count versus CD4 count when ARVs 
commenced (N=384) 
 
Table 4.25: Linear regression of most recent CD4 count versus CD4 count when 
ARVs were commenced  
Coefficientsa 
Model Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 
B Std. 
Error 
Beta 
1 
(Constant) 153.734 14.544  10.571 .000 
CD4 count when 
antiretrovirals was 
commenced 
.665 .044 .613 15.177 .000 
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A study conducted in Cote D’Ivoire also reported increments in CD4 counts after 
exposure to ARVs but there was no significant difference based on type of ARVs used 
in response to HAART following treatment for PMTCT. A total of 247 women started 
3TC containing HAART with either NVP or EFV. Their median CD4 count was 188 
cells/mm3. Among 88 women, not exposed to ARVs but who had undergone 36 months 
of follow-up, the median absolute CD4 count increment was +359cells/mm3. Among 112 
women who had been exposed to at least one ARV the absolute increase in CD4 count 
was +363cells/mm3. When analysis was restricted to among those not switched to PIs 
during the follow up, the absolute CD4 count increase was 361cells/mm3. Overall 49 of 
the 247 women who initiated HAART met immunological failure criteria at least once 
during the follow up period (Ekouevi et al 2010:2).  
 
A collaborative analysis of prospective studies in SSA, Latin America and Asia showed 
similar findings that CD4 counts increased after the initiation of ART. The median CD4 
count increased from 114 cells/uL to 395 cells/uL after five years of follow up. Patients 
who initiated ART at higher CD4 counts tended to maintain higher CD4 counts (Nash, 
Katyal, Brinkho, Keiser, May, Hughes, Dabis, Wood, Sprinz, Schechter & Egger 
2008:2294-2295). A study conducted in Lusaka, Zambia, investigated the mortality, 
virological and clinical outcomes among a cohort of women who used PMTCT services. 
The study reported similar findings of women responding well to ART. Mortality was 
reduced by half among the cohorts after ART became available. Out of 161 women who 
were exposed to single dose NVP and who were on treatment for six months, 70.8% 
achieved a viral load <400 copies/ml and 40.4% a viral load <50 copies/ml (Kuhn, 
Samrau, Ramachandran, Sinkala, Scott, Kasonde, Mwiya, Kandasa, Decker, Thea & 
Aldrovandi 2009:136). A study which was conducted in Zambia also reported similar 
findings. The study attempted to determine early clinical and immunological responses 
to NNRTI-based ART among women with prior exposure to single dose NVP. Among 
229 women exposed to NVP, the mean increase of CD4 cell count was 202 cells/uL 
from baseline at 6 months. Of the 1530 NVP unexposed women the mean CD4 count 
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increase was 182cells/uL (Chi, Sinkala, Stringer, Cantrell, Mtonga, Bulterys, Zulu, 
Kankasa, Wilfertz, Weidle, Vermund & Stringer 2007:960) 
 
4.5.2.3 Illnesses diagnosed during the utilisation of PMTCT services 
 
Illnesses that had been diagnosed at enrollment into PMTCT programmes and during 
the follow-up periods are addressed in this section. A total of 34 illnesses had been 
diagnosed among women at enrollment into PMTCT services and 19 illnesses were 
diagnosed during their follow-up visits to the PMTCT services. The number of 
diagnoses does not necessarily mean the number of women since a single woman 
might have more than one illness and several women might have been diagnosed with 
the same illness. To understand the prevalence of these illnesses, the top 12 diagnoses 
are presented. The nature of the prevalence of the illnesses, made it impossible to list 
only the top 10 most prevalent illnesses because those illnesse ranked 10, 11 and 12 
had the same frequencies. The most prevalent illness at enrollment into the PMTCT 
service was oral candidiasis (f=89) which was followed by pulmonary TB (f=39). The 
least prevalent illness was angular cheilitis (f=6). The most prevalent illness during 
follow-up PMTCT service was urinary tract infection (UTI) (f=25) which was followed by 
upper respiratory tract infection (URTI) (f=22). The least prevalent illness during follow 
up was typhoid fever (f=4). 
 
Five new illnesses were among the top 12 during follow-up which had not initially been 
diagnosed among the top at enrollment into the PMTCT service. These illnesses were 
acute bronchitis (f=7), tonsillitis (f=6), anaemia (f=4), typhoid fever (f=4) and acute 
gastroenteritis (f=13). Five illnesses which were among the top 12 at enrollment into the 
PMTCT service vanished from the top 12 illnesses during the follow-up visits. These 
were pulmonary TB (f=39), seborrhoea (f=12), prurigo (f=9), oral hairy leukoplakia (f=6) 
and angular cheilitis (f=6). The incidence of oral candidiasis was reduced by 76 cases 
during the follow-up visits. The incidence of URTI decreased by 17 cases. The 
incidence of herpes zoster decreased by 14 while pneumonia decreased by three and 
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cellulitis by six cases. However, the incidence of UTI increased by 18 cases and 
diarrhoea by one. This shows that the women who used PMTCT did not benefit from the 
service in terms of preventing diarrhoeal diseases, UTIs, acute bronchitis, tonsillitis, 
anaemia, typhoid fever and acute gastro-enteritis. However, the overall prevalence of 
illnesses reduced during the follow-up visit of the women who used PMTCT services.  
The PMTCT treatment cured all TB cases and prevented new ones from developing. 
 
Table 4.26: Top 12 Illnesses diagnosed at enrollment and during follow-up 
attendance of PMTCT services 
S.no Illnesses diagnosed at 
enrollment into PMTCT 
service 
f Illnesses diagnosed 
during follow-up visits 
to PMTCT service 
f 
1 Oral candidiasis  89 UTI  25 
2 Pulmonary TB  39 URTI  22 
3 URTI (f=39) 39 Pneumonia  20 
4 Herpes zoster  34 Herpes zoster  20 
5 Pneumonia  23 Acute gastroenteritis  13 
6 Seborrhoea  12 Oral candidiasis  13 
7 Cellulitis 10 Diarrhoea  7 
8 Prurigo  9 Acute bronchitis  7 
9 UTI  7 Tonsillitis  6 
10 Oral hairy leukoplakia  6 Anaemia  4 
11 Diarrheoa  6 Cellulitis  4 
12 Angular cheilitis  6 Typhoid fever  4 
 
 
Five of the six publications, addressing the impact of other illnesses on women’s health 
during their utilisation of PMTCT services, indicated that PMTCT programmes had no 
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effect on the treatment of sexually transmitted infections (STIs). None of these 
publications mentioned the effect of PMTCT programmes on the treatment of severe 
anaemia (Both & Roosmalen 2010:1445-1447). A study from Thailand, assessed 
pregnancy outcomes among women using ART. Out of 204 women, 22 developed 
anaemia. Out of these 22 women, 13 did so six weeks after exposure to ARVs and nine 
before exposure to ART. Nausea and vomiting were documented in only four of the 
pregnant women’s records (Areechokchai et al 2009:10). A study from the USA 
examined the association of latest CD4 counts with risk of non-AIDS diseases in a 
cohort of 1 397 patients who initiated ART. Non-AIDS diseases considered by the study 
were liver, cardiovascular, renal and cancer conditions. A total of 80 patients developed 
non-AIDS conditions but these declined with the highest most recent CD4 counts. Thus 
the higher the patients’ CD4 counts were, the lower were their rates of non-AIDS events 
(Baker, Peng, Rapkina, Abrams, Silverberg, MacArthur, Cavert, Henry & Neaton 
2008:841). A study which was conducted in Tanzania, reported haematological changes 
in women exposed to AZT-containing regimens for PMTCT. Two cohorts of women 
participated in the study group 1 (f=82) with AZT intake and group 2 (f=62) without AZT 
intake for PMTCT during pregnancy. It was found that among group 1 (with AZT) 
women had significant decreased red blood cell, white blood cell and granulocyte 
counts, as well as increased red cell distribution width and platelet counts (Ziske, Kunz, 
Sewangi, Lau, Dugange, Hauser, Kirschner, Harms & Theuring 2013:3). 
 
4.5.3        HIV status of respondents’ infants 
 
This section presents the HIV status of the infants using the DNA-PCR test results. The 
MTCT rate of HIV was 6.0% (f=23) among children whose HIV-positive mothers used 
PMTCT services, implying that 94.0% (f=361) the infants were HIV-negative. By the 
time infants were ≤6 weeks of age, 65.6% (f=253) of them had been tested with the 
DNA-PCR test and when they were >6 weeks of age 34.4% (f=132) of them had been 
tested. Infants’ HIV status was further categorised by the timing of DNA-PCR tests and 
it shows that among the 253 infants, 6.7% (f=17) tested HIV-positive and among 132 
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infants, 4.5% (f=6) tested HIV-positive. Those infants tested after six weeks of age could 
have acquired the infection either after six weeks or at ≤6 weeks of age. Accordingly, it 
was not possible to determine prenatal and post-natal HIV transmission rates because 
132 infants did not get DNA-PCR test at ≤6 weeks and 236 infants did not get repeat 
tests after six weeks of age. It would have been possible to determine the prenatal and 
post-natal HIV transmission rates if all infants got DNA-PCR test results at ≤6 weeks 
and those tested HIV-negative got repeat tests after six weeks of age. The current 
PMTCT practice and record of DNA-PCR test result does not allow the calculation of 
transmission rates at these two periods. Rather the crude MTCT rate was calculated to 
be 6.0%. 
 
Table 4.27: HIV status of the infants using DNA-PCR test (n=384)  
HIV status of the infant Frequency Percent (%) 
HIV-positive 23 6 
HIV-negative 361 94 
Total  384 100 
 
 
According to the WHO (2010a:12), the use of recommended PMTCT interventions can 
reduce MTCT to less than 5% in the breast feeding population. The MTCT rate in this 
research is 1% higher than the WHO recommendation. Similar findings were reported in 
the Dominican Republic study with 6.4% MTCT rate. However, the latter study analysed 
the results of those infants’ HIV status whose mothers used sdNVP (Lorenzo et al 
2012:3-5). A lower MTCT rate of 2.1% had been documented by a Nigerian study 
(Esene & Omoigberale 2012:107-110).  
 
A higher rate of MTCT of 15.86% was reported by a Kenyan study (Azcoaga-Lorenzo et 
al 2011:276-278). According to a study conducted in China, the rate of MTCT among 
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infants whose mothers used ARVs was 9.23% which is higher than the current study’s 
finding of 6.0%. The finding revealed that PMTCT intervention did not reach an 
expected goal of less than 5% MTCT rate in China (Li, Zhao, Zhang, Wu, Chen, Liang, 
Xu & Yu 2013:3). A study conducted in Cameroon also presented HIV status of infants 
at 11.6% which is higher than the current study’s finding (Noubiap, Bongoe & Demanou 
2013:3). 
 
4.5.4   FACTORS AFFECTING MOTHER TO CHILD TRANSMISSION OF HIV IN 
ADDIS ABABA 
 
Factors that could have a significant effect on the rate of MTCT included nipple fissures, 
ARVs taken by the mother, ARV prophylaxis given to the infant, birth weight, gestational 
age during delivery and APGAR score. However, gender of the infant, mode of delivery 
and maternal age did not have significant association with the rate of MTCT. Each of 
these variables will be discussed in the following sections.  
 
4.5.4.1 HIV status of the infant versus nipple fissures 
 
Out of the 384 respondents, 6.8% (f=26) had nipple fissures. As many as 38.5% (f=10) 
of these women’s infants were HIV-positive. Among those without nipple fissures, only 
3.6% (f=13) had HIV infected infants. The rate of MTCT was higher among those 
mothers with nipple fissures. A chi-square test also showed an OF that was higher than 
the EF of women with nipple fissures by 7.4 among those with HIV infected infants. On 
the contrary, the OF was smaller than the EF among women without nipple fissures by 
8.4 for those with HIV-infected infants. There was also a significant association between 
HIV status and nipple fissures at the 0.05 p value (P<0.01). The risk of acquiring HIV 
among infants whose mothers had nipple fissures was 10.59 times higher than for those 
whose mothers did not have nipple fissures (RR=10.59; 95%CI=5.15, 21.80).  
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Table 4.28: HIV status of the infants correlated with the presence or absence of 
respondents’ nipple fissures (N=384) 
 
Nipple 
fissure 
                       HIV status   
Total HIV-positive HIV-negative 
Present % 38.5  61.5  100  
 f 10 16 26 
Absent % 3.6  96.4  100  
f 13 345 358 
Total % 6.0  94.0   100  
 f 23 361 384 
 
Table 4.29 Chi-square test of mothers’ nipple fissures versus infants’ HIV status  
(N=384) 
 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 52.223 1 .000 
N of Valid Cases 384   
 
According to a recent update on parent-to-child-transmission of HIV from India, the 
postpartum MTCT rate ranged from 5% to 15%. Mastitis, cracked nipples and 
abscesses of the breast were factors that predisposed infants to post natal MTCT. 
Furthermore decreased epithelial integrity of the oral cavity of the infant (oral thrush) 
could lead to maternal nipple thrush and fissures (Hazarika 2010:63-64). A study from 
Zimbabwe documented the relationship between abnormal breast conditions and 
vertical transmission of HIV. In this study mothers with abnormal breast conditions at 
enrollment in the PMTCT programme were four times more likely to transmit HIV to their 
children (Gumbo et al 2010:719). Another Zimbabwean cross-sectional study indicated 
that laboratory results of mastitis were associated with breast milk HIV 1 RNA but not 
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with HIV 1DNA loads. Thus HIV 1 DNA loads were not increased during mastitis (Gantt, 
Shetty, Seidel, Matasa, Musingwini, Woelk, Zijenah, Katzenstein & Frenkel 2007:570). 
 
4.5.4.2 HIV status of the infant versus gender of the baby 
 
There were 185 male and 199 female infants included in the current study. The 
proportion of male to female ratio of babies was 0.48:0.52. There were 14 HIV-positive 
male infants and 9 HIV-positive female infants. The MTCT rate of HIV among the male 
infants was 7.6% while the transmission was 4.5% among the females. The chi-square 
test showed an observed frequency that was higher than the expected frequency by 2.9 
among male HIV infected infants. On the other hand the observed frequency was lower 
than the expected frequency by 2.9 among female HIV infected infants. Nevertheless 
this difference was not statistically significant at 0.05 P value using the chi-square test 
(P=.209). The gender of the infant was not significantly associated with MTCT. 
Therefore there was no significant difference in risk of acquiring HIV from their mothers 
between male and female infants (RR=1.67; 95%CI= 0.74, 3.77).  
 
 
Figure 4.7:  HIV status versus gender of the infant (N=384) 
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Table 4.30: Chi-square test: HIV status of the infant versus gender of the infant 
(N=384) 
 Value df Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 1.579a 1 .209   
N of Valid Cases 384     
 
 
The proportion of male to female was in line with the 2007 census statistics of Ethiopia. 
In Addis Ababa, Ethiopia, the total population was 2 739 551 with a male to female ratio 
of 0.48:0.52 (PSC 2007:7). A study which was conducted in northwestern Ethiopia 
reported similar findings. That study used 509 mother-infant pair for final analysis. 
Among these infants, 263 were male infants and 246 female infants making male to 
female ratio of 0.52:0.48. Sex of the infant was not significantly associated with MTCT. 
Nevertheless, among the 509 HEIs, 51 (10.0%) were HIV infected (Koye & Zeleke 
2013:03). 
 
This finding was also supported by another study conducted in an urban hospital in 
Kuwazulu-Natal, South Africa. The number of male HEIs was 122 and the number of 
female HEIs was 129 (Chetty et al 2010:5). Another study conducted in Zambia 
reported similar finding as to male to female ratio where out of 28 320 babies included 
in the study, half of them were males. However, the overall transmission of HIV among 
these HEIs was 12.2% (Torpey, Mandala, Kasonde, Bryan-Mofya, Bweupe, Mukundu, 
Zimba, Mwale, Lumno & Welsh 2010:3).  
 
4.5.4.3   HIV status of the infant versus weight of the infant 
 
All the infants (N=384), included in this study had the newborn weight measurements 
recorded in their files. Out of these 384 infants, 5.2% (f=20) were underweight with birth 
weights of less than 2.5kg, 91.7% (f=352) of them with normal birth weight ranging from 
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2.5 to 4.5kg and 3.1% (f=12) were overweight weighing 4.5kg or more at birth. The 
average birth weight was 3.44kg that ranged from 2kg to 5.5kg. The MTCT rate among 
those babies who were underweight was 15.0%. Among those with normal birth weight, 
the MTCT rate was 4.3% and among those who were overweight the MTCT rate was 
41.7%. Therefore the MTCT rate was higher among overweight and underweight 
babies.  The Chi-square test showed that the OF was higher than the EF among HIV 
infected infants with birth weight above 4.5kg by 4.3 and among those with birth weight 
less than 2.5kg birth weight by 1. The OF was lower than the EF among HIV infected 
infants with birth weights ranging from 2.5kg to 4.5kg by 6.1.  
 
There was a significant association between HIV status of the infant and newborn 
weight at 0.05 P value (P<0.01). Underweight infants were 3.52 times more at risk than 
normal weight infants to acquire HIV (RR=3.52; 95%CI=1.11, 11.17) and overweight 
infants were 9.78 times more at risk than normal weight infants to acquire HIV 
(RR=9.78; 95%CI=4.25, 22.48).  
 
During the first post natal follow-up visit, 380 (99.0%) infants had weight measurements 
recorded in their files. During the second visit 367 (95.6%), during third visit 305 
(79.4%), during fourth visit 256 (66.7%), during fifth visit 232 (60.4%) and during the 
sixth visit 195 (50.8%) of the infants had weight measurements recorded in their files. 
The average weight increased from 4.5kg from the first visit to 8kg during the sixth visit. 
Since weight measurements of the infants were not normally distributed, the Friedman 
test was used to show that increments of the infants’ weights were significant at p value 
of 0.05 (P<0.01).  
 
 
 
 
153 
 
Table 4.31: HIV status of the infant versus newborn weight (N=384) 
 
Newborn 
weights 
                       HIV status   
Total HIV-positive HIV-negative 
< 2.5kg % 15  85  100  
 f 3 17 20 
2.5-4.5kg % 4.3  95.7  100  
 f 15 337 352 
>4.5kg % 41.7  58.3  100  
 f 5 7 12 
Total % 6  94  100  
f 23 361 384 
 
Table 4.32 Friedman test for babies’ body weights in kilograms at subsequent 
clinic visits 
Visits 1st  
weight 
2nd  
weight 
3rd  
weight 
4th   
weight 
5th  
weight 
6th  
weight 
df Asymptomatic 
significance 
Mean 
rank 
1.04 2.00 3.02 3.99 5.02 5.93 5 0.000 
 
A study, conducted in Zimbabwe, documented similar findings to those reported in the 
current study indicating that low birth weight infants were at increased risk of acquiring 
HIV. The study was prospective because it followed a cohort of mother-infant pairs for 
15 months. Among infants with birth weight of ≥2500g, 30.2% (f=73) became HIV-
positive. Among infants with birth weight of <2500g, 57.1% (f=12) became HIV-positive 
(Gumbo et al 2010:722). 
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A study conducted in Cameroon reported birth weights of infants. A cohort of 587 HIV-
positive mother-infant pairs were included in the study. The average birth weight was 
3145.30 gram that ranged from 1300-4760 gram (Nlend et al 2011:4). A study 
conducted in China also reported a slightly different finding from the Cameroon study. 
The birth weight was measured for 194 single live births (excluding multiple births). The 
median birth weight was 2850 gram (range1450-4000 gram). Among these, 19.6% of 
the babies were classified as having low birth weights and 6.7% of the infants were 
diagnosed as HIV-positive. Further analysis revealed that factors associated with low 
birth weight included the  mother’s weight of less than 45 kg at antenatal clinic 
enrollment, gestational age of less than 37 weeks at delivery, CD4 count less than 
100cells/ul at antenatal clinic enrollment and HI viral load of more than 100 000 
copies/ml (Lan et al 2012:405).  
 
4.5.4.4 HIV status of the infant versus ARVs taken by the mother 
 
A total of 55 (14.3%) respondents took ARV prophylaxis and 329 (85.7%) took ART for 
PMTCT. Out of 55 respondents who took ARV prophylaxis, 85.5% (f=47) had HIV-
negative infants while 14.5% (f=8) had HIV-positive infants, implying a MTCT rate of 
14.5%. Out of the infants of 329 respondents who used ART, 95.4% (f=314) were HIV-
negative and 4.6% (f=15) were HIV-positive, implying a MTCT rate of 4.6%. Out of 361 
HIV-negative infants (384-23 HIV-positive infants), 87.0% (f=314) of their mothers were 
on ART and 13.0% (f=47) of their mothers took ARV prophylaxis. 
 
A chi-square test showed that the OF was higher than the EF by 4.7 among HIV 
infected infants born from mothers who took ARV prophylaxis. The OF was lower than 
the EF by 4.7 among HIV-infected infants whose HIV-positive mothers took ART. There 
was a significant association between type of ARVs (ARV prophylaxis versus ART) 
given to the mother with HIV status of the infant at 0.05 p value (P=0.004). The risk of 
acquiring HIV among infants whose mothers used ARV prophylaxis was 3.19 fold higher 
than those whose mothers used ART (RR=3.19; 95%CI=1.42, 7.17). 
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Figure 4.8: HIV status of infants versus ARVs taken by their mothers for PMTCT 
(N=384) 
 
Table 4.33: Chi-square test: HIV status of the infants versus ARVs taken by their 
mothers for PMTCT (N=384) 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 8.346 1 .004 
N of Valid Cases 384   
 
A study form Cameroon reported a similar finding, showing that multi-drug ART could 
prevent MTCT. Out of the 418 mother infant pairs retained for data analysis, the overall 
MTCT rate of that Cameroonian study was 6.6% ((Tchendjou et al 2010:4). Another 
study from Burkina Faso reported a similar finding in terms of the rate of MTCT versus 
the type of ARVs received for PMTCT (ARV prophylaxis versus ART). That study 
reported that 326 women received short course ART (ARV prophylaxis) and 260 women 
received HAART. The rate of MTCT was higher among those who took ARV 
prophylaxis (short course ART) (6.2%) as compared to those who took HAART (0%) 
(Kouanda et al 2010:844-847).  
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A South African study reported about the effect of different HAART regimens and the 
duration on MTCT. Data were reported about 1142 women and 873 of their infants 
whose HIV status was determined at 4-6 weeks after birth. The overall MTCT rate was 
4.9%. Women who became pregnant while on HAART had a MTCT rate of 0.7% and 
women who initiated HAART during pregnancy had a MTCT rate of 5.7%. Women with 
CD4 count >250cells/mm3 who received sdNVP had a MTCT rate of 7.9% while women 
presenting to the clinic during or after the delivery of their infants with no ARV 
prophylaxis had a MTCT rate of 17.4% (Hoffman, Black, Technau, Van der Merwe, 
Currier, Coovadia & Chersich 2010:37-38). 
 
4.5.4.5 HIV status of the infants versus ARV prophylaxis given to the infants 
 
Out of the 384 infants that participated in the current study, 98.7% (n=379) had received 
ARV prophylaxis for PMTCT and 1.3% (n=5) of them did not receive it. Among those 
infants who received ARV prophylaxis, 376 of them received NVP, one infant received 
d4T+3TC and two infants received AZT+NVP. Among those infants who received ARV 
prophylaxis, the MTCT rate was 5.5% (f=21) and the rate among those who did not 
receive ARV was 40.0% (f=2).  A chi-square test shows that among infants who took 
ARV prophylaxis and were HIV infected the OF was less than EF by 1.7. Among infants 
who did not take ARV prophylaxis and became HIV infected OF was higher than EF by 
1.7. This was also statistically significant at 0.05 p value (P=0.001). Among those who 
received NVP the number of HIV infected infants were 19, among those who received 
d4T+3TC the number was one and the number among those who received AZT+NVP 
was one. Nevertheless, most of those who received ARV prophylaxis were those who 
took NVP. The risk of acquiring HIV among those infants who did not receive ARV 
prophylaxis was 7.22 fold more than for those infants who received ARV prophylaxis 
(RR=7.22; 95%CI= 2.28, 22.83). The result shows ARV prophylaxis given to the infants 
reduced their risk of acquiring HIV. 
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Figure 4.9:  HIV status of the infants versus ARV prophylaxis taken by the infants 
(N=384) 
 
A similar finding was reported by a study, conducted in Haiti, to assess improving 
outcomes in infants of HIV-infected women in a developing country. The Haiti study 
analysed data from 551 infants born to HIV-positive mothers. Those mothers and their 
infants were given short course monotherapy ARVs for prophalyxis. The MTCT rate 
without therapy was 13% and the rate after a single dose of NVP was 10.8% (Noel, 
Mehta, Zhu, Rouzier, Marcelin, Shi, Nolte, Severe, Deschamps, Fitzgerald, Johnson, 
Wright & Pape 2008:2-4). A study, conducted in Zambia, also reported that ARVs 
helped to lower the MTCT rate. The study analysed HIV early infant diagnosis to 
estimate rates of perinatal HIV transmission in Zambia. It analysed data of from 28 320 
babies and 71.5% of them had received ARV prophylaxis. The MTCT rate at six weeks 
when ARVs prophylaxis was received by the baby was 15.8% (Torpey 2010:3-5). A 
Nigerian study also reported that ARV prophylaxis helped to lower the MTCT rate. The 
study analysed data from 702 babies, of whom 434 had received single dose NVP at 
birth plus AZT for four weeks. When both mother and baby received ARVs, the MTCT 
rate was 4.8% at zero to six weeks of age, and 6.6% at six weeks to six months of age. 
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When both mother and baby had not received ARVs, the MTCT rate was 19.5% at zero 
to six weeks of age, and 39.8% at six week to six months of age (Anoje et al 2012:304). 
 
4.5.4.5 HIV status of the infant versus mode of delivery  
 
There were 272 vaginal deliveries, four assisted vaginal deliveries, six deliveries by 
episiotomies and 102 deliveries by caesarean sections. The rate of MTCT among 
infants delivered vaginally was 7.0% (f=19), among those delivered by assisted vaginal 
delivery it was 25.0% (f=1), among those born by episiotomy 16.7% (f=1) and among 
those delivered by caesarean section 2.0% (f=2). The rate of MTCT was highest among 
those infants born by assisted vaginal deliveries. The rate of MTCT was lowest among 
those infants delivered by caesarean sections. Nevertheless, there was no statistically 
statistical significant difference in risk of acquiring HIV among infants born vaginally and 
by caesarean section (RR=3.56; 95%CI=0.84, 15.02).  
 
Even though the RR was greater than one, 95% CI contains one which shows no 
significant association. Likewise there was no significant difference in risk of acquiring 
HIV among infants born vaginally and by other kinds of delivery. The only difference in 
risk of acquiring HIV among infants was noted among those born by assisted vaginal 
deliveries and caesarean sections (RR=12.75; 95%CI=1.44, 113.10). This implies that 
infants born by assisted vaginal deliveries were 12.75 fold more at risk of MTCT than 
those delivered by caesarean sections. Out of four infants delivered by assisted vaginal 
deliveries, 75% (f=03) of their mothers took ART and 25% (f=01) took ARV prophylaxis. 
Out of 102 infants delivered by caesarean sections, 93.1% (f=95) of their mothers took 
ART and 6.9% (f=7) took ARV prophylaxis. Hence, more mothers of infants delivered by 
caesarean sections took ART than those of infants born by other means.  
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Figure 4.10: HIV status of infant versus mode of delivery (n=384) 
 
Findings were reported by a study conducted in Western Europe, indicated that 
caesarean sections reduced the chances of MTCT. As many as 5 238 mother-child 
pairs were enrolled in the study. Among premature infants, the crude MTCT rate among 
those delivered by elective caesarean section, emergency caesarean sections and 
vaginal deliveries were 2.8%, 6.2% and 21.6% respectively (European Collaborative 
Study 2010:370). 
 
However, inconclusive findings have been reported by other studies. A study from 
Cameroon reported that the majority of the deliveries were normal (91.4%). Mode of 
delivery, either normal or by caesarean section was not significantly associated with HIV 
status of the infant ((Tchendjou et al 2010:5). Another study from Thailand reported a 
similar finding. It included 246 women of whom 72% had normal deliveries, 19% had 
caesarean sections, 2.8% had vacuum extractions and 0.8% had forceps extractions 
(Areechokchai et al 2009:9-12).  
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4.5.4.6 HIV status of the infant versus gestational age at delivery  
 
Among 384 infants, pre-term deliveries at gestational age of less than 37 week were 
12.5% (f=48), term deliveries 85.4% (f=328) and post-term deliveries 2.1% (f=8). Among 
pre-term deliveries, the MTCT rate was 22.9% (f=11), among term deliveries the MTCT 
rate was 3.7% (f=12) and among post term deliveries the MTCT rate was 0%. The 
MTCT rate was highest among those infants who were born pre-term. A chi-square test 
showed that the OF was higher than the EF by 8.1 for HIV infected infants born at pre-
term whereas the OF was lower than the EF by 7.6 for HIV infected infants born at term. 
This was also statistically significant at 0.05 p value (P<0.01). The risk of acquiring HIV 
among infants born pre-term was 10.74 fold more than for infants born at term 
(RR=10.74; 95%CI=5.22, 22.09).  
 
 
 
 
 
Figure 4.11: HIV status of the infant versus gestational age at delivery (N=384) 
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Table 4.34: Chi-square test: HIV status of the infants versus gestational age at 
birth 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 
28.10
0 
2 .000 
N of Valid Cases 384   
A study from Thailand documented findings about the prevalence of mode of delivery 
among women who took ART. Among 246 women, 84.6% had full term deliveries and 
10.2% pre-term deliveries. Pre-term delivery was significantly higher among pregnant 
women on combined ART and among those who started PMTCT during labour 
(Areechokchai et al 2009:9-12). A study from China reported that the gestational age at 
delivery for infants born from HIV infected women was 39 weeks (range 31-42 weeks). 
Therefore 9.79% of the deliveries were pre-term and 90.21% were deliveries at full 
term. Among the pre-term deliveries, one baby became HIV-positive and 18 remained 
HIV-negative, yielding an HIV infection rate of 5.3%. Among the full term deliveries, 12 
became HIV-positive and 163 remained HIV-negative, yielding an HIV infection rate of 
6.9% (Lan 2012:405-406). Thus the Chinese study reported a slightly higher incidence 
of HIV infection among babies born at full term than among prematurely born babies. 
 
4.5.4.7 HIV status of the infant versus maternal age 
 
The median age of the women was 28.1 years, ranging from 19 to 38 years.  Many 
women (f=180; 46.9%) fell within the age group of 26-30 years old. On the other hand, 
few women (1.3%; f=5) fell within the 16-20 age group. The MTCT rate among different 
for various age groups: 
• 0% in the 16-20 year group 
• 5.4% in the 21-25 year group 
• 6.1% in the 26-30 year group 
• 4.3% in the 31-35 year group 
• 21.4% in the 36-40 year group.  
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The highest rate of MTCT was observed among those infants born from mothers in the 
age group of 36-40 and the lowest MTCT rate was among those infants born from 
mothers in the age group of 16-20. Among mothers with age group of 36-40, 92.9% 
(f=13) took ART and 7.1% (f=1) took ARV prophylaxis. Among mothers with age group 
of 16-20, 60% (f=3) took ART and 40% (f=2) took ARV prophylaxis. The chi-square test 
also showed that the OF was higher than the EF by 2.2 among HIV-infected infants 
whose mothers fell within the age group of 36-40 years and by 0.2 among HIV-infected 
infants whose mothers’ age group was 26-30. On the other hand, the OF was lower 
than the EF by 0.3 among HIV-infected infants whose mothers fell within the age group 
of 16-20, by 0.5 among HIV-infected infants whose mothers were 21-25 years old and 
by 1.6 among HIV-infected infants whose mothers were 31-35 years old. Nevertheless 
this difference was not statistically significant showing no association between HIV 
status of the baby and maternal age at 0.05 p value (P=0.149). 
 
Table 4.35: HIV status of the infants versus their mothers’ ages (N=384) 
Maternal age  HIV-positive HIV-negative TOTAL 
16-20 % 0  100  100  
f 0 5.0 5.0 
21-25  % 5.4  94.6  100  
f 5 87 92 
26-30 % 6.1  93.9  100  
f 11 169 180 
31-35 % 4.3  95.7  100  
f 4 89 93 
36-40 % 21.4  78.6  100  
f 3 11 14 
Total % 6.0  94.0  100  
N 23 361 384 
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Table 4.36 Chi-square test of HIV status of the infant versus maternal age 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 6.771 4 .149 
N of Valid Cases 384   
 
 
A study which was conducted in Zimbabwe reported similar findings as no significant 
risk of HIV transmission was based on differences of maternal age. The mean maternal 
age among those who transmitted HIV to their infants was 26.24 years old (f=192). The 
mean maternal age among those who did not transmit HIV to their infants was 26.91 
years (f=89) (Gumbo et al 2010:719). However, a different finding had been reported 
from a study conducted in South Africa. The study included a sample size of 658 
mother-infant pairs. The overall rate of MTCT was 8.8% (f=535). It reported that women 
aged >25 years were more likely to transmit HIV to their infants. The association 
between maternal age and MTCT could be a function of the advancement of the 
disease (Coetzee, Hilderbrand, Boulle, Draoer, Abdullah & Goemaere 2005:491-492).   
 
4.5.4.9 HIV status of the infants versus their APGAR scores 
 
The APGAR scores, presented in this study, were assessed during childbirth and used 
for evaluating the infants’ appearance, pulse rate, grimace, activity and respiration. 
Each part was assessed from zero to two. A child who got two for every aspect had an 
APGAR score of 10. The mean APGAR score was 8.44, ranging from 5 to 10. Only six 
of the neonates got APGAR scores of less than seven. The number of neonates with 
normal APGAR scores of ≥ 7 were 378. Among the newborns, 52.1% (f=200) had 
recorded APGAR scores of 9, 39.6% (f=152) had APGAR scores of 8 and 6.0% (f=23) 
obtained 7. The other scores combined were 2.4% (f=9). Among those infants with low 
APGAR score of less than seven, the MTCT rate was 66.7% (f=6). Among infants with 
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normal APGAR scores, the MTCT rate was 5%. The rate of HIV transmission was 
higher among those infants with APGAR scores below 7. A chi-square test showed that 
the OF was higher than the EF by 3.6 among HIV infected infants with low APGAR 
score while the OF was lower than the EF by 3.6 among HIV-infected infants with 
normal APGAR scores. This difference was statistically significant showing an 
association between APGAR score and HIV status of infants at 0.05 p value (P<0.01).  
Infants with low APGAR scores were 13.26 times more at risk than infants with normal 
APGAR scores to acquire HIV (RR=13.26; 95%CI=6.48, 27.13). 
 
Table 4.37:  HIV status of the infants versus their APGAR scores (N=384) 
APGAR 
score 
                       HIV status  
Total HIV-positive HIV-negative 
< 7 % 66.7  33.3  100.0  
f 4 2 6 
≥ 7 % 5.0  95.0  100.0  
f 19 359 378 
Total % 6.0  94.0  100.0  
N 23 361 384 
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Figure 4.12: Cumulative percent of newborns’ APGAR scores (n=384) 
 
Table 4.38: Chi-square test: HIV status of the infants versus APGAR scores 
(N=384) 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 39.854 1 .000 
N of Valid Cases 384   
 
A study which was conducted in Kwazulu-Natal, South Africa, reported a different 
finding as there was no statistically significant difference of APGAR scores among HIV 
infected and uninfected babies. That study used a total of 55 mother-baby pairs’ 
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peripheral blood samples for analysis. The median APGAR score was nine and 10, one 
and five minutes after delivery respectively. The pooled rate of transmission of HIV-1 
infected mothers to their babies was 0.27 (Moodley 2009:17-18). A study from Poland 
also reported few infants born from HIV infected mothers got low APGAR scores. The 
study group consisted of 35 infants. APGAR scores were 10 for 21 infants, 9-7 for 13 
infants and only one child scored 5 (Mania, Kemnitz, Mazur-Melewska, Figlerowicz, 
Cudnoch, Sluzewski, Kowala-Piaskowska & Mozer-Lisewska 2012:181).  
 
A Nigerian study conducted a prospective matched case control study. The study 
population comprised of 406 women of whom 203 were HIV-positive pregnant women 
receiving HAART for PMTCT and the other 203 negative controls. Their infants’ APGAR 
scores of less than 7 were comparable between the two groups (Olagbuji, Ezeanochie, 
Ande & Oboro 2009:991-992). Another study conducted in Nigeria reported similar 
finding as to APGAR score. A total of 446 baby-mother pairs were followed for minimum 
period of 6 months and 4.5% of the neonates had an APGAR score of 1-6 and 95.5% 
had an APGAR score of 7-10 (Chama, Bello, Ajayi, Sarma & Gashau 2010:363-364). 
Thus studies from different countries did not provide conclusive evidence that HIV-
positive women’s babies would have APGAR scores below 7. 
 
4.5.4.10 Logistic regression of factors affecting mother to child transmission of 
HIV 
 
Since the HIV status of the infant is a dichotomous categorical outcome variable (HIV-
positive versus HIV-negative), binary logistic regressions were calculated. A forced 
entry method was used to place all the predictors onto the regression model with 
significant association to HIV status of the infant. The bivariate analysis indicated that 
there was a significant difference in the odds of infants being HIV infected if their 
mothers had nipple fissures compared to those infants whose mothers did not have 
nipple fissures (COR=16.59; 95%CI=6.32, 43.53). Likewise the odds of an infant being  
HIV-positive is increased significantly among those with birth weights of less than 2.5kg  
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as compared to those weighing 4.5kg or more (COR=3.97; 95%CI=1.05, 15.02). This 
implies that both infants weighing less than 2.5kg and those weighing more than 4.5kg  
at birth, had a somewhat greater risk of being HIV-positive than infants with normal birth 
weights ranging from 2.5kg to 4.5 kg.  
 
There was a significant difference as to the odds of an infant becoming HIV infected 
among those born from mothers who took ARV prophylaxis as compared to those who 
took ART (COR=3.56; 95%CI=1.43, 8.86). The odds of an infant to contract HIV were 
significantly reduced among infants who took ARVs as compared those who did not 
take ARVs (COR=0.88; 95%CI=0.14, 0.56). The odds of an infant to have HIV was 
significantly higher among those with low APGAR scores (below 7) as compared to 
those with higher APGAR scores of at least 7 (COR=37.79; 95%CI=6.51, 219.4). 
 
In the multivariate analysis, the odds of an infant with a birth weight of less than 2.5kg to 
acquire HIV was not significantly different from that for infants with birth weights of 4.5kg 
or more (AOR=1.78; 95%CI=0.27, 11.10). The odds of an infant to contract HIV was not 
significantly different among those born from mothers who took ARV prophylaxis as 
compared to those who were born from mothers who took ART (AOR=3.31; 
95%CI=0.87, 12.59). The interaction effect of the exposure variables did not have 
significant effects on the odds of an infant to acquire HIV (p=695). The logistic 
regression model correctly predicted the HIV status of 95% of the infants. The model to 
predict the HIV status of infants used those independent variables that had significant 
associations in the multivariate analysis.  
 
Y = -4.87+10.99(X1)+0.05(X2)+28.8(X3).  
 
Symbols Y and X represent the dependent and independent variables as: Y=HIV status 
of the infant; X1=Nipple fissure; X2= ARVs given for the baby; X3= APGAR score. Thus 
the odds of infants born from mothers with nipple fissures to become HIV infected is 
10.99 times higher than those infants born from mothers without nipple fissures 
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(AOR=10.99; 95%CI=3.03, 39.93). The odds of infants who took ARV prophylaxis to 
become HIV infected is 0.05 times higher than those infants who did not take ARV 
prophylaxis (AOR=0.05; 95%CI=0.002, 1.02). In other words ARV prophylaxis given to 
the infants protected them from HIV infection. The odds of infants with low APGAR 
scores to contract HIV was 28.8 times higher than for infants with high APGAR scores 
(AOR=28.8; 95%CI= 2.88, 287.7).  
 
Table 4.39:  Bivariate logistic regression: factors affecting MTCT (N=384) 
Exposure 
Variables 
HIV status of the 
Infant 
COR p-
value 
95%(CI) 
Positive Negative 
Nipple 
fissure 
Present 10 16 16.59 0.00 (6.32, 43.53) 
Absent 13 345    
Newborn 
weight 
<2.5kg 3 17 3.97 0.043 (1.05, 15.02) 
2.5-
4.5kg 
15 337 0.25 0.10 (0.05, 1.33) 
>4.5kg 5 7    
ARVs 
given for 
the 
mother 
ARV 
Proph. 
8 47 3.56 0.006 (1.43, 8.86) 
ART 15 314    
ARV 
given for 
the infant 
Yes 21 358 0.88 0.01 (0.14, 0.56) 
No 2 3    
APGAR 
score 
<7 4 2 37.79 0.00 (6.51, 219.4) 
≥7 19 359    
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Table 4.40:  Multivariate logistic regression: factors affecting MTCT (N=384) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.6   SUMMARY   
In this chapter data of 384 mother–infant pairs were analysed, presented and 
discussed. At the beginning socio-demographic features of the mothers were analysed. 
This was followed by factors affecting PMTCT service utilisation. These factors were 
analysed based on the major tenets of HBM. Perceived susceptibility was analysed in 
line with women’s HIV status knowledge at presentation for ANC versus educational 
Exposure Variables HIV status of the 
Infant 
AOR p-
value 
95%(CI) 
Positive Negative 
Nipple 
fissure 
Present 10 16 10.99 0.00 (3.03, 39.93) 
Absent 13 345    
Newborn 
weight 
<2.5kg 3 17 1.78 0.55 (0.27, 11.10) 
2.5-
4.5kg 
15 337 0.117 0.06 (0.12, 1.13) 
>4.5kg 5 7    
ARVs 
given for 
the mother 
ARV 
Proph. 
8 47 3.31 0.08 (0.87, 12.59) 
ART 15 314    
ARV given 
for the 
infant 
Yes 21 358 0.045 0.052 (0.002, 1.02) 
No 2 3    
APGAR 
score 
<7 4 2 28.80 0.004 (2.88, 287.7) 
≥7 19 359    
Interaction    0.45 0.695 (0.01, 23.88) 
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levels, marital status and employment status. The highest percentage of women who 
attended university/college level education, 94.6% (f=53) knew their HIV status before 
presentation for ANC. Percentage of women based on their marital status from highest 
to lowest who knew their HIV status before presentation for ANC were widows (100%), 
living in union (90.0%), married (86.5%), never married (80.0%), separated (66.7%) and 
divorced (0%). The highest percentage of women who knew their HIV status at 
presentation for ANC based on employment status were self-employed (19.0%: f=73).  
Perceived severity was assessed in relation to HIV status of respondents’ partners 
versus awareness of respondents’ partners that they were using PMTCT services. Out 
of 313 partners who were HIV-positive, 97.8% (f=306) were aware of their partners’ 
utilisation of PMTCT services while 2.2% (f=7) did not know. Perceived barriers were 
explained in relation to marital status versus disclosure of HIV status, stigma and 
discrimination and employment status versus monthly income. Most of the women who 
used PMTCT services were married and most respondents attained grades 9-12 
educational levels. The respondents earned a monthly income whether they were 
employed or not. They experienced limited stigma and discrimination.  
 
PMTCT services were also evaluated in relation to HCT, ARVs for PMTCT and infant 
feeding counseling and practices. Most of the women used HCT services and ethical 
standards were maintained such as privacy and confidentiality. Approximately 20% of 
the respondents initiated ART before they were eligible to do so and 25% were 
receiving ARV prophylaxis when they were in fact eligible for ART. Most respondents 
preferred exclusive breast feeding. Patients who used PMTCT services in Addis Ababa 
were satisfied with the infrastructure, accessibility, availability and affordability of 
PMTCT services as well as with the nurses/midwives. 
 
Health outcomes of the mothers were assessed using CD4 counts, WHO stage and 
illnesses diagnosed during PMTCT services. CD4 counts increased during the course of 
PMTCT but this was not complemented by improvements in the WHO clinical stages. 
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Different illnesses had been diagnosed at enrollment and during follow up of PMTCT 
services. The average rate of MTCT was 6.0% which was higher than the WHO 
recommendation of 5.0% for breastfed infants. Significant factors that could affect the 
rate of MTCT were nipple fissures, ARV prophylaxis versus ART given to the mothers, 
infants’ ARV prophylaxis, infants’ birth weights, gestational age and APGAR scores. 
The next chapter focuses on conclusions, limitations and recommendations so that the 
final objective of the study can be addressed by providing recommendations based on 
the findings of the study. 
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CHAPTER 5  
CONCLUSIONS, LIMITATIONS AND RECOMMENDATIONS 
 
 
5.1 INTRODUCTION 
 
This chapter presents a summary of the study’s findings, the conclusions based on 
these findings, limitations of the study and recommendations for improving PMTCT 
service in Addis Ababa and for conducting future studies. Making recommendations to 
enhance women’s utilisation of PMTCT services in Addis Ababa was one of the 
objectives of the study, which will be addressed in this chapter, as the other objectives 
were addressed in chapter 4.  
 
This study used a quantitative research approach with a retrospective cohort design. 
The data were collected retrospectively from 384 mother-infant pairs who used PMTCT 
services at 12 healthcare centers in Addis Ababa. Both structured interviews and 
document reviews were used to gather data. Stratified random sampling was used to 
sample individual women-infant pairs who used PMTCT services. The health facilities 
comprised public hospitals, public health centers and private hospitals. Both descriptive 
and inferential statistics were used during data analysis.  
 
5.2   SUMMARY OF RESEARCH FINDINGS 
 
The research findings, as discussed in Chapter 4, are summarised in this section.  
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5.2.1 Summary of the respondents’ demographic characteristics 
 
The largest number of respondents (46.9%; f=180) fell within the 26-30 year age group, 
but almost all (95.1%; f=365) participating mothers’ ages ranged from 21 to 35.  Most 
respondents (88.5%; f=340) were married, and belonged to Christian religions (81.0%; 
f=311).  Only 37.8% (f=145) had attained grades 9-12 while 14.6% (f=56) had acquired 
university or college education.  This implies that 47.7% (f=183) of the respondents had 
no schooling or only progressed up to grade 8 at school.  The respondents’ average 
monthly income was 2533.7birr but ranged from 100 to 9200birr (when 1USD was 
equivalent to 19birr).  There was a positive correlation between the respondents’ 
monthly incomes and their levels of qualifiations (ANOVA P<0.01).  
 
The baseline CD4 counts of 69.5% (f=267) of the respondents was below 350 
cells/mm3, but this percentage dropped to 58.3% (f=224) for the most recently recorded 
CD counts. The percentage of respondents with CD4 counts greater than 350 cells/mm3 
increased from 30.5% (f=117) at baseline to 41.7% (f=160) at the most recently 
available CD4 counts. 
 
Before their initial attendance of the ANC clinic as many as 84.9% (f=326) knew about 
their HIV-positive status, while 15.1% (f=59) were unaware of their HIV status.  
Reportedly 81.5% (f=313) of the respondents’ partners were also HIV-positive. 
 
5.2.2  Factors affecting the utilisation of PMTCT services in Addis Ababa  
 
The different factors affecting the utilisation of PMTCT services in Addis Ababa were 
discussed in section 4.3 of this thesis according to the major tenets of HBM. These 
tenets are perceived susceptibility, perceived severity and perceived barriers. 
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5.2.1.1   Perceived susceptibility  
 
As can be seen from table 4.1, only 5.7% (f=22) of the respondents never attended 
school. The others (94.3%; f=402) attained some level of education. Women with higher 
levels of education (grades 9-12 and university/college education) were more likely to 
know their HIV status before presenting at ANC clinics than women with lower 
educational levels (no schooling and up to level 8 schooling). Thus women with higher 
levels of education had a more realistic perceived susceptibility of transmitting HIV to 
their infants, and thus an increased likelihood of using PMTCT services, than women 
with lower levels of education. 
 
Most respondents (88.5%; f=340) were married. Women who had male partners (being 
married, being widowed or living in union without being married) were more likely to 
know their HIV status at presentation for ANC than women without male partners. 
Although this correlation was statistically significant, Cramer’s V (V=0.216) was weak.  
Nevertheless this finding seemed to indicate that women with male partners perceived 
themselves to be more susceptible to MTCT, and thus to use PMTCT services, than 
those without male partners. 
 
The employment status of the respondents was classified into full time employed 
(39.6%; f=152); part time employed (7.3%; f=28); self-employed (19.0%; f=73); and 
unemployed (34.1%; f=131). The highest percentage of self-employed (91.8%; f=67) 
women knew their HIV status before presentation for ANC while 88.5% (f=116) of the 
unemployed, 82.9% (f=126) of the full time employed and 60.7% (f=17) of the part-time 
employed women had such knowledge. This could be attributed to self-employed and 
unemployed women’s greater flexibility of their free time to attend health services. This 
finding could also be interpreted as indicating that self-employed women had a higher 
perceived susceptibility of MTCT than women from other employment categories, and 
thus a greater likelihood of implementing actions to prevent their infants from being HIV-
positive by using PMTCT services. 
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5.2.1.2   Perceived severity  
 
Perceived severity was assessed based on the possible consequences of their HIV-
positive status, as perceived by the mothers. One of the consequences is transmission 
of HIV to their partners. Most of the respondents’ partners were HIV-positive (81.5%; 
f=313). As can be seen from figure 4.1, 97.8% (f=306) of the 313 respondents’ positive 
partners knew that the women used PMTCT services, while 18.6% (f=8) of those with 
unknown HIV status and, 92.9% (f=29) of the HIV-negative partners had such 
knowledge. There was an association between awareness of the partners’ HIV status 
and the partners’ knowledge that the women used PMTCT services.  While more than 
90% of the partners’ with known HIV status were aware of the respondents’ utilisation of 
PMTCT services, 18.6% (f=8) of partners with unknown HIV status had such 
knowledge.   
 
This finding indicated that couples’ HIV testing should be promoted as knowledge of 
their partners’ HIV status (whether positive or negative) seemed to enable couples to 
perceive the severity of the consequences of HIV for themselves and for their children.  
Such perceived severity, shared by both partners, could enable more pregnant women 
to utilise PMTCT services. 
 
5.2.1.3   Perceived barriers 
 
Perceived barriers were examined in terms of obstacles that could make the utilisation 
of PMTCT services difficult for the women. 
 
5.2.1.3.1 Marital status 
 
Most respondents were married (88.5%; f=340). Married women were more likely to 
disclose their HIV-positive status and to use PMTCT services than unmarried women. 
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By disclosing their HIV status, it becomes possible to get support and encouragement to 
use PMTCT services.  
 
5.2.1.3.2  Stigma and discrimination 
 
Stigma and discrimination encountered by the respondents was classified as perceived 
stigma, internalised stigma and discrimination. Perceived stigma and discrimination deal 
with negative attitudes and practices by third persons towards these women. 
Internalised stigma concerned self-stigmatisation by the women. Section 4.3.3.2 of this 
thesis indicates that the most prevalent kind of stigma was internalised stigma. This 
implies that the women were stigmatising themselves as 66.7% (f=256) of the women 
felt worthless, 60.7% (f=256). 233) felt guilty and 36.7% (f=141) isolated themselves 
from friends or family during the preceding 12 months because they were HIV-positive.  
 
Internalised stigmatisation posed a greater barrier to utilise PMTCT services than 
perceived stigma and discrimination.  Thus the respondents’ own perceptions 
influenced their utilisation of PMTCT services to a greater extent than those of their 
friends, family members and communities. 
 
Women who reported internalised stigma had lower CD4 counts compared to those who 
did not face such stigma but this was not statistically significant. 
 
5.2.1.3.3   Monthly incomes 
 
Self-employed women earned higher incomes than unemployed or full time or part time 
employed women. These higher incomes could have afforded easier access to the 
healthcare facilities, explaining why more self-employed women, than the other 
categories of women, knew their HIV-positive status when they arrived at the ANC 
clinics. Economic constraints might have posed barriers to some respondents to access 
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healthcare facilities for their initial HIV-positive diagnoses, but all respondents managed 
to access the PMTCT services, irrespective of their financial incomes. 
 
 
5.3.2    Process of PMTCT services in Addis Ababa 
 
PMTCT services in Addis Ababa were discussed in section 4.4. The services discussed 
included HIV testing and counseling, ARVs for PMTCT and infant feeding counseling 
and practices.  
 
5.3.2.1 HIV testing and counseling of pregnant women 
 
In this study, the majority of the women (84.9%; f=326) knew their HIV status when they 
presented at ANC clinics and 58.9% (f=192) had received the pre-test information 
during group sessions. Out of those 58 women who did not know their HIV status when 
presenting themselves at the ANC clinics, 72.4% (f=42) received their pre-test 
information during individual sessions.  Most respondents indicated that they could ask 
questions (97.7%; f=375) and that they had the right to refuse HIV testing (99.0%; 
f=380) during the pre-test information sessions. Almost all women (99.7%; f=383) 
believed that their privacy and confidentiality were maintained during the pre-test 
information sessions and 99.5% (f=382) indicated this to had been the case during HIV 
testing and counseling. From these responses it is evident the health care providers 
followed the national guideline during the provision of HIV testing and counseling. This 
is the case because Ethiopia’s FMOH recommends three approaches to be followed as 
pre-test information. These are group sessions, individual sessions and couples’ 
sessions. Individuals can ask questions and also have the right to refuse HIV testing 
without compromising their healthcare services (FMOH 2011:11-12).  
 
 
 
178 
 
5.3.2.2    Anti-retrovirals prescribed for the prevention of mother-to-child    
 transmission of HIV 
 
ARV prophylaxis or ART should be prescribed to women at PMTCT services according 
to the FMOH’s guidelines by considering each woman’s CD4 count and WHO stage. 
 
5.3.2.2.1  Treatment prescribed in relation to respondents’ CD4 counts 
 
Table 4.16 shows the ARV interventions for PMTCT in terms of the respondents’ CD4 
counts and WHO stages. Respondents were expected to receive ARV prophylaxis 
when they were not eligible to receive ART as long as their CD4 counts were 
≥350cell/mm3.  Women with CD4 counts <350cell/mm3 required ART, in terms of the 
WHO guidelines (WHO 2013). 
 
Out of 384 respondents, only 14.3% (f=55) received ARVs (prophylaxis) and 85.7% 
(f=329) received ART (treatment).  However, out of the 55 respondents on ARV 
prophylaxis, 25.5% (f=14) started taking ARVs when their CD4 counts were below 350 
cells/mm3. Thus 25.5% of those respondents receiving ARV prophylaxis were supposed 
to receive ART. On the other hand 20.4% (f=67) of the 329 women receiving ART, were 
supposed to receive ARV prophylaxis and not treatment.  
 
This finding indicates that the healthcare workers did not adhere to the FOH guidelines 
pertaining to providing ARV prophylaxis or ART according to the respondents’ CD4 
counts.  However, each patient’s WHO stage of the disease needs to be considered in 
addition to the CD4 count when deciding whether to prescribe ARV prophylaxis or ART.  
 
Nevertheless, 25.5% (f=14) received ARV prophylaxis when they should have received 
ART in relation to their CD4 counts.  Thus the healthcare workers did not follow the 
WHO’s (2013:94) guidelines in prescribing ARV prophylaxis instead of ART to these 14 
respondents with CD4 counts below 350mm3. 
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5.3.2.2.2  Treatment prescribed in relation to respondents’ WHO stage of illness 
 
In terms of the WHO (2013:94) guideline ART should be prescribed for all persons with 
the WHO clinical stage of III of IV, regardless of the CD4 count.  In this study all 
respondents (100%; f=7) in WHO stage IV received ART and of those in stage III 95.7% 
(f=89) received ART.   
 
Thus only 4.3% (f=4) of respondents with WHO stage III disease received ARV 
prophylaxis instead of ART.  The healthcare workers did not follow the WHO (2013:94) 
guideline in prescribing ARVs to these four respondents. 
 
5.3.2.3  Infant feeding options 
 
The three infant feeding options used by the respondents were discussed in section 
4.4.3 of this thesis. The respondents received counseling from the healthcare workers 
about exclusive breast feeding (83.1%; f=319), mixed feeding (10.9%; f=42) and 
replacement feeding (5.5%; f=21).  
 
Most respondents (87.0%; f=334) used exclusive breast feeding during the first six 
months of their infants’ lives, while 3.0% (f=11) used mixed feeding and 10.0% (f=39) 
used replacement feeding such as cow’s milk, formula feeds and/or porridge. Most 
respondents (98.5%; f=323) were counseled by nurses about their infant feeding 
options. 
 
The WHO (2010b:6) recommends that infants of HIV-positive mothers should be 
exclusively breast fed until six months of age and then complementary feeding should 
be introduced. Based on the current study’s findings, most respondents (87.0%; f=334) 
used exclusive breast feeding for the first six months of their infants’ lives.  Thus the 
healthcare workers seemed to meet the WHO recommendation concerning infant 
feeding in the majority of cases. 
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5.3.3   Outcomes of the utilisation of PMTCT services 
 
The different outcomes of the utilisation of PMTCT services include patients’ 
satisfaction, health status of the mothers and HIV status of the infants. Factors affecting 
MTCT are also summarised in this section. 
 
5.3.3.1 Respondents’ satisfaction levels with PMTCT services  
 
Respondents’ satisfaction levels were assessed for different domains, namely 
infrastructure, accessibility and availability of PMTCT services, affordability of PMTCT 
services and their perceptions about the nurses/midwives. The highest level of patients’ 
satisfaction was found towards expectation about the infrastructure with a mean score 
of 3.67 out of 5. 
 
The dissatisfied patients (with the health facilities’ cleanliness and attractiveness) had 
significantly higher CD4 counts than the satisfied patients, but this was a weak 
association according to the Bonferroni test (P=0.076; 95%CI=317, 8).  As patient’s 
clinical conditions worsened (according to the WHO stages), their satisfaction with the 
cleanliness and attractiveness of the facilities decreased significantly (P<0.01, but 
Cramer’s V showed a weak association (V=0.235). 
 
5.3.3.1.1   Expectations about the infrastructure 
 
As can be seen from table 4.18, most respondents were very satisfied or satisfied with 
seven expectations about the infrastructure. They were generally satisfied with the 
cleanliness, attractiveness, comfort and safety of the facility.  The only aspect with 
which many respondents were dissatisfied was the reported wheelchair unfriendliness 
of the healthcare facilities. However, as most respondents (96.4%; f=370 – see table 
4.2) were up to 35 years old, the reported lack of wheelchair friendliness at the 
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healthcare facilities could not have posed a major barrier to accessing PMTCT services. 
(However, no questions were asked about the respondents’ possible disabilities so no 
definite conclusions could be drawn about this aspect). 
 
5.3.3.1.2   Accessibility and availability of PMTCT services 
 
As can be seen from table 4.19, most respondents (89.1%; f=342), reported that it took 
them 30 minutes or longer to reach the PMTCT clinic. Most respondents (82.6%; f=317) 
indicated that PMTCT services were provided at convenient hours and that they could 
access referral services when required (93.0%; f=357). However, 34.4% (f=132) 
indicated that the clinics were sometimes unable to supply their medications when the 
clinics’ medicine stocks were depleted. 
 
Thus most respondents were satisfied with the PMTCT services, but had to spend 30 
minutes or longer to reach facilities and more than 34.4% (f=132) indicated that clinics 
could not always supply their prescribed medicines. 
 
Those respondents, who were very satisfied with the accessibility and availability of 
PMTCT facilities, had higher CD4 counts than the dissatisfied patients, statistically 
significant at P=0.05 (ANOVA).  As the respondents’ clinical conditions deteriorated, the 
number of patients satisfied with the services also declined, significant at P=0.002, but 
Camer’s V showed a weak association (V=0.162). 
 
5.3.3.1.3    Affordability of PMTCT services 
 
 
The affordability of PMTCT services was discussed in section 4.5.1.3. Of the 
respondents, 61.2% (f=235) agreed that they could afford to pay the fees for the 
PMTCT services whereas 26.6% (f=102) disagreed while 12.2% (f= 47) were uncertain. 
Although 61.2% (f=235) of the respondents were satisfied with the affordability but 
26.6% (f=102) were dissatisfied with this aspect of the PMTCT services.  However, as 
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most respondents (85.7%; f=329) indicated that they received healthcare services even 
if they were unable to pay for such services, the reported dissatisfaction of some 
respondents (26.6%; f=102) with the affordability of healthcare services could not be 
explained.  Providing free PMCTCT services to women unable to pay is in line with 
Ethiopia’s national policy to enhance free services for key maternal and child health 
issues (FMOH 2010b:4).  
 
Most respondents (87.3%; f=335) regarded the care received to be worth the money 
they paid and also that the treatment was acceptable (96.9%; f=372). Few respondents 
indicated that healthcare workers discriminated against patients on the basis of race 
(4.2%; f=16), age (3.1%; f=12), or status (6.8%; f=26). 
 
The very dissatisfied patients had higher CD4 counts than others (P=0.036).  As the 
respondents’ clinical conditions deteriorated, the number of satisfied patients decreased 
per WHO stage (P=0.06 and V=0.133). 
 
5.3.3.1.4 Respondents’ perceptions about nurses/midwives 
 
Most respondents (91.1%; f=350) agreed that they felt comfortable talking to nurses, 
asking nurses questions (96.9%; f=372) and that nurses treated patients respectfully 
(85.4%; f=328). However, only 68.8% (f=264) of the patients reported that 
nurses/midwives explained the patients’ problems, indicating that 31.2% (f=120) of the 
respondents reportedly did not get such explanations from nurses/midwives. As many 
as 51.6% (f=198) of patients agreed that there were too few nurses/midwives in the 
health facilities. In addition, 39.6% (f=152) of the respondents indicated that 
nurses/midwives sometimes ignored some of the patients’ questions.   
 
There was no significant correlation between respondents’ perceptions of 
nurses/midwives and their most recent CD4 cell counts.  The number of satisfied 
respondents decreased as their clinical conditions deteriorated. 
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5.3.3.2   Respondents’ health outcomes 
 
As discussed in section 4.5.2 of this thesis, the respondents’ health outcomes were 
measured using CD4 counts, WHO disease staging and other illnesses diagnosed while 
using MTCT services. In this study these parameters were obtained from the patients’ 
charts. The number of respondents, for whom both parameters had been documented, 
decreased overtime.  
 
• CD4 counts 
 
The mean (average) CD4 count increased from the first measurement (302.1cells/mm3) 
up to the sixth measurement (414cells/mm3), showing an average increase of 
111.9cells/mm3 which was statistically significant (per repeated measure ANOVA of 
P=0.008). However, this finding might have been confounded by the fact that only 5.7% 
(f=22) of the respondents’ CD4 counts were recorded for six times.  This implies that 
94.3% (f=362) of the respondents’ CD4 counts were missing at their sixth visit to the 
PMTCT facility. 
 
• WHO disease stage 
 
Despite the increased mean CD4 count, indicating immunological recovery, this did not 
result in improved clinical health outcomes of the respondents.  This was the case 
because the percentage of women in WHO clinical stages III and IV did not decrease 
from the first to the sixth visits. This was probably the case because the CD4 counts did 
not increase sufficiently (to at least 500cells/mm3) which would be the minimum required 
CD4 levels to restore the clinical health status of the respondents. 
 
However, the small number of records of both CD4 counts and WHO stages of the 
respondents might have impacted on these findings. At the sixth visit, only 31.3% 
(f=120) of the respondents’ WHO stages were recorded. 
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• ARV prophylaxis versus ART in relation to maternal health 
 
Out of 384 respondents, only 14.3% (f=55) received ARVs and 85.7% (f=329) received 
ART.  The mean CD4 count increased by 62 cells/mm3 (from 267 to 329) among 
respondents on ART compared but only by nine cells/mm3 (from 471 to 480) among 
those on ARV prophylaxis. Thus the average increment was almost seven times higher 
among those who took ART as compared to those who took ARV prophylaxis.  
 
There was a statistically significant positive correlation (r=0.613, P<0.01) between the 
respondents’ CD4 counts at commencement of treatment versus their most recent CD4 
counts. Women who started ARVs with higher CD4 counts had higher most recent CD4 
counts, irrespective of whether they were on ARV prophylaxis or on ART. 
 
• Other illnesses diagnosed during the PMTCT programme 
 
At enrollment into the PMTCT programme, oral candidiasis was the most prevalent 
illness reported by 89 respondents followed by 39 with pulmonary tuberculosis. The 
number of women diagnosed with oral candidiasis, at enrollment, decreased by 76 
during follow up visits. All tuberculosis cases were cured and no new tuberculosis case 
occurred although 22 cases of upper respiratory tract infections were recorded during 
follow-up visits.  The most prevalent complaint during follow-up visits was urinary tract 
infection (f=25). 
 
Overall, maternal health status seemed to improve in terms of other illnesses by using 
PMTCT services, probably attributable to the respondents’ increased CD4 counts.  
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• HIV status of respondents’ infants 
 
As presented in section 4.5.3, the crude MTCT rate was 6.0% (f=23). The WHO 
(2010a:12) maintains that PMTCT interventions could reduce MTCT to less than 5% in 
breast feeding populations and to less than 2% in non-breast feeding populations. In the 
current study 87.0% (f=334) of the respondents exclusively breast fed their babies while 
2.9% (f=11) used mixed feeding (and only 10.2% or 39 mothers used replacement 
infant feeding). This implied that overall 89.9% (f=345) of the respondents were breast 
feeding and that the crude MTCT rate was 6.0%. It was impossible to calculate the 
MTCT rate before and after six weeks of age.  This was the case because 132 infants 
were not DNA-PCR tested before the age of six weeks and 236 infants were not tested 
in this way after six weeks of age.   
 
5.3.3.3 Factors affecting mother to child transmission of HIV in Addis Ababa  
 
Nine variables had been analysed to assess factors affecting the rate of MTCT as 
discussed in section 4.5.4. 
 
• Infants’ HIV status versus presence of mothers’ nipple fissures 
 
The rate of MTCT among respondents who had nipple fissures was 38.5% (f=11) which 
was higher than 3.6% (f=13) among those without nipple fissures. The strength of 
association was also very high (RR=10.59). Nipple fissures increased the risk for MTCT, 
implying that an infant whose mother had nipple fissures had a 10.59 greater risk of 
becoming HIV-positive than an infant whose mother had no nipple fissures. 
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• Infants’ HIV status versus gender 
 
There were 185 male infants of whom 14 (7.6%) were HIV-positive.  Out of the 199 
female infants, nine (4.5%) were HIV-positive, indicating a higher MTCT rate among the 
male infants than among female infants.  However, this difference was not statistically 
significant (P=0.209), implying that gender did not affect the infants’ risk of MTCT.  
 
• Infants’ HIV status versus birth weight 
 
Table 4.31 indicates that most infants (fell within the normal birth weight range of 2.5kg 
to 4.5kg (91.7%; f=352). The MTCT rate was highest among those infants who were 
overweight during birth (41.7%; f=5) and followed by low birth weight of less than 2.5kg 
(15%; f=85). Birth weight, above and below the normal range (2.5kg-4.5kg) increased 
the risk of MTCT.  
 
• Infants’ HIV status versus ARVs taken by the mother 
 
The 2011 national PMTCT guideline of Ethiopia recommends ARV prophylaxis for the 
HIV infected pregnant woman as early as 14 weeks of gestation if she  is not eligible for 
ART (FMOH 2011:28-29). In this study most respondents were eligible for and received 
ART (85.7%; f=329). Those respondents who received ART had a lower MTCT rate 
(4.5%; f=15) than the MTCT rate of 14.5% (f=8) of those who received ARV prophylaxis 
(RR=3.19; 95%CI=1.42, 7.17).  Thus the infants of respondents on ARV prophylaxis 
had a 3.19 greater risk of being HIV-positive than the infants of respondents using ART. 
 
• HIV status versus ARV prophylaxis administered to the infant 
 
Most of the respondents’ infants (98.7%; f=379) received ARV prophylaxis, implying that 
only 1.3% (f=5) did not receive ARVs. Out of the 379 infants who received ARV 
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prophylaxis, most (99.2% (f=376) received NVP. The MTCT rate was significantly higher 
among those who did not receive ARV prophylaxis (40.0%; f=2) as compared to those 
who had done so (5.5%; f=21). Providing infants with ARV prophylaxis reduced the risk 
of MTCT (RR=7.22; 95%=2.28, 22.83). 
 
• Infants’ HIV status versus delivery method  
 
Most babies were delivered normally (70.8%; f=272). Only four (1.0%) respondents had 
assisted vaginal deliveries and one of these babies was HIV-positive. The MTCT rate 
among the 272 normally delivered babies was 7.0% and among those 102 babies 
delivered by caesarean sections it was 2.0% (f=2). Nevertheless there was no 
significant risk difference among those born vaginally and by ceasarean section 
(RR=3.56; 95%CI=0.84, 15.02).   
 
• Infants’ HIV status versus gestational age at delivery 
 
Most babies (85.4%; f=328) were delivered at full term, but 12.5% (f=48) were delivered 
pre-term at less than 37 weeks’ gestation and 2.1% (f=8) were delivered post-term. The 
MTCT rate was 22.9% (f=11) among pre-term delivered infants while it was 3.7% (f=12) 
among full term and 0% among post term babies.  Babies delivered pre-term had a 
10.74 times greater risk of MTCT than babies delivered at full term (RR=10.74; 
95%CI=5.22, 22.09).   
 
• Infants’ HIV status versus maternal age 
 
The highest MTCT rate of 21.4% was recorded among the respondents aged 36-40 
(f=14) followed by the group aged 26-30 (f=180) with a MTCT rate of 6.1% while the 
MTCT rate was 0% among respondents aged 20 or younger. No statistical significant 
association was shown between maternal age group and HIV status of the infant by 
Fisher’s exact test (P=0.149).  This finding might have been affected by the small 
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number of respondents aged 36 or older and 20 or younger.  Nevertheless increased 
maternal aged seemed to be correlated with an increased MTCT risk.   
 
• Infants’ HIV status versus their APGAR scores 
 
Most neonates (98.4%; f=378) had normal APGAR scores of ≥7 (n=378). As shown in 
table 4.37, the MTCT rate was higher (66.7%; f=4) among those infants with APGAR 
scores below seven than among infants with APGAR scores of seven or higher (6.0%; 
f=23). This finding might have been influenced by the small number of infants (f=6) who 
had APGAR scores below 7.   However, these infants with such lower APGAR scores 
had a relative risk of 13.26 of MTCT compared to those infants who had APGAR scores 
of 7 or more. 
 
5.4     CONCLUSIONS 
 
The conclusions are based on the findings of the current study as presented in chapter 
4 and summarised in sections 5.2 and 5.3 of this chapter.  The statistical findings 
agreed for descriptive statistics using percentages and frequencies, chi square 
calculations, relative risk determinations.  Calculated logistic regressions, including 
bivariate and multivariate analyses (see section 4.5.4.10) supported the descriptive 
statistics and were thus not emphasised in this final chapter. 
 
5.4.1   Conclusions: factors affecting the utilisation of PMTCT services in Addis 
Ababa 
 
These factors affecting the respondents’ utilisation of PMTCT services in Addis Ababa 
were grouped according to the major tenets of the HBM, namely perceived 
susceptibility, perceived severity and perceived barriers. 
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5.4.1.1 Perceived susceptibility 
 
Respondents, who had more realistic perceptions of the risk of MTCT and were more 
likely to know their HIV-positive status before attending the ANC clinics, were those 
who: 
• had higher levels of education 
• had male partners 
• were self-employed. 
 
5.4.1.2  Perceived severity 
 
Most respondents’ male partners who knew their own HIV status (more than 90.0% 
whether positive or negative), were aware of the fact that the respondents utilised 
PMTCT services but only the minority (18.6%) of male partners with unknown HIV 
status had such knowledge. 
 
5.4.1.3  Perceived barriers 
 
Barriers that made the utilisation of PMTCT services difficult, included: 
• being unmarried 
• stigma (but internalised stigma to a greater extent than perceived stigma and 
discrimination) 
• economic constraints. 
 
5.4.2  Evaluation of PMTCT services in Addis Ababa 
 
• HIV testing and counseling  
 
The health care workers reportedly followed Ethiopia’s guidelines when providing HIV 
testing and counselling services to the respondents.  Privacy and confidentiality were 
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maintained, the respondents could ask questions and knew that they could refuse to be 
tested. 
 
• ARV prophylaxis versus ART 
 
Ethiopia’s guidelines were not strictly followed by health care workers when prescribing 
ARV prophylaxis or ART to pregnant women.  As the CD4 counts of 25.5% of the 
respondents on ARV prophylaxis were below 350cells/mm3, they should have been on 
ART. Of the respondents on ART, 20.4% should have received ARV prophylaxis. 
 
• WHO  stage of illness 
 
The health care workers did not follow the WHO (2013:94) guideline in prescribing ART 
as four respondents in WHO stage III did not receive ART. 
 
5.4.3   Infant feeding 
 
The WHO (2010b:6) guidelines were applied because 87% of respondents used 
exclusive breastfeeding for the first six months of their infants’ lives. 
 
5.4.4  Respondents’ satisfaction with PMTCT services 
 
The respondents were satisfied with the cleanliness, attractiveness, comfort and safety 
of the health facilities but mentioned that the clinics were not wheelchair friendly. 
 
Although most respondents required more than 30 minutes to reach a PMTCT clinic, 
they regarded the clinic hours to be convenient. 
 
Clinics could not always supply medications (ARVs) to the respondents (mentioned by 
34.4%). 
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Most respondents could afford to pay for their PMTCT services, but knew that they 
could access these services free of charge if they should be unable to pay.  This is 
according to Ethiopia’s guidelines (FMOH 2010b:4). 
 
The respondents had favourable perceptions about the nurses/midwives although they 
considered the number of nurses/midwives to be too small.  Some respondents (39.6%) 
indicated that nuses/midwives sometimes ignored patients’ questions. 
 
There were no consistent correlations between respondents’ levels of satisfaction with 
the PMTCT services and their CD4 counts, but generally their satisfaction levels 
declined as their WHO stage of the disease deteriorated. 
 
5.4.5  Respondents’ health outcomes 
 
The respondents’ average CD4 count increased statistically significantly (from a 
baseline of 302.1cells/mm3 to 414cells/mm3 at the most recent results, showing an 
average increase of 111.9cells/mm3). 
 
Improved clinical health outcomes (improved WHO stage of illness) did not occur, 
despite the improved CD4 counts.  (This might be due to the fact that the CD4 cell 
counts did not increase to at least 500cells/mm3).  
 
The respondents mean CD4 cell counts increased by 62 if they were on ART compared 
to an average increase of 9 if they were on ARV prophylaxis. 
 
Irrespective of whether the respondents were on ARV prophylaxis or on ART, women 
who started treatment with higher CD4 counts had higher most recent CD4 counts than 
others. 
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The most common other illnesses among the respondents were oral candidiasis and 
pulmonary tuberculosis which were treated effectively. 
The crude MTCT rate was 6.0%. 
 
5.4.6  Factors affecting the MTCT rate 
 
These factors were discussed in section 4.5.4 and summarised in section 5.3.3.4 of this 
thesis.  The following conclusion are based on these previously discussed and 
summarised findings, indicating that the MTCT rate was: 
• higher among infants whose mothers had nipple fissures (RR10.59) 
• not significantly affected by the infants’ gender because there was no significant 
difference in the MTCT rate between males and females 
• higher amongst infants with birth weights above and below the normal range of 
2.5-4.5kg 
• higher among infants whose mothers were on ARV prophylaxis compared to  
infants whose mothers were on ART 
• significantly higher among infants who did not receive ARV prophylaxis than 
among those who received such medication (RR7.22) 
• not significantly different for infants born by caesarian section compared to those 
who had normal vaginal deliveries 
• significantly higher for babies born preterm than for babies born full term or post 
term (RR10.74) 
• not statistically correlated with the mothers’ ages 
• significantly higher among infants with APGAR scores below 7 (RR13.26) 
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5.5     RECOMMENDATIONS  
 
In this section recommendations will be provided based on the research findings and 
conclusions. One of the research objectives was to make recommendations to enhance 
women’s utilisation of PMTCT services in Addis Ababa. Hence, this objective will be 
addressed in this section. 
 
5.5.1 Recommendations to address women’s perceived susceptibility, perceived 
severity and perceived barriers to utilise PMTCT services 
 
5.5.1.1 Perceived susceptibility 
 
Better education for women should be promoted. Women with higher levels of 
education earned higher incomes, were self-employed and could make independent 
decisions (about HIV testing and about the utilisation of PMTCT services).  HIV testing 
and counselling directed at couples should continue as most respondents had male 
partners.  However, these services should also target women without male partners. 
 
5.5.1.2 Perceived severity 
 
The male partners of all women attending HIV and/or ANC clinics should know their (the 
men’s) HIV status.  This will enable HIV prevention and PMTCT actions to be taken to 
reduce the severity (reduced risk of MTCT) to the infant and to reduce the risk of 
infection or re-infection of both partners, reducing the severity of HIV for the partners. 
 
5.5.1.3 Perceived barriers 
 
HIV testing and counselling and the availability of PMTCT services must be promoted 
among all women irrespective of their marital status. 
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Health education efforts must address issues of stigma and discrimination, but 
especially self-stigmatisation among HIV-positive women, to enable more women to use 
PMTCT services. 
 
Women must be informed about the availability of free PMTCT services if they cannot 
afford to pay for these services. 
 
5.5.2   Recommendations to improve the PMTCT services in Addis Ababa 
 
Health care workers must continue to adhere to the national guidelines during HIV 
testing and counselling, and for maintaining privacy and confidentiality during these 
procedures.   
 
The health care workers must adhere to the national guidelines (concerning CD4 counts 
and the WHO stage of illness) when prescribing ARV prophylaxis versus ART during 
PMTCT.  Prescribing ARV prophylaxis, when ART should have been prescribed, will not 
provide the maximum benefits to the pregnant woman nor to her infant, and could 
endanger both their lives. 
 
Health education should continue to emphasise the importance of exclusive 
breastfeeding while also informing the pregnant women about replacement feeding 
options. 
 
The cleanliness, attractiveness, comfort and safety of the PMTCT clinics should be 
maintained. 
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All clinics should ensure that they have sufficient supplies of ARVs.  Clinics’ reported 
inability to supply ARVs to pregnant women and their infants could jeopardise the 
success of the entire PMTCT programme in Ethiopia. 
 
Nurses/midwives should not ignore patients’ questions. 
 
Patients’ CD4 counts and WHO stage of illness must be recorded as specified in the 
national guideline.  Regular audits of patients’ PMTCT records should be done so that 
shortcomings can be identified and addressed. 
 
In order to reduce the MTCT rate, health care providers must:  
• prevent nipple fissures, treat any nipple fissure effectively and educate mothers 
about the increased risk of MTCT in the presence of nipple fissures 
• provide adequate ANC care to reduce the number of infants born with birth 
weights below 2.5kg as these infants had a higher rate of MTCT than others  
• ensure that all pregnant women who qualify to get ART do get the correct 
treatment as infants whose mothers were on ART had a lower MTCT rate than 
those whose mothers were on ARV prophylaxis 
• administer ARV prophylaxis to every infant whose mother is HIV-positive as this 
reduces the MTCT rate markedly 
• monitor women in labour effectively to enhance every baby’s chances of having 
an APGAR score of at least seven as these babies had a lower MTCT rate than 
those with APGAR scores below seven. 
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5.5.3  Recommendations to increase the utilisation of PMTCT services in Addis 
Ababa   
 
HIV counseling and testing services should target people of all ages and both genders, 
irrespective of marital status.  During VCT counseling, the benefits of using PMTCT 
services should be mentioned to all persons so that the people of Addis Ababa could 
become more knowledgeable about PMTCT services. Couples’ testing and sharing of 
information about one’s HIV status should also be encouraged because this will 
facilitate the utilisation of PMTCT services, if they have the support of significant others, 
when required. 
 
Girls’ education levels must be improved because better educated women can earn 
better salaries and make independent decisions to use PMTCT services, unlike women 
with limited or no education. 
 
Women who benefitted from PMTCT services could be recruited to work as volunteers 
to inform other women about the benefits of PMTCT services. 
 
The clinics providing PMTCT services should continue to be clean, safe and 
comfortable.  Patients’ waiting times at these clinics should be monitored and managed 
so that patients do not get discouraged by having to wait many hours at the clinics.   
 
Clinics should never encounter shortages of ARVs as women could get discouraged if 
they have to visit a clinic more than once for one prescription.  The effectiveness of 
ART, and indeed of the entire PMTCT programme could be annihilated, if ARVs cannot 
be supplied to a woman at every clinic visit. 
 
Stigma and discrimination must be addressed during health education sessions.  
However, the negative effects of self-stigmatisation must be also be addressed during 
all HIV-related health education sessions, and in all such printed materials.  Women 
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experiencing self-stigmatisation while using PMCTC services must be identified and 
counseled or referred to appropriate health care workers.  All types of stigmatisation 
and discrimination might impact negatively on women’s likelihood of utilising PMTCT 
services. 
 
5.5.4   Recommendations to enhance the PMTCT services rendered by 
nurses/midwives 
 
Most respondents were pleased with the nurses/midwives’ services and attitudes.  
However, all patients’ questions should be answered. 
 
Management should ensure that there are sufficient numbers of nurses/midwives on 
duty to attend to all patients within reasonable periods of time. 
 
Regular audits of patients’ records should be done and cases where the CD4 counts 
and/or WHO stages were not recorded should be addressed. 
 
All instances of the unavailability of ARVs should be recorded and investigated to 
prevent similar future shortages. 
 
Nurses/midwives should receive regular in-service education on PMTCT service 
provision, research being conducted in this field, and the health outcomes of women 
and infants who were treated by specific facilities. 
 
The basic curriculum of nurses/midwives should be revised regularly to ensure that the 
nurses/midwives are conversant with the latest country-specific guidelines. 
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5.5.5   Recommendations for future research 
 
Future studies should compare the situation in the capital city of Ethiopia, Addis Ababa, 
with that occurring in other cities, towns and rural areas where women might perceive 
susceptibility, severity and barriers in different ways, requiring different interventions to 
enhance the utilisation of PMTCT services. 
 
Structured interviews were conducted with women and data were collected from the 
women’s and from their babies’ records. Future studies could use focus-group 
interviews and/or individual in-depth interviews to yield more in-depth information about 
the women’s lived experiences of using PMTCT services.   
 
Future observations of the PMTCT services rendered to women, could yield information 
about the real life occurrences of patients and health care providers in these clinics. 
 
HIV-positive women who did not use PMTCT services should be targeted by future 
studies to identify reasons why these women failed to utilise the available PMTCT 
services in Ethiopia.  Similarly, women who discontinued using PMTCT services should 
be targeted for future studies to identify reasons why they did so.  The CD4 counts and 
WHO stage (and VL if possible) of these women should be compared to those of 
women who continued using PMTCT services for the duration of the programme.  The 
HIV-status of the infants of these three groups of women should also be compared to 
reveal the potential benefits of the PMTCT programme for mothers and infants. 
 
Effective contraception utilisation among HIV-positive women should be investigated by 
future studies, including the women’s potential willingness to agree to surgical 
sterilisation. If HIV-positive women use effective temporary or permanent contraception, 
their number of future pregnancies could be reduced with potential benefits for these 
women themselves and for their children.  Reduced numbers of pregnancies among 
HIV-positive women could contribute to huge savings of health care costs. 
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Condom use among HIV-positive women prior to and during their pregnancies as well 
as during the period of breastfeeding should be examined by future studies.  Condoms 
should be used during and after pregnancies, not only by serum-discordant couples but 
also in cases where both partners are HIV-positive to prevent possible re-infection and 
increased VL with increased risk of MTCT for the infant.  Unless HIV-positive mothers 
use condoms effectively throughout their pregnancies and periods of breastfeeding, all 
efforts of the PMTCT programme might be useless. 
 
Future studies must endeavor to determine the HIV status of HIV-positive mothers’ 
infants when breastfeeding stopped altogether (probably at the age of 12-24 months) 
and compare these findings for infants whose mothers used PMTCT services with those 
whose mothers did not do so.  Such findings would be able to demonstrate the realistic 
potential long term benefits of the costs of PMTCT services in Ethiopia in relation to the 
infants’ HIV status. 
 
Future research should determine how the pregnant women became HIV-positive, and 
how they realised that they were indeed HIV-positive.  This knowledge should be 
incorporated into HIV prevention programmes. 
 
The possibility that replacement (formula) fed babies’ risk of MTCT could be limited 
should be investigated in areas where water supplies are safe and accessible.  These 
findings should be compared to the MTCT risk of breastfed babies in similar areas. 
 
Researchers should identify reasons why the respondents’ CD4 counts and WHO 
stages were reported irregularly and suggest ways of improving these records.  
Simultaneously the absence of VL counts should also be addressed.  Such knowledge 
could help to enhance the quality of PMTCT services rendered to women and their 
infants, while also improving the quality of future research results. 
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Further research should be conducted among women whose CD4 counts did not 
improve and/or those with deteriorated WHO stages while using PMTCT services.  
These cases actually indicate PMTCT failure and the reasons for such failure should be 
identified and addressed to render PMTCT services more effectively in future.  Such 
failure could possibly be attributed to service factors (inaccessibility, unaffordability, 
unavailability of ARVs, poor records, prescribing ARV prophylaxis instead of ART) or to 
patient factors (low CD4 count, non-adherence to ARVs, other infections including TB, 
high VL, failure to use condoms, severe anaemia, severe malnutrition, breastfeeding 
during pregnancy). 
 
 
5.6    LIMITATIONS OF THE STUDY 
 
The study was conducted in Ethiopia’s capital city, Addis Ababa.  Thus the findings 
cannot be generalised to other geographic areas of Ethiopia, without conducting similar 
studies in randomly selected other regions of this country. 
 
Only women who used PMTCT services participated in this study, making it impossible 
to compare the findings from this group of women with women who did not use PMTCT 
services and/or with women who discontinued using these services. 
 
This study did not address contraceptive issues.   
 
This study did not enquire how the respondents became HIV-positive as no questions 
that might have been interpreted as indicating any blame to the respondents could be 
asked during the structured interviews.  
 
No questions were asked about condom used before, during and after their pregnancies 
to avoid embarrassment to the respondents.  
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The HIV status of the babies remained unknown when breastfeeding stopped 
altogether. 
 
No comparisons could be made between breastfed babies and babies who were on 
replacement feeding, because the latter number of infants was too small. 
 
Some records were incomplete.  For example, the respondents’ CD4 counts and WHO 
stages were not recorded regularly and decreased over time. This might have impacted 
on the quality of the statistics.  No VL records were available. 
 
Reasons were not identified to explain some respondents’ decreased CD4 counts 
and/or deteriorated WHO stage of illness. 
 
5.6    CONTRIBUTIONS OF THE STUDY  
 
The study used the HBM and Donabedian’s model. The different tenets of these models 
were applied in this study. The reasons behind PMTCT service use were explained by 
the HBM while patient satisfaction, factors affecting MTCT rate and health status of 
mother were explained by Donabedian’s model.  
 
From a clinical and public health perspective, the study’s findings could help to improve 
PMTCT services, maternal health outcomes and reduction of the MTCT rate among 
infants.  
 
The findings can also help the country to improve its PMTCT prorgramme, develop 
appropriatae guidelines, design policies and conduct further research based on these 
findings and recommendations. Therefore PMTCT programme managers, health care 
providers, health science students, researchers and HIV/AIDS patients could possibly 
benefit by taking note of this study’s findings.  
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This study’s findings indicate that the rate of MTCT can be reduced if nipple fissures are 
avoided, infants are born at full term, infants are not under- or over weight at birth, and 
have normal APGAR scores.  Based on the identified limitations of this study, possible 
directions for future studies were recommended that could help to expand the 
knowledge about PMTCT services in Addis Ababa.  Two important aspects relate to the 
unavailability of information about the HIV status of infants after the cessation of 
breastfeeding, whose mothers used PMTCT services compared to those whose 
mothers discontinued using these services and those whose mothers did not use 
PMTCT services at all.   Information is also lacking about the HIV status of infants after 
the cessation of breast feeding compared to the HIV status of infants who received 
mixed and supplemental feeding at the same age.  These findings should be cross 
tabulated according to the three infant groups’ feeding methods with their mothers’ 
utilisation, non-utilisation or cessation of PMTCT services.   
 
5.7    CONCLUDING REMARKS 
 
The study set out to identify factors influencing women’s decisions to use PMTCT 
services.  The findings indicated that better educated, self-employed women who had 
male partners were more likely to know their HIV-positive status and to utilise these 
services than other women.  Most male partners who knew their own HIV status 
(whether positive or negative) knew that the women used PMTCT services but only the 
minority of males whose HIV status was unknown had this knowledge.  Barriers that 
influenced women’s decisions negatively to utilise PMTCT services included being 
unmarried and experiencing stigma and financial constraints. 
 
Most respondents were satisfied with the PMTCT services, but recommended that more 
nurses/midwives should be employed and that all the patients’ questions should be 
answered.  Reportedly health care providers followed the national guidelines during HIV 
counseling and testing but not always in prescribing ARV prophylaxis versus ART, with 
potential adverse consequences for the health of the women and their infants.  Clinics 
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could not always provide ARVs, with potential negative consequences for the entire 
PMTCT programme’s outcomes. 
 
Although the respondents’ average CD4 counts improved while using PMTCT services, 
their WHO stages of illness did not improve. Both these parameters were progressively 
poorer recorded in the respondents’ files as time went on. 
 
The MTCT rate could be significantly reduced if mothers’ nipple fissures could be 
prevented, babies could be borne at full term with average weight and APGAR scores of 
7 or more and if all infants could get ARV prophylaxis. 
 
During the course of this study it became evident that the ultimate measure of success 
of PMTCT services is the HIV-negative status of an infant who has an HIV-positive 
mother.  Infants’ HIV status in Ethiopia is usually determined before or at six weeks and 
sometimes at six months.  Many babies are breastfed for longer than six months, up to 
24 months, in Ethiopia.  It is vital to determine the HIV status of infants at the final 
cessation of breastfeeding and to compare these findings for babies whose mothers are 
HIV-positive and used PMTCT services, discontinued these services and never used 
these services at all.  These findings should be compared to those of infants who were 
never breastfed but who had HIV-positive mothers, by performing multivariate analyses.   
 
The wisdom of providing PMTCT services to pregnant women and infants for many 
months, without knowing the HIV status of these infants after breastfeeding had been 
stopped finally, became questionable.  As HIV-negative women could become HIV-
positive during pregnancy and while breastfeeding, replacement feeding for infants 
might have benefits for all infants exceeding the potential benefits of PMTCT services.  
However, this would require adequate access to safe water supplies and to formula 
(milk powder).  Providing safe water supplies would benefit entire communities, not only 
pregnant women and their infants.  The future directions of PMTCT services should be 
re-considered, based on the HIV-status of infants after the cessation of breastfeeding. 
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===================================================================================== 
Annexure 1: Data collection tool English version 
Instrument 1. Structured interview schedule: mothers 
Section A: Patient characteristics 
1. Interview number  
2. Medical Record Number (MRN)  
3. ART or Pre-ART number  
4. Health facility number  
5. Age of the mother   
6. Age of the baby (in months) at the time of 
interview 
 
7. Name of the data collector  
8. Name of the health facility  
9. Where do you live? Region Sub city Woreda/Kebele 
   
Section B: Infant feeding counseling and practice 
1. How often was the mother 
counseled about infant feeding 
options before and after baby’s 
birth? 
 
2. About which baby feeding 
options was the mother 
counseled? 
 
3. Which  baby feeding option 
actually used? 
 
4. If the mother chose formula 
feeding, what kind of instruction 
did she receive?  
I. Demonstration 
how to use a cup 
and spoon 
II. Written 
instruction    
III. 
Both 
IV. No 
instruction 
 5. If the mother has chosen to 
stop breastfeeding, what type of  
feeding is she  giving her baby? 
 
6. Who undertakes follow- up 
discussions and/or checks with 
the mother about the baby’s 
feeding? 
 
 
 
 
I. Health 
care 
provider, 
please 
specify 
II. 
Community 
volunteer, 
please 
specify 
III. Family 
member, 
please 
specify 
IV. No 
body 
7. For how long has the mother 
been feeding the baby in her 
chosen manner? 
 
8. What complementary foods are 
given to the child? 
 
9. At what age was 
complementary food introduced to 
the baby? 
 
 
Section C: Patient satisfaction 
Scoring, based on likert scale 1=strongly agree 2=agree 3=uncertain 4=disagree 
5=strongly disagree 
I. Expectations about the infrastructure 
 1 2 3 4 5 Remark 
1. The health facility is  clean and attractive       
2. The waiting room is comfortable        
3. There are enough seats in the waiting room.       
4. The toilets are clean and in good, working order       
5. The health facility is a safe place for patients       
6. The health facility is a wheelchair friendly 
environment 
      
7. There are visible directions for patients to know 
where to go. 
      
8. There is a notice with the name and contact details 
of the person in charge for the day, should any 
problems arise or patients wish to contact the person 
in charge of the facility 
      
9. All things considered, I am satisfied with the 
infrastructure of the health facility. 
      
II. Accessibility and availability of the PMTCT services 
 1 2 3 4 5 Remark 
1. It takes me more than 30 minutes to get to the 
health facility. 
      
2. The health facility renders services during 
convenient hours 
      
3. How many minutes do you have to wait  before you 
are being attended to at this facility 
 
4. What do you think could be done to reduce these 
waiting times at this clinic? 
 
 
5. Sometimes I cannot get the prescribed medicines 
because of shortages (‘stock-outs’) 
      
6. I can reach  a referral hospital when necessary       
7. After being seen at the clinic how many minutes do 
you have to wait at the pharmacy to receive your 
medicines? 
 
8. Why do you think patients have to wait so long at 
the pharmacy to receive their medicines? 
 
 
9. There is a visible suggestion box in the health 
facility to voice my opinions and concerns 
anonymously 
      
10.  All things considered, I am satisfied with the 
accessibility and availability of the PMTCT services 
      
III. Affordability of PMTCT service 
 1 2 3 4 5 Remark 
1. How much money do you have to pay for transport 
to reach the clinic (one way)? 
 
2. How much do you pay for the services of ANC at 
each visit? 
 
3. How much do you pay for the clinic’s PMTCT 
service for yourself and your baby at each visit? 
 
4. How much do you spend on your family’s food 
(groceries) per week? 
 
5. I do receive health care at this clinic even if I 
cannot pay the money asked 
      
6. The care I received is worth the money I paid       
7. Treatment given is of acceptable quality       
8. The healthcare workers discriminate among 
patients according to race 
      
9. The healthcare workers  discriminate among       
patients according to age 
10. The healthcare workers  discriminate among 
patients according to status 
      
11.  I can afford to pay the fees for the PMTCT 
services 
      
IV. Perception of the patients about the nurses/midwives 
 1 2 3 4 5 Remark 
1. There are too few nurses/midwives at this clinic       
2. I feel comfortable talking to the nurses/midwives       
3. The nurses/midwives  treat me with respect        
4. The nurse/midwives explain to me what is wrong 
with me  
      
5. What risks the nurses/midwives explain to you 
could be involved with PMTCT 
 
 
6. What benefits the nurses/midwives explain to you 
could be involved with PMTCT 
 
 
7.  I can ask question from the nurses/midwives  
without being afraid 
      
8. I am pleased with the way I am treated by the 
midwives at this health facility 
      
9. The nurses/midwives sometimes use words that I 
do not understand.  
      
10. The nurses/midwives ignored some of the 
questions I asked. 
      
11. All things considered, I am satisfied with the 
interaction between me and the nurses/midwives. 
      
 
Section D: HIV testing and counseling 
1. In which way 
was HIV  
information 
provided 
before you 
were tested ?     
I. Group session       II. Couples  
 
III. Individual 
 
2. I could  ask questions during the HIV pre-
test information session   
I. Yes     II. No 
3. I was informed by the nurse/midwives, 
during the pretest information session, that I 
have the right to say “No” to HIV testing    
I. Yes     II. No 
4. I received counseling after the HIV testing 
has been completed.    
I. Yes       II. No 
5. What is the reason made you to test for HIV? 
 
6. Was your privacy maintained during HIV 
testing and counseling? 
Yes No 
7. Was your confidentiality maintained during 
HIV testing and counseling? 
Yes No 
8. Have you disclosed your HIV status? If 
yes to whom? 
Yes 
If yes to whom 
 
No 
Section E. Factors affecting PMTCT service utilisation 
1. 
Marital 
status 
of the 
I. Never 
married 
  II. Live 
in union   
III. 
Married 
IV. Separated V. Divorced      VI. 
Widowed  
 
mother 
2. What is the 
highest level of 
education you 
have passed? 
I.  I have 
never 
attended 
school   
II. Grade 
1-6   
III. Grade 7-8     IV. Grade 
9-12      
V. 
University/
College 
 
3. What is your employment 
status? 
I.Full time 
employed 
II.Part-time 
employed 
III.Self 
employed  
 
IV. 
Unemployed.  
 
4. My monthly income is  ……. birr, per month 
 
5. I have to travel ………. Km from my home to this health facility 
 
6. What is religion of the mother   I. Christian        II. Muslim      III.Other, please 
specify 
 
 
7. Stigma and discrimination 
Perceived stigma 
7a. Some people are afraid to touch me once they know I 
have HIV  
Agree disagree 
7b. Some people have physically backed away from me 
once they learned I have HIV  
Agree Disagree 
7c. Some people act as if it is my fault I have HIV  Agree Disagree 
7d. People seem uncomfortable being around me once they 
learn I have HIV  
Agree Disagree 
Internalised stigma 
7e. I sometimes feel worthless because I am HIV positive  Agree Disagree 
7f. I feel guilty because I have HIV  Agree Disagree 
7g. In the past 12 months, have you ever found yourself 
avoiding or isolating yourself from friends or family because 
of your HIV status  
Yes No 
Enacted stigma (discrimination) 
 In the past 12 months, have you faced any of the following? 
7h. Excluded from social events Yes No 
7i. Abandoned by partner Yes No 
7j. Abandoned by other family members Yes No 
7k. Verbally abused or ridiculed Yes No 
7l. Physically assaulted Yes No 
7m. Fired from work Yes No 
7n. Expelled from your home Yes No 
7o. Had property take away Yes No 
7p. Denied health services Yes No 
8. What did you know  about PMTCT before you were diagnosed with HIV positive? 
 
9.  Who provided you 
with this knowledge 
about PMTCT?    
I. Health 
extension 
worker    
II. 
Community 
volunteer    
III. Health care 
provider   
IV. Mass 
media   
V. 
Other, 
specify
: 
 10. What is your partner’s HIV test 
result?     
I. HIV positive 2. HIV negative  3. Unknown by 
me          
               
11. Does your partner know that 
you use  PMTCT services? 
I. Yes II. No 
12: In what ways does your 
partner make it easier or more 
difficult for you to use the PMTCT 
services? 
 
 
 13. How many people know that 
you are HIV infected? 
 
14. Please list the people who 
know about your HIV status. 
(only list first three persons) 
 
15. In what ways do these persons 
(other than your partner) assist 
you to use PMTCT services? 
 
 
Instrument 2. Document review checklist: Mothers  
Section A: Health status of the mother 
1. CD4 count (give also date) 1st 
count 
2nd 
count 
3rd 
count 
4th 
count 
5th 
count 
6th 
count 
 2. CD4 count most recent (give 
also date) 
 
3. WHO clinical stage (give also 
date) 
1st 
visit 
2nd 
visit 
3rd 
visit 
4th 
visit 
5th 
visit 
6th 
visit 
 
4. WHO clinical stage most recent I. 1 II. 2 III. 3 IV. 4 
5. Other illnesses diagnosed at 
enrollment 
 
6. Other illnesses developed later 
on during follow up 
 
Section B: Factors affecting HIV status of the baby 
1. Weight of the mother  1st 
visit 
2nd 
visit 
3rd 
visit 
4th 
visit 
5th 
visit 
6th 
visit 
 
2. Weight of the mother most 
recently 
 
3. Height of the mother  
4. Number of pregnancies   
5. Number of live births  
6. Number of abortions  
7.  Number of still births  
8. Nipple fissure  I. Present II. Absent 
Section C: HIV testing and counseling of pregnant women 
1. What is HIV status at 
enrollment? 
I. Known II. Unknown 
2. If known what was the date of 
HIV test? 
 
3. If unknown what was 
gestational age at HIV positive 
test result? 
 
4. If unknown what was the date 
of HIV positive test result 
 
Section D: Antiretroviral for the mother 
1. What antiretrovirals the mother 
took for PMTCT? 
I.ARV 
prophylaxis 
II. ART 
2. Name of medication Morning 
dose  
Midday 
dose 
Evening 
dose 
  
Daily total  
 
(# of pills) (# of pills) (# of pills) (# of pills) 
a.      
b.      
c.      
3. At what gestational age 
antiretrovirals given? 
 
4. CD4 count when antiretrovirals 
was commenced 
 
5.WHO stage when antiretrovirals  
was commenced 
 
6. Where is the antiretrovirals 
given? 
I. ANC 
clinic 
II. Labour 
& 
Delivery 
unit 
III. ART clinic 
7. What ARV side effects 
observed? 
 
8. Is the mother receiving ARV as 
prescribed? 
I. Yes II. No 
Section E: Family Planning  
1. Did the mother used family 
planning services? 
I. Yes II. No 
2. If yes, when? I.Before become 
pregnant 
I. Currently 
3. What was the type of 
contraceptive used? 
 
4. Any side effects of the 
contraceptive? 
 
 
 
Instrument 3. Document review checklist: baby 
Section A: Back ground information 
1. Medical Record Number (MRN)  
2. ART/Pre-ART number  
3. Baby’s date of birth   
4. Gender of the baby I. Male II. Female 
Section B: Factors affecting HIV status of the baby 
1. Mode of delivery I. Vaginal II. Assisted 
vaginal 
III. Episiotomy IV. 
Ceasarean 
section 
2. Newborn APGAR score – give the 
actual score 
 
3. Age of the infant at subsequent visits 1st 
visit 
2nd 
visit 
3rd 
visit 
4th 
visit 
5th 
visit 
6th 
visit 
 
4. Newborn weight  
5. Weight of the baby during 
subsequent visits 
1st 
visit 
2nd 
visit 
3rd 
visit 
4th 
visit 
5th 
visit 
6th 
visit 
 
6. Gestational age during delivery  
7. Any disease of the baby  
Section C: Antiretroviral prophylaxis for the baby 
1. Did the baby receive ARV 
prophylaxis 
I. Yes II. No 
2. If yes, name of ARV drug and 
dosage (according to the age of the 
child) 
Birth to 6 
weeks 
6 weeks 
to 6 
months 
6 months 
to 9 
months 
>9 
months 
to end of 
BF 
a. Name of ARV drug=  
 
   
3. Age of the baby when ARV 
prophylaxis started? 
 
4. For how long was ARV prophylaxis 
given? 
 
Section D: Infant HIV status 
1. What  kind of HIV test was done for 
the baby? (if both tests done indicate as 
such) 
I. DNA-PCR 
 
II. Rapid test 
 
2. At what age did the baby receive the 
HIV test result? 
I. When DNA-PCR 
done 
 
II. When rapid test done 
 
3. What was the result of the test I. DNA-PCR test 
result 
II. Rapid test result 
a. HIV 
positive 
b. HIV 
negative 
a. HIV 
positive 
b. HIV 
negative 
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Annexure 3: Consent form English version 
Consent form (English version) 
You have been selected by chance to participate in a research titled Review of 
Prevention of Mother to Child Transmission of HIV in Addis Ababa, Ethiopia. I must read 
some information to you before we can begin with our interview. I will ask you to sign 
the form to indicate that I have explained the purpose of the study, and of the interview 
to you and that you have agreed to be interviewed out of your own free will. The signed 
form will be sealed in an envelope and placed in one container while the completed 
interview schedule will be placed into another container.  Your name and your baby’s 
name will not appear on the completed interview schedule. 
The form just repeats what I have told you about the study, but I have to read it to you. 
• I understand that I have been asked to participate in a research project exploring 
prevention of mother to child transmission of HIV services provided at hospitals and 
health centers in Addis Ababa, Ethiopia. 
• I understand that during this study I will be asked questions about my own and 
my baby’s health. My responses to these questions and my health information from the 
medical record, as well as my baby’s information from the baby chart, will be recorded 
on the schedule.  
• My participation in the study will be kept confidential, and our names will not be 
recorded on any form and our names will never be mentioned in relation to any 
information provided by me.  Any report, based on the information obtained by 
conducting interviews with patients, will only contain numbers and statistics, no names 
of any patients. 
• During the interview, I can refuse to answer any question that I do not want to 
answer and I may stop the interview at any time, without affecting my care or treatment, 
or my baby’s care or treatment, in any way whatsoever. 
• I realize that I will not benefit directly from this project, and will not be paid in 
money or in kind. However, with my participation, I hope to help investigators 
understand how to improve PMTCT services in Addis Ababa. 
 
Declaration: 
I have read this consent form (or have had it explained to me to my satisfaction). I 
understand what my participation will involve and agree to take part in this interview 
under the terms of this agreement. I have had the opportunity to ask questions about it, 
and my questions have been answered to my satisfaction. 
I voluntarily agree to participate in this study and I understand that I have the right to 
withdraw at anytime without affecting my and/or and my baby’s  care and treatment. On 
behalf of my baby, I also agree to answer questions concerning his/her health and that 
treatment information from the baby chart, and from my clinic chart, may be used to 
evaluate the services provided at this facility. 
Respondent 
Name------------------------------------------                
Date---------------------------------------                                                 
Signature or thumbprint if appropriate---------------------------------- 
Researcher 
Name--------------------------------------- 
Date----------------------------------------- 
Signature-------------------------- 
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Annexure 5: Information sheet English version 
Information sheet (English version) 
I am pleased to inform you that you are selected by chance to participate in our 
research that focuses on review of prevention of mother to child transmission of HIV in 
Addis Ababa, Ethiopia. You are selected to participate in this research by chance and it 
is totally voluntary to continue with this study. The interview takes you only 20 minutes 
to complete. There is no anticipated risk associated with this study. However, you can 
discontinue from participation at anytime you want. However, your participation helps us 
to understand PMTCT service, patient satisfaction, health status of the mother, factors 
affecting rate of transmission of HIV from mother to child, PMTCT service utilisation and 
HIV status outcome of babies. The research is planned with the following objectives to: 
 Describe HIV status of infants whose mothers used PMTCT services in Addis 
Ababa 
 Evaluate the health outcomes of mothers using PMTCT services in Addis Ababa 
 Assess patients’ satisfaction levels with PMTCT services in Addis Ababa 
 Evaluate PMTCT services in Addis Ababa 
 Identify factors affecting HIV status of infants and PMTCT service utilisation in 
Addis Ababa 
 Compare PMTCT services and its outcomes at hospitals and health centres in 
Addis Ababa 
 
No names will be written on the interview schedule and the report will be written 
anonymously. The information will be generated confidentially using numbers only. 
There is no direct financial incentive or other in kind benefit for participation into this 
research but your participation helps us to improve the service. If you have questions 
you can ask anytime using the following address. Tefera Girma; Tell: 0911382129; email: 
42014735@mylife.unisa.ac.za 
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Bureau Ethical Committee 
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